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Abstract 
 
Background: Giardiasis is an intestinal diarrhoeal illness caused by the 
flagellate protozoan parasite Giardia intestinalis (synonymous with Giardia 
lamblia and Giardia duodenalis). Traditionally, giardiasis has been 
diagnosed in patients using faecal concentration and microscopy techniques. 
Non-microscopy based tests available for the laboratory diagnoses of 
giardiasis include recent innovations in polymerase chain reaction (PCR) 
and immunoassays with increased sensitivity. The laboratory diagnosis of 
giardiasis is complicated by the intermittent excretion of the parasite and 
asymptomatic presentation that sometimes occurs with this infection. 
Clinicians may on occasion treat patients for giardiasis on clinical suspicion 
alone when diagnostic tests have failed to identify Giardia intestinalis and 
some of the patients do get better putting into question the performance of 
the diagnostic test used. At the Hospital for Tropical Diseases (HTD) in 
London the ova, cysts and parasite microscopy (OCP-M) is the front line test 
for diagnosing giardiasis. 
Aim: The aim of this study was to critically analyse the performance of a 
commercial and a published real-time PCR diagnostic tests for their 
potential use as front line tests for the diagnosis of giardiasis in the clinical 
parasitology diagnostic laboratory at the HTD. Storage conditions that will 
allow the best yield of Giardia intestinalis DNA from stored faecal samples 
were also investigated in this study. 
Methods: In the absence of a gold standard, a composite reference standard 
(CRS) of enzyme immunoassay (EIA) and rapid membrane test (RMT) was 
used to evaluate the performance of Primerdesign Ltd. real-time PCR kit for 
Giardia intestinalis (which detects only assemblages A and B subtypes) and 
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a real-time PCR assay using Verweij et al published primers (Verweij real-
time PCR) which targeted the (SSU) rRNA gene. The two tests were 
compared with the OCP-M test in a diagnostic accuracy study using a non-
probability sampling technique with consecutive samples. 
Results: The Verweij real-time PCR which targeted the (SSU) rRNA gene 
showed a diagnostic sensitivity of 93.4 % (95 % CI: 86.2 to 97.5 %) and a 
specificity of 74.7 % (95 % CI: 63.6 to 83.8 %) with a limit of detection 
(LOD) of < 5 cysts/ml. The Primerdesign Ltd. real-time PCR which also 
targeted the gdh gene showed a diagnostic sensitivity of 61.5 % (95 % CI: 
50.8 to 71.6 %) and specificity of 98.7 % (95 % CI: 93.2 to 99.8 %) with a 
limit of detection (LOD) of ≤ 114 cysts/ml. Also, with a serially diluted 1 in 
10 dilutions of a known concentration Giardia intestinalis DNA solution, 
the Verweij real-time PCR produced efficiency (E) of 96 % (the slope was -
3.414) with a correlation coefficient (R
2
) of 0.99 and a copy number 
variance predominantly less than 10 % (< 10 %). The Primerdesign Ltd. had 
E = 100 % (the slope was -3.342), R
2 
= 0.95, and a copy number variance 
predominantly greater than 10 % (> 10 %). 
In this study, the OCP-M missed 16.5 % Giardia positive stool 
samples contrasted with 6.6 % missed by the Verweij real-time PCR. The 
Verweij real-time PCR therefore showed approximately 10 % increase (i.e. 
16.5 % - 6.6 %) in detection rate over the OCP-M and with an estimated 
detection limit of < 5 cysts/ml of stool, it also correctly identified 70 % 
(14/20) of the discrepant cases as true positives. OCP-M identified 10 % 
(2/20). When sensitivities were adjusted for the Verweij real-time PCR as a 
result of enhancement in the detection rate of the CRS, 19.3 % (94.3 % - 75 
% = 19.3 %) more positive cases were noted. The Verweij real-time PCR 
proved to be more robust than the OCP-M and the Primerdesign Ltd. PCR 
and has therefore been shown to be more suited for deployment as a first 
line diagnostic test than the other two index tests. Even in combination with 
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the OCP-M, the sensitivity remained unchanged at 93.4 %. With its high 
specificity, the Primerdesign Ltd. Giardia PCR kit may be useful for 
partitioning clinical history for epidemiological studies but with LOD of  ≤ 
114 cysts/ml of stool and R
2
 < 0.99 when faecal samples are involved, it will 
require further optimisation for use on clinical samples. Up to the end of 
April 2013, a literature search showed no independent evaluation of this 
Giardia real-time PCR kit. 
Storage affects molecular analyses and from the findings of this study, 
stool samples are best stored in industrial methylated spirit and kept at 4-6 
o
C if they are to be used for real-time PCR for Giardia intestinalis detection. 
Alternatively they can be stored in the freezer at -20 
o
C without industrial 
methylated spirit. Samples should however be tested within three months of 
storage. 
Conclusion: The reason why some patients get better when they are treated 
empirically following microscopy negative results for Giardia intestinalis 
may be found in the fact that, in this study, the OCP-M failed to detect 16.5 
% of positive cases. The Verweij real-time PCR performed better than the 
OCP-M and showed an improvement of 10 % in Giardia intestinalis 
detection rate. The Primerdesign Ltd. Giardia PCR kit requires further 
optimisation for use on clinical samples. The Verweij real-time PCR was 
more robust than the OCP-M and the Primerdesign Ltd. PCR and therefore 
is more suited for use as a first line diagnostic test with best results obtained 
when stool samples are first treated with industrial methylated spirit, stored 
in the fridge at 4-6 
o
C and tested within three months of storage. 
 The Verweij real-time PCR assay may be used as a standalone test for 
in combination with the OCP-M, there was no improvement in the 93.4 % 
sensitivity when it was used alone. The OCP-M, however, has the advantage 
of identifying the presence of other parasites.  
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Chapter 1: Introduction 
1.1 Giardiasis 
Giardiasis is an intestinal diarrhoeal illness caused by the flagellated 
protozoan parasite Giardia intestinalis (synonymous with Giardia lamblia and 
Giardia duodenalis). This chapter discusses the global burden of giardiasis and 
the history of Giardia intestinalis. Following on from these, a discussion of the 
biology of the parasite and the immune response that the human body produces 
against it is given. The remainder of this chapter will be devoted to the clinical 
laboratory diagnosis of giardiasis besides making a case for a more robust test 
to diagnose Giardia intestinalis.  
Giardia infections have been known for many centuries and Giardia 
intestinalis has been a successful parasite because there are different genetic 
strains with different levels of severity and virulence factors making their 
elimination by the body’s defence mechanisms a rather arduous task. Symptoms 
of infection occur when the parasite triggers a reaction. This, however, does not 
always occur and asymptomatic cases have been reported in the literature (Al-
Mohammed, 2011; Almeida et al., 2006). Knowing that different strains exist 
will help in devising diagnostic tests and strategies to combat the infection. In 
addition to there being different genetic strains, there is also the problem of 
antigenic variation, whereby the parasite expresses different surface antigens so 
quickly that the human immune system has no time to produce antibodies 
against it and by that the parasite avoids detection. A variety of serological 
assays have been used to detect circulating antibodies in serum but because of 
the biological characteristics of the parasite and the lack of suitable antigens, the 
sensitivity of serological assays remains poor (Faubert, 2000).  
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The life cycle of Giardia, even though simple (i.e. faecal-oral), presents a 
diagnostic challenge in that the two stages of the parasite (trophozoite and cysts) 
are located in different regions in the body and a two pronged approach may be 
required to detect both stages. Also an added complication is the intermittent 
nature of excretion of the parasite. As consequence, diagnostic sensitivities 
rarely get to 90 % (Duque-Beltrán et al., 2002). In order to understand this 
protozoan parasite better, the current understanding of Giardia genetics and 
strain variation, antigenic variation, and immunological responses to the 
infection are discussed under sections 1.2 and 1.3.  Knowing the biology of this 
parasite will help immensely in the diagnosis and management of this infection.  
1.1.1 Global burden  
Diarrhoeal diseases have been ranked second only to lower respiratory 
tract infections by the WHO in its 2004 update of the leading causes of global 
burden of disease for all ages (WHO, 1996, 2004, 2008). This represents 4.8 % 
of total disability adjusted life years (DALYs), a time-based measure that 
combines years of life lost due to premature mortality and years of life lost due 
to time lived in states of less than full health (Mathers, Fat, & Boerma, 2008; 
Yassin, Amr, & Al-Najar, 2006). Even though future prediction by the WHO 
puts the ranking of diarrhoeal diseases outside the top ten of the leading causes 
of burden of disease, it still remains an illness that requires a robust diagnostic 
tool in addition to public health education to keep it under control. With an 
estimated 280 million symptomatic human incidents per year, Giardia is 
regarded as the commonest cause of protozoan diarrheal infection worldwide 
(WHO, 1996). 
In addition to the impact on society, there are also economic losses in the 
agricultural industry for Giardia intestinalis is also known to infect a broad 
range of mammals resulting in production losses (O'Handley, Buret, McAllister, 
Jelinski, & Olson, 2001). In fact, a study has shown that lambs infected with 
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Giardia parasite experienced significantly decreased weight gain, impaired feed 
efficiency, and reduced carcass weight compared with non-infected lambs 
(Olson et al., 1995). Giardia intestinalis, is showing no signs of abating for after 
a decline in UK incidence over a number of years, there has been a gradual 
increase in reported cases of Giardia infections to the Public Health England 
(PHE) at Colindale, UK (This was formally called the Health Protection Agency 
(HPA)) (Figure 1.1) (HPA, 2011) 
 
In the same way as in the UK, giardiasis is a nationally notifiable 
gastrointestinal illness in the USA and during 2009-2010, the total number of 
reported cases increased 1.9 %, from 19,562 in 2009 to 19,927 in 2010 (Yoder, 
Gargano, Wallace, & Beach, 2012).  
1.1.2 History of Giardia intestinalis  
The Dutch microscopist Van Leeuwenhoek described what, most likely, 
was Giardia intestinalis in his stool when he examined it microscopically in 
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1681. The description of what he saw has been cited by Dobell (1920) as 
follows: 
“All these described particles lay in a clear transparent medium, in 
which I have at times seen very prettily moving animalcules, some rather 
larger, others somewhat smaller than a blood corpuscle, and all of one and 
the same structure. Their bodies were somewhat longer than broad, and 
their belly, which was flattened, provided with several feet, with which they 
made such a movement through the clear medium and the globules that we 
might fancy we saw a pissabed running up against a wall. But although they 
made a rapid movement with their feet, yet they made but slow progress."  
[Cited by  (Dobell, 1920).] 
 
 
 
Van Leeuwenhoek was clearly describing Giardia trophozoites (Figure 1.2). 
This flagellate was initially named Cercomonas intestinalis by Lambl in 1859 
(Ortega & Adam, 1997) and was later renamed Giardia lamblia by Stiles in 
1915 in honour of Professor A. Giard of Paris and Dr. F. Lambl of Prague. 
Many, however, consider the name Giardia intestinalis to be the correct name 
for this protozoan parasite. According to the parasitology department of the 
Centres for Disease Control and Prevention and for Global Health (CDC), the 
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International Commission on Zoological Nomenclature is reviewing this issue 
(Giardiasis, 2009). 
When Giardia intestinalis was initially discovered, it was thought to be a 
harmless commensal organism of the gut. It was not until the 1970s when it was 
associated with community outbreaks and was also found in travellers returning 
from endemic areas with classical symptoms that it came to be considered as a 
pathogen. It has also been  found in as many as 80 % of raw water supplies from 
lakes, streams, and ponds and in as many as 15 % of filtered water samples 
(Ryu, Alum, Mena, & Abbaszadegan, 2007). 
1.1.3 Presentation of giardiasis  
Giardia causes diarrhoea and sometimes malabsorption in both epidemic 
and sporadic forms and it is found worldwide (Ortega & Adam, 1997). The 
symptoms normally encountered vary, with the classical ones being: diarrhoea, 
abdominal cramps, bloating, and flatulence that may persist for weeks and can 
be intermittent or chronic. Fat absorption can be impaired giving rise to 
steatorrhoea. These are non-specific symptoms and giardiasis can easily be 
missed especially in immunocompromised and palliative care patients. 
Asymptomatic infections have also been reported (Al-Mohammed, 2011). 
1.1.4 Transmission of giardiasis 
Giardiasis is transmitted through ingestion of contaminated water and 
food, person-to-person contact in child care centres, and men who have sex with 
men. The life cycle of Giardia is composed of the two stages. They are: The 
trophozoite stage (Figure 1.3) which exists freely in the human small intestine 
and the cyst stage (Figure 1.3) which is the infectious form of the parasite. The 
cyst is relatively inert and is passed into the environment being environmentally 
resistant.  Detection of the motile trophozoites correlates with symptomatic 
giardiasis. Although one can have symptoms with just cysts in the stool and 
both stages (independently or together) are diagnostic indicators of giardiasis. 
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Infections may result from the ingestion of ten or fewer Giardia cysts 
(Rendtorff, 1954).   
No intermediate hosts are required. Upon ingestion of the cyst contained 
in contaminated water or food, excystation occurs in the stomach and the 
duodenum in the presence of acid and pancreatic enzymes. Two trophozoites 
per cyst are released and they pass into the small bowel where they multiply 
rapidly, with a doubling time of 9-12 h. to populate the lumen of the proximal 
small bowel. Here they remain free or attached to the mucosa by the ventral 
sucking disc until encystation is triggered as the parasite transit towards the 
colon. As trophozoites pass into the large bowel, encystation occurs in the 
presence of neutral pH and secondary bile salts. Cysts are passed into the 
environment, and the cycle is repeated (Figure 1.3).  
 
 
The cyst is the stage found more commonly in formed stools and the  
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incubation period is variable, 3-25 days (or longer); median 7-10 days. 
The illness remains communicable as long as cysts are being shed, which 
may be many months. The typical shedding period is however poorly defined 
and may be intermittent. Humans and some animals are hosts for this parasite 
but human to human transmission is more common and well documented. 
Cattle, beaver, and other wildlife may be important in contaminating surface 
water supplies and domestic animals (e.g., dogs) may also be a source for some 
human exposures (Macpherson, 2005). In a short communication, Li et al. 
(2012) reported the finding of Giardia intestinalis zoonotic assemblage A in 
dogs in Guangzhou, Southern China. To prevent the potential risk of 
transmission to humans, they suggested the need for integrated control 
strategies and hygiene measures to control giardiasis (Li et al., 2012). Effective 
control measures cannot be put into place when diagnosis is lacking. Another 
group of researchers, working with Rwandan children, have associated Giardia 
intestinalis assemblage B with impaired child growth (Ignatius et al., 2012). 
Effective laboratory diagnosis of sub-microscopic infections is needed to clarify 
the actual contribution of Giardia intestinalis to morbidity in areas of high 
endemicity for these areas constitute unrecognized reservoirs of transmission 
(Ignatius et al., 2012). 
1.1.5 Treatment of giardiasis 
Several drugs have been used to treat giardiasis. Of particular note are the 
following five agents: nitroimidazoles, quinacrine, furazolidone, 
benzimidazoles, and paromomycin. The nitroimidazoles used to treat Giardia 
infections include metronidazole and tinidazole. They were discovered in 1955 
and at that time found to be very effective against several protozoan parasites 
which included Trichomonas vaginalis and Entamoeba histolytica. It was not 
until seven years later, in 1962, that Darbon et al. (2001) reported the potential 
use of metronidazole for treating giardiasis (Darbon, Portal, Girier, Pantin, & 
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Leclaire, 1962; Gardner & Hill, 2001). Tinidazole is used to treat giardiasis in 
the Hospital for Tropical Diseases (HTD) outpatients department in London and 
is sometimes given as presumptive therapy for giardiasis (S.G. Wright, personal 
communication, June 10, 2010). The nitroimidazoles are effective against 
anaerobic and micro aerophilic pathogens. They exert their mutagenic effects 
when activated through the pyruvate:ferredoxin oxidoreductase pathway. 
Reduced metronidazole, for example, serves as a terminal electron acceptor 
which binds covalently to DNA macromolecule and thereby damages it. This 
eventually results in the death of the trophozoites (Edwards, 1993; Müller, 
1983). A single oral dose of tinidazole has been found to be highly effective 
treatment for giardiasis and is equal in efficacy to a 3-day course of 
metronidazole (Speelman, 1985). 
Quinacrine is an antimalarial drug that is also effective against Giardia 
intestinalis. Its mode of action is not fully known, it is, however, thought to 
intercalate readily with Giardia intestinalis DNA and thereby inhibit nucleic 
acid synthesis. Quinacrine remained the drug of choice until the early 1960s 
when the 5-nitroimidazole group of compounds was reported as having 
antigiardial activity (Escobedo & Cimerman, 2007). 
Furazolidone is one of the nitrofuran compounds created since the class 
was discovered in the 1940s (Gardner & Hill, 2001). It is believed that its 
killing effect is related to the toxicity of reduced products which can damage 
DNA (Gardner & Hill, 2001). The benzimidazoles bind to Giardia intestinalis 
beta-tubulin cytoskeleton causing inhibition of cytoskeleton polymerization and 
impaired glucose uptake (Venkatesan, 1998). Two members of this class of 
compounds are albendazole and mebendazole. Albendazole is well known for 
treating helminth infections but it is also known to have anti-giardial activity 
(Ali & Nozaki, 2007). However, the first large-scale clinical study of 
albendazole, conducted in Bangladesh, showed a lower average efficacy 
compared with metronidazole (Hall & Nahar, 1993). 
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Paromomycin is a member of the aminoglycoside family, first isolated in 
1956. It inhibits protein synthesis in Giardia by interfering with the 50S and 
30S ribosomal sub-units (Edlind, 1989). In vitro testing shows that 
paromomycin has relatively low activity compared with the class of compounds 
mentioned above (Gordts, Hemelhof, Asselman, & Butzler, 1985). 
Treatment failures have been reported with all of the common anti-
Giardia agents including metronidazole, quinacrine, furazolidone, and 
albendazole. It is, therefore, important for clinicians faced with recurrence of 
symptoms after therapy to differentiate between actual drug resistances, cure 
followed by reinfection, and post-Giardia lactose intolerance. In this study, an 
attempt has been made to make this task less difficult for clinicians by 
discovering a more sensitive and robust test that will help with the management 
of this illness.  
1.1.6 Prevention and control of giardiasis 
PHE works to prevent and control communicable diseases. As the mode of 
transmission of giardiasis is via the faecal-oral route and persons remain 
infective as long as cysts are being shed, the illness has the tendency to go on 
for months in closed communities where standards of hygiene are 
unsatisfactory. For this reason, public health guidelines are available in the 
event of an outbreak to handle the situation. When the source of any Giardia 
infection is food borne, it will be recorded and reported under the heading of 
food poisoning by PHE. Antimicrobial treatment of individual cases forms the 
basis of control along with food sanitation (Salmon et al., 2004).  
In the event of a suspected source of infection been identified (e.g., 
contaminated well or infected animal), with the potential for transmitting 
infection to a defined population, advice on measures to avoid exposure is given 
to the individuals involved.  In the next section, the biology of Giardia 
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intestinalis will be discussed with particular reference to the diagnostic and 
potential virulence structures that characterize this parasite.  
1.2 The biology of Giardia intestinalis 
1.2.1 Trophozoite structure 
Giardia intestinalis trophozoites are pear-shaped and are about 12-15 µm by 5-9 
µm in size (Adam, 2001). The trophozoite has a convex dorsal surface and a flat 
ventral surface that contains the ventral disc, a rigid cytoskeleton composed of 
microtubules and microribbons. The trophozoite also contains four pairs of 
flagella, directed posteriorly, that aid the parasite in moving. Two symmetric 
nuclei with prominent karyosomes produce the characteristic face like image 
that appears on stained preparations. 
 
 
It possesses a varied number of median bodies and it has been proposed that the 
median bodies play a part in the in the biogenesis of the ventral disc (Piva & 
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Benchimol, 2004). The location of the median bodies gives the parasite a 
characteristic “smile” when stained with Giemsa (Ankarklev, Jerlström-
Hultqvist, Ringqvist, Troell, & Svärd, 2010). The flagella are named according 
to the part of the trophozoite that they are attached to. That is anterior, posterior, 
caudal, and ventral (Figure 1.4). They are locomotive organs, used during the 
excystation process and are also thought to facilitate the attachment of the 
ventral disc to the epithelial cell surface by creating negative pressure under the 
ventral disc (Piva & Benchimol, 2004). The presence of two symmetric nuclei 
with respect to the long axis in Giardia is rather unusual and it has been 
suggested that they may have slightly different functions because they differ in 
nuclei pore number and distribution (Benchimol, 2005). There is also the 
absence of nucleoli, which are the sites for rRNA transcription in the nuclei of 
higher eukaryotes. Nucleoli contain fibrillarin which is required for pre-rRNA 
processing.  Fibrillarin has been demonstrated to be diffuse rather than localized 
in the Giardia  intestinalis nuclei suggesting that rRNA transcription and 
processing are not localized to certain regions of the nuclei (Adam, 2001).  
However, since the publication of Adam’s paper nucleolar-specific 
molecular markers have revealed the presence of 0.2-0.5 µm-sized intra-nuclear 
sub-compartment domains of fibro-granular nature at the anterior zone of both 
nuclei that may well indicate localized nucleoli as found in higher eukaryotes 
(Carranza & Lujan, 2010). The ventral adhesive disc used for attachment to 
enterocytes is a unique structure and covers the anterior half of the ventral side 
of the trophozoite. It is considered to be a virulence factor as attachment to the 
intestinal wall is vital for its establishment in the intestine. The known 
components of the disc include a family of Giardia-specific proteins such as α- 
and β-tubulin, β-, γ- and δ-giardin, SALP-1 and aurora kinase (Davids, 
Williams, Lauwaet, Palanca, & Gillin, 2008; Elmendorf, Dawson, & 
McCaffery, 2003). Some of these proteins are contractile and cytoskeletal 
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proteins. The ventral disc has also been suggested to play a role in nuclear 
division (Benchimol, 2004; Solari, Rahn, Saura, & Lujan, 2003). 
Giardia has four pairs of flagella and each flagellum has a highly 
conserved basal body from which it emerges (Dawson & House, 2010; Sagolla, 
Dawson, Mancuso, & Cande, 2006). These bodies act as a type of signalling 
transduction and control centre during cell division and differentiation, and 
flagellar assembly (Davids et al., 2008; Dawson & House, 2010; Lauwaet et al., 
2007). The plasma membrane of the Giardia trophozoite is made up of a lipid 
bilayer and a single coat covers the entire surface of the trophozoite. It forms 
the first line of defence against the innate immunity of the host. The plasma 
membrane also acts as the attachment point for the cytoskeleton and regulates 
the processes of endocytosis and exocytosis (Adam, 2001). Giardia 
trophozoites encyst as they go through the gut. 
1.2.2 Cyst structure 
Encystation in Giardia occurs after the parasite has undergone nuclear 
replication, but before cytokinesis. This prepares the cyst to release two 
trophozoites upon excystation. The mature cyst therefore contains four nuclei 
(Figure 1.3). The cyst is smooth-walled and oval in shape, measuring 8-12 µm 
long by 7-10 µm wide. Once the host is infected, trophozoites may appear in the 
duodenum within minutes. Excystation occurs within 5 min of exposure of the 
cysts to an environment with a pH between 1.3 and 2.7 (Mukherjee et al., 2011). 
After infection, the trophozoites attach to the enterocytes via the ventral 
adhesive disk. This may occur through the presence of lectin on the surface of 
the trophozoite or through other mechanical means. Encystation is a continuous 
process during infection. As the trophozoites encounter neutral pH and/or 
secondary bile salts, encystation-specific secretory vesicles (ESVs) appear. 
After 15 h, cyst wall proteins are visible. Within 24 h after the appearance of 
ESVs, the trophozoite is covered with these cyst wall proteins, the form of the 
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cyst has emerged, and new antigens are present. The cyst wall is tough and 
consists of 60 % carbohydrate and 40 % protein that prevents hypotonic lysis in 
the environment (Ankarklev et al., 2010). Three cyst wall proteins (CWP1, 
CWP2, and CWP3) have been identified and these are potential targets for 
enzyme immunoassay tests for diagnosing giardiasis. 
1.2.3 Taxonomy of Giardia intestinalis 
The taxonomy of Giardia is evolving and this account relates to what is 
currently known in this field of study. The 1980 classification of the Protozoa, 
based on morphology, places Giardia in the phylum Sarcomastigophora, sub-
phylum Mastigophora (Flagellata), class Zoomastigophorea, order 
Diplomonadida and family Hexamitidae (Morrison et al., 2007). According to 
the new or current classification, which is based on genetic, structural, and 
biochemical analysis, Giardia belongs to the Phylum Metamonada, Subphylum 
Trichozoa, Superclass Eopharyngia, Class Trepomonadea, Subclass Diplozoa, 
Order Giardiida and Family Giardiidae(Cavalier-Smith, 2003; Plutzer, Ongerth, 
& Karanis, 2010). Giardia is very unusual in the sense that it is a eukaryotic 
single celled organism and yet shares many characteristics with anaerobic 
prokaryotes. It lacks common eukaryotic sub-cellular organelles such as 
mitochondria, peroxisomes, and a discernible steady-state Golgi apparatus 
(Plutzer et al., 2010). The functions of the latter appear to be taken over by other 
structures. For despite the lack of any morphological similarities, Giardia ESVs 
show several biochemical characteristics of maturing Golgi cisternae (Marti & 
Hehl, 2003). 
1.2.4 Genetics and strain variation 
The Genus Giardia currently has six species identified by morphological 
features using light and electron microscopy and subsequently confirmed by 
molecular analysis of the small ribosomal (18S) RNA gene (Adam, 2001; 
Plutzer et al., 2010). These species are associated with particular hosts as shown 
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in Table 1.1. Isolates of Giardia intestinalis are classified into seven 
assemblages, based on the characterization of the glutamate dehydrogenase 
(gdh), small-subunit (SSU) rRNA, and triosephosphate isomerase (tpi) genes 
(Bertrand, Albertini, & Schwartzbrod, 2005). 
 
Giardia species Host 
Giardia agilis Amphibians 
Giardia ardeae Birds (Herons) 
Giardia psittaci Birds (Psittaci) 
Giardia muris Rodents (Mice) 
Giardia microti Rodents (Voles)  
Giardia intestinalis species complex Human and other mammalian hosts 
 
Giardia intestinalis species complex is composed of different strains 
isolated from a large range of mammalian hosts including humans (Cacciò, 
Thompson, McLauchlin, & Smith, 2005; McRoberts et al., 1996). To date, eight 
assemblages (A to H) are delineated within the Giardia intestinalis complex and 
H is not yet fully described. Assemblages A and B only are associated with 
humans and the rest with other mammalian species as shown in Table 1.2. 
Molecular analyses of these assemblages have shown that they are not close 
enough to be grouped under the same species. Sequence analysis indicates that 
the distances between these assemblages are actually greater than those 
separating certain genera of bacteria (Monis et al., 2009). Hence, the suggestion 
that the species complex should be broken up into different species with their 
own particular name assigned to them as shown in Table 1.2 (Lasek-
Nesselquist, Welch, & Sogin, 2010; Lasek-Nesselquist, Welch, Thompson, 
Steuart, & Sogin, 2009). 
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Giardia intestinalis 
assemblage 
Proposed species Host 
A G. intestinalis Humans and other primates, 
dogs, cats, livestock, rodents, 
other wild mammals 
B G. enterica Humans and other primates, 
dogs, cats and some species of 
wild animals 
C/D G. canis Dogs and other canids  
E G. bovis Cattle and other hoofed 
animals 
F G. cati Cats 
G G. simondi Rats 
H (New species not yet 
formally described) 
Pinnipeds (marine mammals) 
 
It is known that the genetic loci of Giardia differ in substitution rates. 
The substitution rates for the partial (SSU) rRNA, bg, gdh, and tpi genes have 
been reported to be 0.01, 0.03, 0.06, and 0.12 substitutions per nucleotide, 
respectively (Wielinga, Ryan, Andrew Thompson, & Monis, 2011). These 
differences have resulted in different resolution of parasite typing. The (SSU) 
rRNA has been used mostly for genotyping, whereas the most variable locus, 
tpi, is usually used for subtyping. The bg and gdh loci, with substitution rates 
between those of the (SSU) rRNA and tpi genes, have a broad application 
spectrum (Table 1.3) (Feng & Xiao, 2011). 
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Gene Primer (sequence [5’-3’]) Size(bp) Specificity Assay type Usages (s) 
tpi  
AL3543 
(AAATIATGCCTGCTCGTCG) 
 
605 
 
Genus 
specific
a
 
 
Nested PCR, 
sequencing 
 
Genotyping 
and 
subtyping 
 AL3546 
(CAAACCTTITCCGCAAACC) 
    
 AL3544 
(CCCTTCATCGGIGGTAACTT) 
532    
 AL3545 
(GTGGCCACCACICCCGTGCC) 
    
      
gdh Ghd1 
(TTCCGTRTYCAGTACAACTC) 
754 Genus 
specific 
Nested PCR, 
sequencing 
Genotyping 
and 
subtyping 
 Gdh2 
(ACCTCGTTCTGRGTGGCGCA) 
    
 Gdh3 
(ATGACYGAGCTYCAGAGGCACGT) 
530    
 Gdh4 
(GTGGCGCARGGCATGATGCA) 
    
      
gdh GDH1 
(ATCTTCGAGAGGATGCTTGAG) 
778 Genus 
specific 
PCR, RFLP, 
sequencing 
Genotyping 
and 
subtyping 
 GDH4 
(AGTACGCGACGCTGGGATACT) 
    
      
gdh GDHeF 
(TCAACGTYAAYCGYGGYTTCCGT) 
432 Genus 
specific 
Seminested 
PCR, RFLP 
Genotyping 
and 
subtyping 
 GDHiF 
(CAGTACAACTCYGCTCTCGG) 
    
 GDHiR 
(GTTRTCCTTGCACATCTCC) 
    
      
(SSU) 
rRNA 
RH11 
(CATCCGGTCGATCCTGCC) 
292 Genus 
specific 
PCR, 
sequencing 
Genotyping 
gene RH4 
(AGTCGAACCCTGATTCTCCGCCCAGG) 
    
 GiarF 
(GACGCTCTCCCCAAGGAC) 
130    
 GiarR 
(CTGCGTCACGCTGCTCG) 
    
      
bg G7 
(AAGCCCGACGACCTCACCCGCAGTGC) 
753 Unknown Nested PCR, 
sequencing 
Genotyping 
and 
subtyping 
 G759 
(GAGGCCGCCCTGGATCTTCGAGACGAC) 
    
 GiarF 
(GAACGAACGAGATCGAGGTCCG) 
     
 GiarR 
(CTCGACGAGCTTCGTGTT) 
511     
 
a
 Does not amplify assemblage D 
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1.2.5  Pathophysiology and pathogenesis 
The host-microbial interactions that govern the outcome of infection are 
not fully understood. Available findings, however, show that microvillus 
atrophy and enterocyte injury resulting from Giardia infection result in 
intestinal malabsorption and hypersecretion (Buret, 2008). Giardia-induced 
enterocyte apoptosis causes the pathophysiological activation of CD8+ 
lymphocytes which in turn induces diffuse shortening of brush border microvilli 
resulting in malabsorption and maldigestion (Cotton, Beatty, & Buret, 2011). 
Osmotic diarrhea can also occur in Giardia infections due to secondary 
lactase and other enzyme deficiencies in the microvilli (Wiser, 2007). 
Nitric oxide is an important mediator of homeostasis. It is synthesized from L-
arginine and any changes in its functions can affect the pathological state of an 
organism. It has been reported that Giardia spp. inhibits nitric oxide production 
by consuming arginine. This could contribute to the variability of the duration 
and severity of infections by this parasite (Pavanelli et al., 2010). 
1.3 Immune response to Giardia intestinalis 
Epidemiological studies have shown that previous infection with Giardia 
is followed by a reduced risk of re-infection and a reduced development of overt 
symptoms (Solaymani-Mohammadi & Singer, 2010).  
1.3.1 Mechanisms of the immune response 
The immune response to microbial pathogens, including Giardia sp., 
relies on both innate and adaptive components. Although the actual host defence 
mechanisms responsible for controlling Giardia infections are poorly 
understood, many studies have demonstrated the development of adaptive 
immune responses as well as innate mechanisms in humans and other animals 
(Gillon, Al Thamery, & Ferguson, 1982; Roxström-Lindquist, Palm, Reiner, 
Ringqvist, & Svärd, 2006). Long et al. (2010) looked at the role of faecal 
chemokines and cytokines in the resolution of diarrhoeal Escherichia coli and 
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Giardia intestinalis infections and found increased levels of monocyte 
chemoattractant protein-1 (MCP-1), IFN-gamma, IL-4, and IL-5 to be 
associated with increased Giardia intestinalis infection duration, while 
increased IL-8 levels were associated with decreased duration (Long et al., 
2010). However, these associations may not represent the development of a 
protective immune response in the gut. More effort should be directed to 
understanding mechanisms of virulence and identifying specific parasite 
virulence factors in order to understand the relative contributions of both the 
host and the parasite to disease (Long et al., 2010). 
1.3.2 Antigens and antigenic variation  
Antigenic variation in Giardia intestinalis is the ability to spontaneously 
switch to a different variant-specific surface protein (VSP). It allows the 
parasite to evade the host's immune response and by that produce chronic and/or 
recurrent infections. There are approximately 190 VSP-coding genes and only 
one is expressed on the surface of each parasite at a particular time. The system 
of regulation of the VSP expression has been shown to comprise RNA-
dependent RNA polymerase, dicer, and argonaute which are known components 
of the RNA interference machinery (Prucca et al., 2008). 
1.3.3 Immune-compromised hosts 
Individuals with HIV and AIDS do not appear to be at particularly 
increased risk of developing symptomatic giardiasis. Parasite clearance is 
believed to be reliant more on secretory immunity in the intestinal lumen than 
cell-mediated responses within the intestinal mucosa. Specific secretory (s) IgA 
has been detected on the surface of Giardia intestinalis trophozoites in human 
jejunal biopsies and jejunal fluid (Farthing, Cevallos, & Kelly, 2008). Anti-
Giardia sIgA has also been found in milk and saliva and there is the suggestion 
that they contribute to protection from giardiasis in breast-fed infants. Current 
evidence suggests that anti-Giardia sIgA has a role in clearing Giardia from the 
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gut lumen, possibly by trophozoites agglutination and/or inhibition of flagella 
motility (Farthing et al., 2008). It has also been observed in clinical practice that 
AIDS patients, and especially those with low immunoglobulin levels, are 
difficult to treat when they get giardiasis (P. Chiodini, personal communication, 
June 14, 2012). Using an enzyme-linked immunosorbent assay to detect IgM, 
IgG, and IgA, specific to Giardia intestinalis trophozoites, Janoff, Smith, and 
Blaser (1988) tested sera obtained from a group of AIDS patients and healthy 
heterosexual men. Patients with AIDS who had acute symptomatic giardiasis 
had significantly lower levels of all antibodies than did the heterosexual 
subjects who had giardiasis; specific IgM too was absent in all but one patient 
with AIDS. In spite of this result, they remarked that the treatment available for 
AIDS patients is independent of the patient’s immune status and therefore 
patients’ with AIDS do not have to suffer from prolonged symptomatic Giardia 
intestinalis infection (Janoff, Smith, & Blaser, 1988). Another group of 
researchers (Cardoso et al., 2011), described the epidemiology of intestinal 
parasites in patients from an AIDS reference centre in Brazil. They suggested 
that the development of symptomatic giardiasis cannot be associated with a 
particular arm of the immune system (Faubert, 2000). Experiments using mice 
have also suggested the importance of CD4+ cells in parasite clearance by 
switching B-cell IgM to IgA production during infection(Farthing et al., 2008). 
Therefore, the suggestion that the treatment given to AIDS patients with 
giardiasis is independent of their immune status is yet to be substantiated. 
1.3.4 Vaccination 
Human vaccination against Giardia infection is currently not available, 
though a crude veterinary vaccine has been licensed for cats and dogs. 
Jenikova et al. (2011) tested the vaccine potential of three conserved antigens 
previously identified in human and murine giardiasis, α1-giardin, α-enolase, 
and ornithine carbamoyl transferase, in a murine model of Giardia 
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intestinalis infection. Their findings indicated that the α1-giardin is a suitable 
candidate antigen for a vaccine against giardiasis (Jenikova et al., 2011).  
It was mentioned in Section 1.3.2 that the system of regulation of the VSP 
expression has been shown to comprise RNA-dependent RNA polymerase, 
dicer, and argonaute, known components of the RNA interference machinery 
(Prucca et al., 2008).  Disruption of the pathway for this system of regulation 
of the VSP expression generates trophozoites simultaneously expressing 
many VSPs. The fact that the parasite uses antigenic variation for survival 
means that the expression of many VSPs at the same time might be a useful 
thing in generating vaccines against the parasite (Prucca, Rivero, & Luján, 
2011; Rivero et al., 2010). 
1.4 Laboratory diagnosis of giardiasis  
Since the 17
th
 century when the Dutch scientist Antony van Leeuwenhoek 
used a microscope to examine his own diarrhoeic stool sample, the microscope 
has become a scientific tool in the control and treatment of protozoal diseases. 
Recent advancement in technology has opened up new approaches for the 
development of improved diagnostic tools for the detection Giardia intestinalis 
(de Waal, 2012). The aim of this section is to highlight how these have 
contributed to the diagnosis of giardiasis and any further developments that may 
be required to improve on .  
1.4.1 Microscopy 
Traditionally, giardiasis has been diagnosed in patients using the faecal 
concentration technique described by Allen and Ridley (Allen & Ridley, 1970; 
Ridley, 1956). The procedures for the direct microscopic detection of cysts and 
trophozoites in fresh or fixed stool specimens are, however, laborious, time 
consuming and require expertise (Gaafar, 2011). Also,  the sensitivity of 
parasite detection is hampered by the intermittent pattern of excretion of the 
parasite which means that they may  be at sub-optimal levels for detection using 
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the direct smear or concentration method (Duque-Beltrán et al., 2002). The 
sensitivity of parasite identification has been reported to increase up to 85 % 
when microscopic examination is performed on three faecal samples obtained 
on different days (Duque-Beltrán et al., 2002; Gaafar, 2011). Both non-invasive 
and invasive procedures have been used to obtain samples for diagnosing 
giardiasis.    
1.4.1.1 Use of non-invasive methods 
Stool samples are commonly examined for the investigation of 
gastrointestinal disturbances. The samples are normally obtained without any 
invasive procedure and the simplest method of microscopic examination is the 
examination of smears with further staining and wet preparations with or 
without staining (Garcia, 1999). A direct wet preparation of a small amount of 
stool mixed with normal saline is prepared on a microscope slide. This is useful 
for the identification of Giardia trophozoites. The advantage is that the 
movement of these parasites can be observed which aids identification. The 
direct wet preparation can also be used to identify the cyst stage of Giardia. 
Further staining of the faecal smear with a Romanowsky-type stain (e.g. Rapid 
Field) and the wet preparation with iodine is often used to improve the 
sensitivity of this technique (de Waal, 2012). The greatest disadvantage of 
smears/wet preparations is their lack of sensitivity. To improve sensitivity, 
methods for concentrating Giardia cysts from a larger volume of starting 
material before microscopic examination have been developed. Of particular 
note is the Allen and Ridley method for stool concentration which is still the 
gold standard for microscopic examination for ova, cysts, and parasites (Allen 
& Ridley, 1970; Ridley, 1956). Formalin (10 %) and ether are mixed with the 
stool sample to remove extraneous substances like faecal fat and large faecal 
debris. The resulting mixture is spun down to deposit the parasites in the form 
of a pellet. The supernatant is discarded and the pellet is examined 
22 
 
microscopically after reconstituting with a couple of drops of normal saline. In a 
study conducted to compare formol-ether concentration techniques and direct 
smear for the diagnosis of intestinal parasites, the formol-ether concentration 
technique detected 65.3 % of positive specimens for one or more parasites 
including Giardia and the direct smear detected 34.7 % (Oguoma & Ekwunife, 
2007) . The formol-ether concentration technique detects Giardia cysts and 
cysts and larvae of other parasites so in this project, the direct smear was added 
to detect Giardia trophozoites which otherwise will not be detected because the 
ether and formalin mixture for the concentration technique destroys the 
trophozoites. Even though the concentration method is relatively more sensitive, 
it, however, does not to detect the trophozoites stage.  
1.4.1.2 Use of invasive techniques 
In patients with chronic diarrhoea and negative stool examinations, the 
diagnosis of giardiasis can be established by the examination of duodenal 
contents. The patient swallows a gelatin capsule on a string (Entero-test)  (Beal, 
Viens, Grant, & Hughes, 1970). After several hours, the capsule is removed by 
pulling the string up and the string is examined microscopically for 
trophozoites. Rarely, duodenoscopy with microscopic examination of duodenal 
fluid or histologic examination of biopsy specimens will be required to establish 
a diagnosis. Although more invasive, it has the advantage of revealing 
alternative diagnoses especially in HIV positive patients who have a weakened 
immune system and therefore are more susceptible to infections (Adam, 1991). 
Also Coeliac disease is looked for in biopsies. Some researchers have found the 
examination of duodenal contents to be more sensitive than the examination of 
stool specimens (Kamath & Murugasu, 1974; Rosenthal & Liebman, 1980). 
This is in contradiction to Goka et al. (1990) who found stool samples to be 
more reliable than duodenal aspirate (Goka, Rolston, Mathan, & Farthing, 
1990). In another study by a different group of workers, cysts were found in the 
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stools of all ten experimentally infected persons, while duodenal aspirates 
yielded negative results (Nash, Herrington, Losonsky, & Levine, 1987). 
Therefore, it would seem that the evaluation of stool and duodenal contents 
complements each other, one test may be positive while the other is negative. 
Experimental infections like this raise significant ethical issues and therefore an 
ethical framework has been offered for evaluating infection-inducing challenge 
experiments, which focuses on the scientific and public health rationale, among 
other things, for conducting these studies (Miller & Grady, 2001). This 
experiment was done on healthy volunteers and extrapolating the results to 
vulnerable groups of people with compromised or immature immune systems 
will not be straightforward. Alternative approaches to this type of investigation 
will be much preferred, hence the need for more sensitive methods to test stool 
samples. 
1.4.2 Immunodiagnosis 
Immunodiagnostic tests use antibody-antigen reactions to diagnose 
infection. In direct detection, the antibodies are usually the reagents and 
antigens are the disease markers. If organisms occur at densities below the 
detection level of the direct method employed, or cannot be directly 
demonstrated because of the particular stage of their life cycle found in the 
biological sample, serological tests are used to diagnose the infection indirectly. 
1.4.2.1 Antibody detection 
Indirect fluorescent antibody test (IFAT) is commonly used to detect the 
presence of antibodies against Giardia intestinalis and by so doing attempt to 
diagnose the infection indirectly. A polyvalent conjugate (recognizing IgG, IgM 
and IgA) is used and a four-fold or greater increase in titre between acute and 
convalescent sera indicates an acute active phase. A single positive reaction 
represents previous exposure, since antibody titres are known to remain 
elevated for at least six months. A titre ≥ 1:32 is considered as antibody 
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detected, and antibody not detected is < 1:16. A titre of 1:16 is considered as 
equivocal and a repeat test, 3 to 4 weeks after the initial specimen, is tested if 
clinically indicated (Mayo Medical Laboratories, 1995). The reason behind this 
cautious approach to the interpretation of the IFAT results is the fact that 
antibodies persist for a long time, even after the elimination of the parasite and 
therefore a positive test does not necessary mean an active infection is going on. 
Serology is not useful for diagnosing acute infections (de Waal, 2012) because 
it takes a long time for the body to develop protective immunity against 
Giardia. Even so, only partial immunity occurs for immunity does not 
necessarily develop following a single infection. In a community that 
experienced two Giardia outbreaks in an interval of five years, people infected 
during the first outbreak were at significantly lower risk during the second 
outbreak (Isaac-Renton, Lewis, Ong, & Nulsen, 1994). There is also variability 
in the humoral response to Giardia infection with infants and young children 
particularly affected because of  their immature immune system and often are 
exposed more to the infection than other age groups (Robertson, 1996). 
Antigenic variation in Giardia species is also one of the reasons why serology is 
not useful for diagnosing acute infections. The parasite changes the expression 
of its surface antigens more often before the body can mount a response to any 
trigger (see Section 1.3.2). Serum antibody testing is useful epidemiologically, 
but is not sensitive or specific enough for the primary diagnosis of individual 
patients (Goka, Rolston, Mathan, & Farthing, 1986; Smith, Gillin, Brown, & 
Nash, 1981; Visvesvara, Smith, Healy, & Brown, 1980). An alternative is to 
detect Giardia intestinalis antigens rather than host antibodies raised against it. 
1.4.2.2 Antigen detection 
Monoclonal antibodies have been raised against Giardia to detect the 
presence of the parasite. For example, The most widely used antigen detection 
immunoassays for Giardia are the direct fluorescent-antibody (DFA) test which 
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detects Giardia cysts (Garcia, Shum, & Bruckner, 1992), and enzyme 
immunoassays (EIAs), which detect soluble stool antigens (Garcia & Shimizu, 
1997, 2000). 
DFA tests (e.g., The Merifluor DFA (Meridian Bioscience, Inc.) provide 
definitive diagnosis by using fluorescein-labelled antibodies against cell wall 
antigens of Giardia cyst. The sensitivity and specificity of the Merifluor DFA 
kit has been reported as 96 to 100 % and 99.8 to 100 % respectively (Johnston, 
Ballard, Beach, Causer, & Wilkins, 2003). This test has greater sensitivity than 
traditional examination of permanent smears for Giardia (Mank, Zaat, Deelder, 
van Eijk, & Polderman, 1997). 
Commercially available EIAs use antibodies for the qualitative detection 
of Giardia antigens in both preserved and unpreserved stool specimens (Rosoff 
et al., 1989). The reported sensitivities of EIAs range from 94 to 97 % and 
specificities range from 99 to 100 % (Johnston et al., 2003). 
EIAs are useful when there are numerous samples to be screened because 
the micro-titre tray can take about 96 samples. The test can also be read 
objectively on a spectrophotometer as well as visually based on the level of 
fluorescence. However, false-negative test results have been reported (Hanson 
& Cartwright, 2001). 
A rapid membrane test (RMT), manufactured by Coris BioConcept uses 
monoclonal antibodies raised against Giardia intestinalis cyst membrane 
antigens to detect the parasite. The kit is CE marked and marketed with the 
product name of Giardia-strip with reported 96.3 % sensitivity and 97.8 % 
specificity with performance compared to microscopy (Coris BioConcept, 
2012).  
 Lack of trained microscopists, costly equipment, and the need to cut down 
turnaround times for the issuing of results have contributed to the development 
of immunochromatographic lateral-flow immunoassays (rapid assays) for 
Giardia intestinalis. These tests are simple, 10 min card assays with reported 
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sensitivity of greater than 97 % and specificity of 100 % (Chan et al., 2000; 
Garcia & Shimizu, 2000).  
1.4.3 Detection of parasite DNA 
The advent of nucleic acid-based diagnostics, in particular the polymerase 
chain reaction in 1985, has revolutionized the diagnosis of infectious diseases in 
general. Given the limitation of staining techniques including the inability to do 
species or genotype identification, various molecular methods have been 
developed to diagnose giardiasis for treatment purposes and epidemiological 
studies. For example, SYBR Green real-time PCR developed by Polley et al. 
(2011) has now replaced microscopy as the frontline test in the detection and 
species identification of microsporidial infections at the Hospital for Tropical 
Diseases in London (Polley, Boadi, Watson, Curry, & Chiodini, 2011). A 
number of conventional species-specific PCRs and probe-based real-time PCRs 
also exist for the detection of Giardia intestinalis (Hopkins et al., 1997; 
Nantavisai et al., 2007; Verweij et al., 2004; Verweij et al., 2003). One such 
molecular method is a real-time PCR assay by Primerdesign Ltd. which targets 
the gdh gene of Giardia intestinalis and a nested conventional PCR targeting the 
(SSU) rRNA gene of Giardia intestinalis has a reported sensitivity of 97.3 % 
(95 % CI: 87.9-99.9 %) and specificity of 100 % (95% CI: 91.3-100 %) 
(Nantavisai et al., 2007). 
The molecular detection of parasite DNA begins with the extraction of 
Giardia genomic DNA from stool samples. The principle is: samples are first 
lysed using proteinase K and buffers are used to provide optimal DNA binding 
conditions. The lysate is loaded onto the DNeasy Mini spin column and that is 
followed with centrifugation. During centrifugation, DNA selectively binds to 
the DNeasy membrane as contaminants pass through. Remaining contaminants 
and enzyme inhibitors are removed in two efficient wash steps and DNA is then 
eluted in water or buffer, ready for use (Figure1.5). This is the method adapted 
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for use on stool samples for this project. For detailed extraction procedure see 
Section 2 and the DNeasy® Blood & Tissue Handbook, Pg 28-30 (DNeasy 
Blood and Tissue Handbook, 2006). 
 
 
With the DNA extracted, the appropriate primers and probe are then 
deployed to set up the PCR as discussed in Section 2. The primer selection takes 
into consideration the purpose of the PCR whether it is for genetic 
characterization or genus identification. This will determine the oligonucleotide 
type to use (see Table 1.3). Probe-based real-time methodology is used in this 
project and therefore along with the primer selection is the choice of an 
appropriate probe (see Section 2). A number of genetic loci for Giardia 
intestinalis targeted by these oligonucleotides are known. Some of these are 
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gdh, tpi, (SSU) rRNA, and β-Giardin. Studies have shown that gene 
polymorphism could group isolates into assemblages (Wielinga & Thompson, 
2007). In a study to evaluate the discriminatory power of genotypic markers for 
identifying nucleotide diversity within sub-genotypes of Giardia intestinalis, 
assemblage B, Siripattanapipong et al. (2007) showed that the combination of 
two loci provides a higher discrimination power for sub-genotypes of Giardia 
intestinalis than using any single locus. The discrimination powers of gdh, tpi, 
β-Giardin, ef1-α , and SSU-rDNA genes were 100, 100, 96.43, 42.86, and 0 % 
respectively (Siripattanapipong et al., 2011). They could not, however, compare 
the results directly because the datasets were from different sources 
(Siripattanapipong et al., 2011). The less variable and conserved (SSU) rRNA 
gene was targeted by the Verweij real-time PCR primers in this project for 
identification of Giardia intestinalis to the genus level. The (SSU) rRNA genes 
of Giardia intestinalis and Giardia muris are 80 % similar and this corresponds 
to about 290 different bases over the length of the gene (Rochelle, De Leon, 
Stewart, & Wolfe, 1997). Verweij et al. (2003, 2004)) designed and used a set 
of primers on the basis of the known (SSU) rRNA gene sequence for Giardia 
intestinalis (GenBank accession no. M54878) such that a 62-bp fragment within 
the (SSU) rRNA gene was amplified and detected specifically for Giardia 
intestinalis.  
The gdh gene was also targeted in this project using the Primerdesign 
Ltd. real-time PCR. This gene has been reported to have a 100 % discriminatory 
power and is capable of both genotyping and sub-typing Giardia isolates 
(Siripattanapipong et al., 2011). These techniques are very useful but they are 
also susceptible to contamination and therefore working areas for extraction 
procedures (“dirty” areas) should be separated from cocktail preparation areas 
(“clean” areas) in order to minimize cross contamination. Non-viable parasite 
DNA could also be detected and therefore clinical judgement will  be needed in 
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the interpretation of PCR results for treatment purposes (Josephson, Gerba, & 
Pepper, 1993). 
1.4.3.1 Conventional polymerase chain reaction  
The conventional PCR requires a DNA template containing the target 
region and two primers flanking the marked region (Figure 1.6). After 
amplification, PCR products are separated electrophoretically on an agarose gel 
according to size. There is a set of known DNA molecular weights (markers) 
run on each gel as standards to aid in the determination of sizes of amplicons 
(Figure 1.7). 
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For this study, the primers, and their sequences, used to amplify a 292-bp region 
of the 5' end of the (SSU) rRNA gene of Giardia intestinalis were RH 11, 
forward primer (1- 18), 5'CATCCGGTCGATCCTGCC3' and RH 4, reverse 
primer (268- 292), 5'AGTCGAACCCTGATTCTCCGCCAGG3' (Hopkins et 
al., 1997). 
To further increase the sensitivity and specificity of the amplification 
procedure, a second round of amplification with a second pair of 
oligonucleotide primers was used in a nested PCR for increased amplification 
products for Giardia DNA. The designed primers for the second round PCR 
were: 
GiarF: 5'GAC GCT CTC CCC AAG GAC3' and  
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GiarR: 5'CTG CGT CAC GCT GCT CG3' (Read, Walters, Robertson, & 
Thompson, 2002).  
1.4.3.2 Real-time polymerase chain reaction 
In real-time PCR, the amplification product is measured at each 
Cycle and the initial quantity of the target can be determined quantitatively. The 
TaqMan chemistry uses a fluorogenic probe to enable the detection of a specific 
PCR product as it accumulates during PCR.  
The basic steps of the process involve the use of an oligonucleotide 
probe. The probe contains a reporter fluorescent dye on the 5´ end and a 
quencher dye on the 3´ end (Figure 1.8). In an intact probe, fluorescence emitted 
by the reporter dye is quenched by the quencher molecule by fluorescence 
resonance energy transfer (FRET) through space. 
 
 
 
If the target sequence is present, the probe anneals downstream from one of the 
primer sites and is cleaved by the 5´ nuclease activity of Taq DNA polymerase 
as this primer is extended (Figure 1.9). 
This cleavage of the probe separates the reporter dye from the quencher dye, 
increasing the reporter dye signal. It also removes the probe from the target 
strand, allowing primer extension to continue to the end of the template strand. 
Thus, inclusion of the probe does not inhibit the overall PCR process. As 
additional reporter dye molecules are cleaved from their respective probes with 
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each cycle, the resulting increase in fluorescence intensity is proportional to the 
amount of amplicon produced.  
Real-time PCR provides for a high-throughput analysis in a closed system 
and considerably reduces the problems of cross-contamination. It is quantitative 
in as much as the cycle threshold is related to the starting number of the copies 
of the target fragment. Real-time PCR has been developed for Giardia using 
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TaqMan probe detection chemistry, where increased fluorescence takes place 
following hydrolysis by Taq DNA polymerase (Verweij et al., 2004; Verweij et 
al., 2003). This has led to various PCR approaches targeting different genetic 
loci to differentiate species and assemblages of Giardia (Almeida, Pozio, & 
Cacciò, 2010; Cacciò, De Giacomo, & Pozio, 2002; Read, Monis, & Andrew 
Thompson, 2004). Chalmers and Katzer (2013) quoting from Taniuchi et al. 
(2011) reported a PCR  approach that replaces probes with carboxylated 
Luminex beads(R. M. Chalmers & Katzer, 2013).The assay uses two multiplex 
PCR reactions with specific primers for protozoa and helminths and replaces 
probes with beads. PCR products attached to beads are detected on a Luminex 
platform. When compared to the probe based PCR, the multiplex PCR-bead 
assay produced an improved sensitivity and specificity of 83 % and 100 % 
respectively (Taniuchi et al., 2011). Multiplexing the assay widens the 
diagnostic screen for a large panel of intestinal parasites. 
1.4.3.3 DNA sequencing 
Post-PCR analyses are usually based on the direct sequencing of the 
amplification products or on the digestion with endonucleases followed by gel-
electrophoresis of the restriction fragments. In the last few years, the molecular 
characterization of a large number of isolates, collected from infected hosts and 
from the environment, has considerably added to the body of information about 
the zoonotic potential and the epidemiology of giardiasis. Indeed, two 
assemblages (A and B) of Giardia intestinalis have been established as human 
pathogens. DNA sequencing has delineated three main groups based on small 
sub-unit (SSU) rRNA sequencing and tim (triosephosphate isomerase gene; 
could also be written as “tpi”) sequencing (Baruch, Isaac-Renton, & Adam, 
1996; Cacciò, 2004). 
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1.4.4 Stool culture 
Stool culture is not useful for diagnosing giardiasis because the organism 
cannot readily be grown from patient samples. The lack of a cell culture model 
for Giardia has also made the determination of viability, infectivity, and 
virulence using molecular methods a technical challenge (Alum, Sbai, Asaad, 
Rubino, & Khalid Ijaz, 2012). PCR has, however, been successfully combined 
with the electrophysiological analysis of cell culture (ECC-RT-PCR) post-
trophozoite attachment. The researchers have concluded that this new integrated 
cell culture assay, can be used as a rapid and cost-effective tool for assessing the 
viability and infectivity of environmental isolates of Giardia sp cysts (Alum et 
al., 2012). 
1.5 The search for a new assay at Hospital for Tropical Diseases 
It has been observed at the Hospital for Tropical Diseases (HTD) in 
London that for some patients with chronic diarrhoea and malabsorption, stool 
microscopy results are repeatedly negative despite ongoing suspicion of 
giardiasis. P. Chiodini (personal communication, April 11, 2008) commented 
that when this group of patients is treated empirically for giardiasis using 
tinidazole many of them get better. In a study by Bolin, 1982, there was a 9 % 
prevalence rate of giardiasis among 100 consecutive patients with chronic 
diarrhoea. Fifteen patients without a definitive diagnosis responded to empiric 
metronidazole or tinidazole therapy (Bolin, Davis, & Duncombe, 1982). In 
another study, patients initially diagnosed with severe irritable bowel syndrome 
(IBS) were treated for Giardia with metronidazole and all symtoms resolved 
(Gunasekaran & Hassall, 1992). A patient with biliary tract dysfunction was 
also treated for giardiasis and all the patient's symptoms disappeared and gall 
bladder visualization returned to normal (Goldstein, Thornton, & Szydlowski, 
1978). A more sensitive diagnostic test could help in explaining these situations. 
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It is possible the parasite burden, on these occasions, was below the detection 
level of the test used. 
Figure 1.10 shows the lines of approach when there is a clinical suspicion 
of giardiasis and treatment is contemplated.  
 
 
 
In the unusual case where a diagnosis cannot be made by looking for the 
parasite in stool samples, endoscopy with duodenal fluid sampling and biopsy 
may be performed. In human immunodeficiency virus-infected patients with 
diarrhoea, whose illness has multiple potential etiologies, this approach will be 
preferred to empiric treatment by some clinicians (Gardner & Hill, 2001). 
Invasive methods like the string test and duodenal aspirate examination may be 
required to detect the trophozoite stage of Giardia (Adam, 1991) in cases where 
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clinical symptoms persist but the stool microscopy results have been 
consistently negative (Figure 1.10). This is particularly useful in 
immunocompromsed patients (HIV+) who because of ineffective immune 
system tend to suffer from gastrointestinal infections that could resemble 
giardiasis. Tinidazole is prescribed for chronic diarrhoea in the HTD 
outpatients’ department as presumptive therapy for giardiasis. In a small study 
at HTD to investigate whether empirical therapy with tinidazole could be 
justified by comparing outcome in those with proven giardiasis and those 
without, one hundred and thirty six patients were studied and of this group, 23 
had proven giardiasis. Fifteen patients of the 23 with proven giardiasis had 
complete symptom relief (65 %); 113 patients had empirical therapy and 64 of 
them had complete symptom relief (57 %) (Crane, Whitehorn, & Wright, 2008). 
The authors concluded that it was possible patients who did not show a clinical 
improvement may have had another pathological process causing their 
symptoms. In addition, those who did improve after tinidazole treatment despite 
having negative stool tests for Giardia may have had another infection that 
responded to therapy with tinidazole or had a Giardia infection that was not 
detected. The outcome of this study has highlighted the need for a more 
sensitive diagnostic test for the diagnosis of Giardia infections. The routine 
diagnostic test for identifying this parasite in the Department of Clinical 
Parasitology is ova, cyst and parasite-microscopy (OCP-M). This method uses a 
combination of three tests to look for Giardia intestinalis. The method, 
however, is not specific for Giardia intestinalis as it can detect other parasites if 
they are present. The three tests are: the formol-ether concentrate for ova, cysts, 
and parasites (OC&P), wet preparation, and rapid Field’s stain. Although 
considered as the “gold standard”, the OC&P test, as a standalone method is 
time-consuming and highly dependent on the skills of the microscopist. Also the 
OC&P method detects cysts only (Allen & Ridley, 1970) so additional tests 
must be performed to detect trophozoites. That is the reason why in the 
37 
 
Department of Clinical Parasitology, wet preparations and smears for staining 
are also made when the stool is unformed or liquid. Because of these additional 
tests, the method is called ova, cysts, and parasites with microscopy (OCP-M) 
to differentiate it from the OC&P which does not include these additional tests. 
Even with the much improved OCP-M over the standard OC&P method, the 
problem of microscopy negative clinical giardiasis is still encountered. This 
emphasises the importance of more sensitive diagnostics (Crane et al., 2008). 
Perhaps the parasites are in such low numbers that they are below the detection 
level of the OCP-M method as well.  
Even though an attempt has been made to overcome some shortcomings 
of the OC&P method by using the OCP-M, there still remains the problem of 
intermittent shedding of cysts which has led to the requirement for patients to 
submit three consecutive stool samples for examination before they are declared 
likely to be free from giardiasis (Figure 1.10). A single stool sample will be 
preferred instead of three.  
The problems connected with the laboratory diagnosis of giardiasis as 
discussed above have resulted in the investigation of a molecular-based 
approach to diagnosing this gastrointestinal infection. Good sensitivity and 
specificity levels have been reported in the literature for molecular-based 
methods for diagnosing giardiasis. However, incorporation of these methods 
into the routine diagnostic laboratory is time consuming and increases the cost 
of a stool examination (Haque et al., 2007; Verweij et al., 2004). 
The Department of Clinical Parasitology is the diagnostic laboratory for 
HTD and offers a reference/referral service and therefore it is expected that 
these diagnostic problems will be addressed in a way that provides the best 
possible service for patients/users. The undertaking may be expensive but the 
service provided will be commensurate with that of a reputable reference 
laboratory offering the best service. The practical benefits of a successful 
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project upon finding a very sensitive test and adopting it into routine practice 
will include the following: 
 1. Patients may no longer be required to submit three stools for the 
laboratory diagnosis of giardiasis before they can be declared free of the 
parasite. One sample may be sufficient.  
2. Invasive techniques like duodenal biopsy or aspirate may no longer be 
actively considered for the diagnosis of giardiasis. Asymptomatic giardiasis 
could be picked up in the investigation of an outbreak or differential diagnosis 
of other conditions. In one study 6.5 % of patients with irritable bowel 
syndrome had Giardia (Grazioli et al., 2006). 
3. Patients may no longer be treated for giardiasis based on clinical 
suspicion alone (empirical treatment).  
1.5.1 Purpose and aim for the research 
OC&P remains the de facto gold standard for the laboratory diagnosis of 
intestinal parasites which include Giardia intestinalis. A non-microscopy based 
test would be desirable. Since Mullis won the Nobel Prize in chemistry in 1993 
for his invention of the PCR technique, the methodology has reached sufficient 
technical maturity to be considered for routine use in clinical laboratories using 
a standardized protocol. Therefore, this study was conducted to determine the  
of real-time PCR methodology in the diagnosis of giardiasis. An attempt will be 
made to evaluate some selected non-microscope- based methods used to 
diagnose Giardia infection with a view to finding the best test to diagnose 
giardiasis. These tests will be compared with the OCP-M method currently in 
use which requires the use of a microscope to look for the parasite itself. The 
non-microscope-based tests selected for inclusion in the assessment protocol 
will be those that detect components (e.g. antigens and DNA) of the parasite 
rather than the whole intact parasite. The question answered in this study was: 
In patients with suspected Giardia intestinalis infection (giardiasis), would the 
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use of non-microscopy-based tests, when compared with the light microscopy 
test (OCP-M), lead to improved detection of the parasite in human stool 
samples? Consequently, the aim of this study was to determine the sensitivity 
and specificity of OCP-M and real-time PCR assay for Giardia intestinalis 
detection by using a composite reference standard test of enzyme immunoassay 
and rapid membrane test.  
1.5.2 Objectives of the study 
Six objectives for this research are described in Table 1.4. 
 
 
Objective no. Description 
01 
To carry out an exploratory investigation using spiked stool samples to 
determine any differences in performance between the index tests: Ova, cyst 
and parasite-microscopy (OCP-M) and real-time PCR. 
02 
To carry out an exploratory investigation using spiked stool samples to 
ascertain the analytical sensitivity and specificity of the reference tests: 
Enzyme immunoassay (EIA) and rapid membrane test (RMT) 
03 
To evaluate and compare the accuracy measures for OCP-M and real-time 
PCR using a non-probability sampling technique with consecutive samples. 
04 
To compare the accuracy measures for real-time PCR to that of a 
combination of OCP-M and real-time PCR. 
05 
To investigate the effect of different storage conditions on the detection of 
Giardia intestinalis DNA in human stool samples. 
06 
To develop an algorithm and a business plan for use in the Department of 
Clinical Parasitology for the laboratory investigation of giardiasis 
incorporating real-time PCR. 
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1.5.3 Ethics 
Before this project started, an application for the assessment of it for 
ethical review was submitted to the NHS Research Ethics Committee (NHS 
REC). After considering it in the light of how they differentiate research from 
other activities, it was decided that this project did not require ethical review 
(SL24 Project version 4.0 ref. 09L 446). Upon their advice, I checked with the 
local R&D Department for any further review arrangements or sources of 
advice that may apply to projects of this type. Again, the reply received from 
the senior research administrator for the joint UCLH/ UCL Biomedical research 
unit at University College London Hospitals NHS Foundation Trust (UCLH) 
indicated that no further review was required since the study was considered as 
an audit (P. Diamond, personal communication, January 04, 2010). With these 
decisions received, the project then began.  
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Chapter 2: Analytical verification of 
diagnostic tests for Giardia 
intestinalis 
2.1 Introduction 
 
The requirement for verification and validation procedures for  
assays in general is discussed in the international quality standard for medical 
laboratories ISO 15189:2007 (Raymaekers, Smets, Maes, & Cartuyvels, 2009). 
The International Conference on Harmonisation of Technical Requirements for 
Registration of Pharmaceuticals for Human Use (ICH) document ICH Topic Q 
2 (R1) published by European Medicines Agency also provides guidance on 
validation of analytical procedures (Procedures, 1995). Another document that 
also provides information on validation and quality control of the PCR methods 
used for the diagnosis of infectious diseases is the Office International des 
Epizooties (OIE) Terrestrial Manual 2008 ("OIE Terrestrial Manual," 2008), 
published by European Medicines Agency. With the proliferation of both 
commercial and non-commercial assays for the detection of Giardia, the need 
for standardization and quality assurance are required. Sloan (2007) quoting 
from the Clinical and Laboratory Standards Institute document CLSI MM3-A2, 
defined verification as the one-time process completed to determine or confirm 
test performance characteristics before the test system is used for patient testing, 
and validation as the continuous process of proving that a procedure, process, 
system, equipment, or method works as expected and achieves the intended 
results. Components of validation are quality control, proficiency testing, 
employee competence, and instrument calibration (Sloan, 2007). Presently, the 
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challenges to the clinical microbiology laboratory for introducing assays like the 
real-time PCR test systems include what verification experiments are required 
and how many and which types of specimens should be tested (Sloan, 2007). 
For the purpose of this study, publications available from agencies ICH, OIE, 
and CLSI together with the publications of Raymaekers et al. (2009) and Sloan 
(2007) assisted in providing guidelines for establishing and confirming the 
performance characteristics and accuracy measures of the diagnostic tests 
evaluated in this research project. For analytical verification, the three main 
areas chosen for investigations were analytical sensitivity, analytical specificity, 
and PCR reaction efficiency. 
Analytical sensitivity, as opposed to diagnostic sensitivity, is the lowest 
detection level of a test (Saah & Hoover, 1997). It is also known as limit of 
detection (LOD). Analytical specificity, on the other hand, refers to the ability 
of the test to detect, e.g. Giardia intestinalis, rather than any other parasite in 
the stool sample.  
Analytical specificity was investigated for the five tests by using a pooled 
Giardia-negative stool with various types of parasitic, bacterial, and fungal 
organisms: Entamoeba coli, Endolimax nana, Entamoeba histolytica/dispar, 
Yeasts, Escherichia coli, Klebsiella sp., Citrobacter sp., Proteus sp., 
Enterococcus faecalis, Cyclospora cayetanensis and Cryptosporidium sp. 
Bacterial pathogens were not available but have already been tested in a 
previous study (Verweij et al., 2003). The pooled Giardia-negative stool and the 
serially diluted samples for the trophozoites and cysts were all tested with the 
two real-time PCRs, OCP-M, EIA, and the RMT.  
Real-time PCR, also called quantitative PCR or qPCR, provides the 
amount of a target sequence or gene that is present in a sample. The efficiency 
of a PCR reaction has effect on the threshold cycle (Ct.), where Ct is the 
intersection between an amplification curve and a threshold line (Figure 2.1). It 
is a relative measure of the concentration of target in the PCR reaction (Real-
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time PCR: Understanding Ct, 2011). A positive signal in real-time PCR is 
detected by the accumulation of fluorescence. The Ct is inversely proportional 
to the amount of starting nucleic acid target in the sample. In order words, the 
lower the Ct level the greater the amount of target nucleic acid in the sample 
and vice versa. 
 
 
 
The actual numerical values of the Cts depend on the reagents and the real-time 
thermocycler used and may not be used as the basis for comparing two Real-
time PCR methods. The following observations have been made and are 
generally accepted: Cts < 29 are strong positive reactions indicative of abundant 
target nucleic acid in the sample. Cts of 30-37 are positive reactions indicative 
of moderate amounts of target nucleic acid. Cts of 38-40 are weak reactions 
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indicative of minimal amounts of target nucleic acid which could represent an 
infection state or environmental contamination(Real Time PCR Ct Values, n.d.). 
Efficiency reflects the performance of the assay in achieving what it has 
been designed for. It is derived from the function for the amount of PCR 
product formed: N = N0 × E
n
. N represents the number of amplified molecules 
and N0 is the initial number of molecules. The number of amplification cycles is 
n and E is the efficiency which is ideally 2. The standard curves are derived 
from the function described above: n = -(1/ log E) × log N0 + (log N/ log E). 
Therefore, the slope of the line equals -(1/ log E) and the efficiency can be 
calculated from this (Mygind et al., 2002). 
 
 
 
Low efficiency conditions produce a standard curve with a different slope from 
that under high efficiency. In Figure 2.2, two samples (X and Y) amplified 
under low and high efficiency conditions show different Ct values for the same 
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target concentration. The high-efficiency condition (the blue curve) gives a later 
Ct at high concentrations and a better sensitivity at low target concentrations. 
The PCR efficiency is dependent on the assay, the master mix performance, and 
sample quality. Efficiency between 90 and 110 % is generally considered 
acceptable. The nearer the value to 100 %, the better the efficiency (Real-time 
PCR: Understanding Ct, 2011). Reaction efficiencies were compared between 
the two named real-time PCRs. 
This early phase of the project was designed to verify the analytical 
potential of all the tests (i.e. both index and reference tests) deployed in this 
study. In order to achieve this, Giardia positive stool, obtained from routine 
practice, was liquefied with PBS pH 7.2 and Giardia cysts were counted with 
the aid of C-Chip counting chamber following the manufacturer’s guidelines 
(Appendix I). One in five serial dilutions were prepared in a Giardia-negative 
stool which was also liquefied with PBS pH 7.2 to give the following range of 
dilutions with estimated cysts numbers/ml (Table 2.1). 
 
Sample tube no. 1 2 3 4 5 6 7 
No. of cysts/ml 71, 000 14,200 2840 568 113.6 22.7 4.5 
 
Giardia intestinalis trophozoites (Alexeieff Portland-1 strain) were also 
similarly counted using C-Chip counting chamber and 1 in 10 serial dilutions 
prepared for the estimation of detection limit (Table 2.2).  
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Sample tube no. 1 2 3 4 5 6 7 
No. of trophozoites/ml 9.2x10
4 
 9.2x10
3 
  9.2x10
2
 92 9.2 0.92 0.092 
 
The cysts and the trophozoites dilutions were tested with all the five 
diagnostic assays deployed in this study: OCP-M, RMT, EIA, Primerdesign Ltd. 
real-time PCR, and Verweij real-time PCR. The methods for testing have been 
discussed under Section 2.2. 
In order to standardize and compare the amplification efficiencies of the 
Verweij real-time PCR and the Primerdesign Ltd. real-time PCR, 10-fold 
dilutions were prepared from the DNA solution in Tube 1 of Table 2.1 after 
diluting it 1 in 2 first and then followed by the 1 in 10 dilutions (Table 2.3). The 
DNA was extracted from a stool sample with a known number of Giardia 
intestinalis cysts (7.1 x 10
4
 cyst/ml of stool) as determined by light microscopy. 
Sample tube no. 1 2 3 4 5 
No. of cysts/ml 35,500 3,550 355 35.5 3.55 
 
The range of dilutions for the standard curve was chosen to offer the 
maximum chance of detecting Giardia DNA in every dilution tube by both real-
time PCRs. As the dilutions were for efficiency determination and not LOD per 
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se, the lower end concentrations were, therefore, not extended to 1 or 2 
cysts/ml. Only the two real-time PCRs (Verweij et al. and Primerdesign Ltd.) 
were used to test these 1 in 10 serially diluted Giardia DNA solutions. 
 
2.2 Methods 
The reference test was a composite of EIA and RMT with a conventional 
PCR (CPCR) used only to resolve discrepant test results. And the index tests 
were ova, OCP-M, Verweij real-time PCR, and Primerdesign Ltd. real-time 
PCR. 
2.2.1 Ova, cyst, and parasite microscopy 
This is a formol-ether sedimentation technique for concentrating parasites 
in stool samples for identification microscopically. The method is not directed 
at Giardia intestinalis alone, it can detect other parasites as well. It maximizes 
the numbers of organisms detected when they are too scanty to be seen 
otherwise (Allen & Ridley, 1970; Ridley, 1956). The examination of stained 
direct faecal smears for vegetative forms of parasites was not part of the 
methodology initially. The procedure has been referred to as “ova, cyst and 
parasite” (OC&P). It was later on that modifications to the OC&P emerged. A 
modified form of the OC&P is used at HTD-Clinical Parasitology and this will 
be described fully in this section and evaluated in this project. Ridley and Allen 
faecal concentration technique is non-invasive and detects mainly the cyst form 
of Giardia intestinalis in stool samples. Its usage as a diagnostic technique has, 
however, the problem of compliance. Because three negative stool samples, 
taken on separate days, are required for the confirmation of cure after treatment 
or for the confirmation of a negative diagnosis following clinical suspicion of 
giardiasis, patients are less inclined to comply.  
The method uses the Parasep faecal parasite concentrator (Figure 2.3). 
Three 3 ml of either ethyl ether or ethyl acetate was used to remove fat and 
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debris from 1 g (1 ml if liquid) of stool with 6 ml of 10 % formalin added to kill 
bacteria and other microbial flora in a mixing chamber (Figure 2.3). After 
filtration, followed by centrifugation at 3000 rpm for 1 min, the parasite was left 
in the pellet at the bottom of the sedimentation cone with faecal debris trapped 
in the catchment area above the filter (Figure 2.3). Fat in the form of a plug was 
left in the ether layer on top of the formalin column.  
 
The filter had 425 µm pores that allowed parasites to go through and 
larger faecal debris held behind it. After discarding the formalin-ether layer, a 
couple of drops of normal saline were used to reconstitute the pellet which was 
then examined microscopically. A drop of iodine was used to identify internal 
structures of cysts. 
When unformed or liquid stools were encountered, direct wet 
preparations and rapid Field’s stained faecal smears were also prepared to 
supplement the spun deposit to look for trophozoites of Giardia intestinalis. In 
this project, this approach has been referred to as OCP-M to differentiate it from 
the original Allen and Ridley OC&P test. All the 213 samples that were 
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archived for this study were processed in the course of normal routine practice 
using Parasep. They were examined microscopically with the addition of wet 
preparations and stained smears on all unformed and liquid samples.  
2.2.2 Rapid membrane test 
Giardia-Strip 
This is a single one-step immunochromatographic membrane test. The kit is 
called Giardia-Strip and Coris BioConcept is the manufacturer of this 
commercial diagnostic kit. The principle behind this ready-to-use test is: 
monoclonal antibodies raised against Giardia intestinalis cyst’s membrane 
antigens are conjugated with colloidal gold and the conjugate is deposited or 
localized on a polyester membrane. When the strip is dipped into a diluted 
faecal sample, the solubilised conjugate migrates with the sample by passive 
diffusion and any Giardia cysts that might be present forms a complex with the 
conjugate and the complex becomes immobilized when bound to the anti-
Giardia reagent. This results in the development of a red line at the specified 
location on the strip. Any unbound conjugate continues to migrate and then 
comes into contact with a second reagent line, an anti-chicken IgY polyclonal 
antibody. The resulting red line confirms that the test is working properly. The 
test result is visible within 15 minutes.  
Procedure (Figure 2.4): 
1. Using a pastette, 0.5 ml (15 drops) of the dilution buffer solution were put 
in a 3 ml tube 
2. Using a 10 µl loop, 2 loops of liquid stool (1 loopful when the stool was 
formed) were added to each tube from 1. The loop was used initially to break up 
formed stools before mixing the sample with them.  
The tubes were vortexed to homogenize each sample preparation.  
 Using plastic disposable pipettes the contents of all tubes were transferred into 
a corresponding deep-welled micro titre tray, with appropriately labelled 
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positions. The sampling loop and pastettes were discarded and appropriately 
labelled sensitized strips were applied to each well in the direction indicated by 
a red arrow (Figure 2.4). The set up was left at room temperature for 15 
minutes. Positive test results were observed earlier when both the control line 
and the test line became visible. 
 
 
 
Interpretation of results 
The results were read within 15 minutes following the manufacturer’s 
instructions. 
Negative test result: only one (1) red line (upper). No other band was present 
Positive test result: two (2) red lines. Any signal on the test line was recorded as 
a positive test  
Invalid test result: No detectable reddish-purple band at the control line (upper) 
A couple of the tests failed and had to be repeated because of improper 
diffusion of the faecal suspension thought to be due to the high viscosity of the 
samples. Vortexing the samples for longer rectified the situation. 
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The Giardia strip by Coris BioConcept was chosen for this study because 
it detected Giardia cysts membrane bound antigens with the manufacturer’s 
quoted excellent figures for sensitivity and specificity, using microscopy as the 
gold standard, as 96.3% and 97.8% respectively. It was quick and easy to set up 
and results were obtained after 15 minutes of waiting. The company is also 
based in the UK and this offered convenience when dealing with the 
manufacturer regarding purchases and deliveries. The cost of the strips was also 
affordable at £55 per a kit capable of performing 25 tests. 
See Appendix II for further information regarding the use of this kit. 
2.2.3 Enzyme immunoassay (EIA) 
Giardia II (TECHLAB) Kit 
The GIARDIA II test is an enzyme immunoassay used for the qualitative 
detection of Giardia intestinalis cysts antigen in human stool samples. The test 
uses monoclonal and polyclonal antibodies to detect soluble cell-surface antigen 
of Giardia intestinalis. This diagnostic kit is developed and manufactured by 
TECHLAB. The principle of test is as follows: 
A microassay plate is coated with monoclonal antibody to Giardia 
intestinalis cell-surface antigen. The immobilized monoclonal antibodies bind 
any Giardia intestinalis antigen if present in the stool. Upon the addition of 
conjugate, a complex is formed which is composed of the monoclonal antibody, 
the Giardia intestinalis antigen, and the conjugate. After washing the plate to 
remove any unbound materials, substrate is added and the enzyme portion of the 
conjugate in this enzyme-antibody-antigen complex breaks down the substrate 
with the development of colour that may be estimated visually or read 
calorimetrically at 450 nm wavelength (Figure 2.5) 
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Method: 
1. One in five dilution was prepared for each test sample (samples were 
previously stored at -20 
o
C with no preservative added) by adding 100 µl of 
liquid stool (0.1 g if formed) to 400 µl of diluent. 
2. One hundred µl of diluent was transferred into each test well of the 
microassay plate. 
3. One drop (50 µl) each of diluted samples from 1 was added to corresponding 
test wells of the micro-assay plate containing the 100 µl diluent. 
4.  The micro-assay plate was gently tapped on the sides to mix and left 
covered at room temperature for 1 h. The contents of the assay wells were 
tipped into a discard jar and the assay plate washed for a total of 4 times using 
the x1 wash solution, striking the plate on a paper towel in between washes to 
remove residual liquid. 
Monoclonal Ab  
Polyclonal Abs  
Giardia Ag 
Enzyme 
Substrate 
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5. One drop (50 μl) of conjugate (red cap) was added to each well and 
gently tapped to mix. The plate was covered and left at room temperature to 
incubate for 30 minutes. 
6.  The washing procedure (Step 4) was repeated. 
7.  Two drops (100 μl) of substrate (blue cap) were added to each well and 
the plates gently tapped on the sides to mix. It was then incubated at room 
temperature for 10 minutes. 
8.  One drop (50 μl) of stop solution (yellow cap) was added to each well at 
the end of the 10 minutes incubation. The plate was gently tapped to mix and 
left at room temperature again for a further 2 minutes for colour development.  
10.  The addition of the stop solution converted the blue colour to a yellow 
colour (Figure 2.6), which was read by measuring the absorbance at 450 nm on 
a Dynamic Microplate Microtek Ds spectrophotometer. The instrument was  
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blanked against air. Visual recordings were also made. 
The kit controls, positive and negative, were included in each run with 
each series of test specimens and the interpretation of the test results were also 
made with due reference to Table 2.4. Optical density of < 0.15 at 450 nm was 
read as negative and ≥ 0.15 was read as positive.  
 
Absorbance at 450 nm Visual colour Interpretation 
< 0.15 
Clear to slight yellow resembled 
the negative control well in 
intensity of colour.  
Negative - below 
detectable limits of assay 
≥ 0.15 
Pale yellow to strong yellow. 
Obviously more yellow than the 
negative control well. 
Positive - specimen 
contains Giardia antigen    
 
The Giardia II (TECHLAB) kit was chosen for this study because it detected 
soluble Giardia cysts antigens, as opposed to membrane bound antigens as 
mentioned above for the Giardia strip. The manufacturer’s quoted excellent 
figures for sensitivity and specificity, using microscopy as the gold standard, 
were 100 % and 100 % respectively. The company is based in the UK and this 
offered convenience when dealing with the manufacturer regarding purchases 
and deliveries. The cost of the EIA kit was also affordable at £199.34 and 
£330.88 for evaluation and general pricing respectively. Each kit performed 96 
tests. For further information regarding the use of this kit, see Appendix III. 
2.2.4 Primerdesign Ltd. real-time PCR 
The Primerdesign Ltd. genesig kit for Giardia is designed for the in vitro 
quantitation of Giardia intestinalis genomes by targeting the glutamate 
dehydrogenase gene (gdh). The primers and probes specifically detect Giardia 
intestinalis assemblages A and B, the sub-types known to infect humans 
(Genesig advanced kit handbook, HB10.03.03). This assay is marketed as a 
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research kit and there does not appear to be any record of it having been 
assessed independently in a clinical laboratory setting before. The real-time 
PCR instrument Rotorgene Q 6000 (Corbett Research UK Ltd.), the DNA 
extraction procedure, and the environmental mastermix used were all available 
in house and were not exclusively designed for the sole accompaniment of the 
Primerdesign Ltd. kit. The kit contents relevant to this study and the 
recommended reagent volume per reaction were: Giardia intestinalis specific 
primer/probe mix (colour code brown for 150 reactions, FAM labelled, BHQ 
quenched), 1µl; Giardia intestinalis positive control template (colour code red 
for standard curve); 1 in 10 dilutions from 2 x 10
5 
copies/µl down to 2 copies/µl 
to provide solutions for the standard curve;  Internal/ extraction control DNA 
(colour code blue for 150 reactions), 4 µl added before extraction, this 
recommended volume will not deplete the oligonucleotides in the mastermix at 
the expense of Giardia intestinalis positive patient and control samples.  
The Primerdesign Ltd.real-time PCR  kit was chosen for this study because the 
target for detection was the gdh gene of Giardia intestinalis, as opposed to the 
(SSU) rRNA gene, the target for the Verweij real-time PCR. The company is 
based in the UK and this offered convenience when dealing with the 
manufacturer regarding purchases and deliveries. The cost of the kit was also 
affordable at £395 for a kit capable of performing 150 tests. For further 
information regarding the use of this kit, see Appendix IV. 
DNA extraction 
This involved three stages:  
1. Washing the stools samples 
2. Lysis of the Giardia parasite, and 
3. Extraction of the DNA. 
1. Washing the stool samples 
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This washing step was devised at HTD-Parasitology to remove soluble PCR 
inhibitors before DNA release and extraction. Stool samples previously stored 
at 4 
o
C were used.  
a. About 0.5 g (a pea size) of formed stool or 500 µl of liquid stool 
(vortexed to mix) was transferred into a 2 ml screw capped sarstedt tube 
using a wooden applicator.  
b. One ml of PBS pH 7.2 was added. The mixture was vortexed to mix well 
and then spun at 14,000 rpm for 5 min. 
c. After discarding the supernatant into a formalin discard container, the 
pellet was weighed and the weight recorded.  
d. Stool samples weighing less than 500 mg had the equivalent of 200 µl of 
PBS pH 7.2 per 100 mg of stool added to it as shown in the chart given 
below Table 2.5. This created a 1:2 diluted stock. All suspensions were 
initially mixed with wooden applicators. 
Weight of stool (mg) Amount of PBS (µl) 
0-125 250 
125-190 375 
191-250 500 
251-310 625 
311-375 750 
376-440 875 
441-500 1000 
 
When a stool sample weighed more than 500 mg, a 1:1 dilution was 
created first (Table 2.6) before being diluted subsequently to 1:2 with the PBS 
(250 µl of 1:1 suspension plus 250 µl of PBS). 
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Weight of stool (mg) Amount of PBS (µl) 
501-625 625 
626-750 750 
751-875 875 
876-1000 1000 
 
The 1:2 diluted stocks were vortexed to mix until they were homogenized then 
200 µl was transferred into a new and labelled 1.5 ml snap top centrifuge tube 
containing 1 ml of PBS pH 7.2. The samples were vortexed briefly to mix and 
then spun at 14000 rpm for 5 min. After discarding the supernatant, the pellets 
were stored at 4 
o
C when extraction could not be done immediately. 
2. Lyses 
DNA was extracted from 0.5 g of formed stool or 500 µl of liquid stool 
using a modified QIAamp DNA Mini kit protocol for tissue extraction (Qiagen 
Ltd.) (Polley et al., 2011). Prior to extraction, this was supplemented by the 
addition of a standardized quantity of Escherichia coli transformed with a green 
fluorescent protein (GFP) gene (Murphy, McLauchlin, Ohai, & Grant, 2007). 
The GFP served as the extraction control as well as the internal control for the 
PCR. The following steps were followed: 
 
a. ATL buffer (390 µl) was added to the resultant pellet.  
b. Proteinase K (40 µl) was added and the pellet was dislodged and broken 
up with the pipette tip. 
c. Four µl of DNA extraction control (Primerdesign Ltd. kit) and 5 µl green 
fluorescent protein (GFP) (DNA extraction control for the Verweij PCR) 
were added to the tube. 
d. The mixture was vortexed for 1 minute and incubated at 56 oC in the 
heating block for 30 min.  
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e. After the 30 min incubation, the tubes were vortexed again and then 
incubated at 56 
o
C overnight. 
 
3. Extraction of DNA (Using QIACUBE and Qiagen spin-column kits) 
 
a. After the overnight incubation, the lysed samples were each vortexed for 
1 min. 
b. Samples were centrifuged at 6500g for 1 min in a micro-centrifuge. 
c. Two hundred and forty µl of the supernatant was transferred into safe 
lock 2 ml tubes (labelled Qiagen sample tubes, RB (2 ml)). 
d. Two ml safe lock tubes containing sample supernatants were loaded into 
the sample block of the Qiacube and then the block was transferred into 
the Qiacube as per extraction sheet. 
e. The QIACUBE was used to extract the DNA using a modification of the 
tissue program eluting DNA into 100 µl of buffer. 
 
Preparation of standard curve solutions using the positive control template 
(RED): 
1.  Nine hundred µl RNAse/DNAse free water was pipetted into 5 tubes and 
labelled 2-6. 
2.  One hundred µl of positive control template (RED) was pipetted into 
tube 2. 
3.  The tube was vortexed thoroughly. 
4. The pipette tip was changed and 100 μl pipetted from tube 2 into tube 3. 
5.  The tube was vortex thoroughly to mix. One hundred μl was pipetted 
from tube 3 into tube 4. 
6.  The serial dilution was continued up to and included tube 6 (Table 2.7). 
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Standard Curve Copy Number 
Tube 1 Positive control (Red) 2 x 10
5 
per µl 
Tube 2 2 x 10
4 
per µl 
Tube 3 2 x 10
3 
per µl 
Tube 4 2 x 10
2
 per µl 
Tube 5 20 per µl 
Tube 6 2 per µl 
 
The reaction mix was prepared according to (Table 2.8). 
Component                                                                                             Volume 
Environmental mastermix                                                                            10 µl 
G.intestinalis Primer/probe mix (BROWN)                                                  1 µl 
Internal extraction control primer/probe mix (BROWN)                              1 µl 
RNAse/DNAse free water (WHITE)                                                             3 µl 
Final Volume                                                                                                15 µl  
 
Five µl DNA extract was added to the final volume of 15 µl to provide a total 
reaction volume of 20 µl. The following amplification cycles were used: 
Enzyme activation at 95 
o
C for 5 min, followed by 50 cycles of a two-step 
reaction of 10 s denaturation at 95 
o
C and 60 s data collection at 60 
o
C. Further 
information is provided in the manufacturer’s Genesig Advanced kit handbook, 
HB10.03.03 (Appendix IV). 
Two replicate known patient-positive controls were run at the same time 
with the kit control using environmental master mix. 
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Within tube signal Run control 
Interpretation 
Target Internal control Negative  Positive  
+ve +ve -ve +ve +ve 
+ve -ve -ve +ve +ve 
-ve +ve -ve +ve -ve 
-ve -ve -ve -ve PCR run fail 
+ve +ve +ve +ve PCR run fail 
+ve = positive, -ve = negative 
The real-time PCR was performed in triplicate on both the serially diluted 
Giardia-positive patient sample and the Giardia trophozoites culture to 
determine the detection level of the assay. Fluorogenic data for Giardia DNA 
was collected through the cycling A. Green channel and the extraction/internal 
control was detected through the cycling A. Yellow channel. The 
manufacturer’s guidelines were followed in the interpretation of results (Table 
2.9). The internal control of a sample with a high genome copy number of 
Giardia intestinalis may fail to produce amplification plot when the mastermix 
oligonucleotides get used up by the excess Giardia DNA. This does not 
invalidate the test and should be interpreted as a positive experimental result. 
The positive and negative controls however should produce the expected results 
otherwise the assay has failed. For further information, see Quantitation of 
Giardia intestinalis genomes see Genesig advanced kit handbook, HB10.03.03 
(Appendix IV). 
Comparison of environmental mastermix with Precision x2 mastermix 
Precision x 2 mastermix supplied by Primerdesign Ltd. for use with the 
Primerdesign Ltd. kit was compared with environmental mastermix using 36 
samples that were tested positive when environmental mastermix with the 
Primerdesign Ltd. kit and also with the Verweij real-time PCR primers. Only 
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positive samples were tested because from the LOD data in this study, reactions 
using environmental mastermix with the Verweij real-time PCR primers 
produced the lowest detection limit and therefore that became a benchmark for 
the Precision x 2 mastermix using the primers that came with the Primerdesign 
Ltd. kit. 
2.2.5 Verweij real-time PCR 
This real-time PCR, unlike the previous one described above, used the (SSU) 
rRNA gene target for the identification of Giardia intestinalis. It is based 
largely on the published work of Verweij et al (2004) and has been used 
extensively in other studies (Calderaro et al., 2010; Haque et al., 2007; 
Schuurman, van Zwet, Lankamp, van Belkum, & Kooistra-Smid, 2007; Verweij 
et al., 2004). The Verweij et al PCR has been optimised for use in the 
Department of Clinical Parasitology and as a fully accredited laboratory with 
CPA (UK) ltd., the assay has to be validated prior to clinical use. It has 
therefore been included in this study. 
 
Primers and probes                                            Oligonucleotide sequence 5'– 3' 
Real-time PCR 
Giardia  intestinalis  
Giardia -80F                                                   5'-GACGGCTCAGGACAACGGTT-3' 
Giardia -127R                                                 5'-TTGCCAGCGGTGTCCG-3' 
Giardia -105T                                                 5'CY5-CCCGCGGCGGTCCCTGCTAG-3'BHQ2 
Green fluorescent protein (GFP) 
gpfF                                                                5'-CCT-GTC-CTT-TTA-CCA-GAC-AAC-CA-3' 
gpfR                                                                5'-GGT-CTC-TCT-TTT-CGT-TGG-GAT-CT-3' 
2gpfROX                                                        5'ROX via Amine C6-TAC-CTG-TCC-ACA- 
                                                                                CAA-TCT-GCC-CTT-TCG-3'BHQ-2 
Conventional PCR 
RH 11                                                                 5'-CATCCGGTCGATCCTGCC-3' 
RH 4,                                                                  5'-AGTCGAACCCTGATTCTCCGCCAGG-3' 
GiarF:                                                                 5'-GAC GCT CTC CCC AAG GAC-3' 
GiarR:                                                                 5'-CTG CGT CAC GCT GCT CG-3' 
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These primers and probe set consisted of forward primer Giardia-80F and 
reverse primer Giardia-127R, and the Giardia intestinalis-specific double-
labelled probe Giardia-105T (Biolegio, Malden, the Netherlands). They were 
used at a final concentration of 400 nM each for the forward and reverse 
primers and 120 nM for the probe in 25 µl reaction containing 5 µl template 
DNA (Table 2.11).  
The assay incorporated an internal/external control of green fluorescent 
protein (GFP) primers and probe (Table 2.10) which consisted of forward 
primer gpfF, reverse primer gpfR, and double-labelled probe 2gpfROX at final 
concentrations of 300 nM, 300 nM, and 100 nM respectively (Murphy et al., 
2007). The amount required in each reaction tube was worked out in a previous 
exercise using internal control validation data (S.D. Polley, personal 
communication, October 10, 2010). A sample is deemed positive for GFP 
control amplification if it has a Ct value ≤ x. Where x = mean Cts (for the 
negative extraction control and patient samples + 1.23 std. dev. Cts of patients’ 
samples).  Cts  ≤  x are acceptable result and Cts > x require a 1 in 10 dilution of 
the sample for the assay to be repeated to counteract any inhibitor effect. When 
thus diluted, a positive Ct result is considered to be less than or the same as the 
mean of all the Cts plus 5 since the Cts will be expected to go up because of 
lesser amount of DNA present as a result of the dilution factor. These 
parameters were set experimentally to exclude 5 % of the data points (95 % CI). 
The cut-off Ct value for Giardia intestinalis was 40. This means that, any 
patient sample with a Ct value greater 40 will be considered as a negative result.  
 Amplification was performed in a Rotor-Gene Q6000 (Corbett Life 
Sciences) using TaqMan(R) environmental master mix 2.0 (Applied 
Biosystems). The cycling conditions were: Hold: 95 
o
C for 10 min, (Step 1: 95 
o
C for 15 s, and step 2: 60 
o
C for 60 s), steps 1 and 2 repeated for 45 cycles. A 
sample was recorded as positive for Giardia intestinalis DNA when the 
detected fluorescence on the red channel was greater than 0.5 (as determined by 
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Rotor-Gene Q software series 2.02 (Build 4), with a Ct ≤ 40 (cut off value)). 
Also the GFP had Cts not above the average of the GFP Cts for the run 
(excluding the positive control) plus 1.23. If the figure was more than this, the 
sample was repeated with a 1 in 10 dilution (according to internal validation 
data). The test result for the 1 in 10 dilution was accepted if the GFP Ct was not 
above the average of the GFP Cts for the run (excluding the positive control) 
plus 5.0. 
gF1R1 Primers and probe  1.9 µl 
GFP Primers  and Probe  1.9 µl 
H2O  3.7 µl 
Environmental mastermix  12.5 µl 
Cocktail µl per tube  20 µl 
DNA  µl per tube  5 µl 
 
2.2.6 Conventional PCR simulation of Verweij real-time PCR  
Conventional PCR (CPCR) simulation of the Verweij real-time PCRfor 
the 62 bp amplicon of Giardia intestinalis was performed on apparent false 
positive samples where the real-time positive result could not be confirmed by 
the composite reference standard or any of the other test results. The same 
reagents used for the real-time PCR were used for the conventional PCR 
including, Giardia-80F and Giardia-127R primer pairs, but without the probe. 
A G-Storm thermocycler (Kapa Biosystems Model GS00001) was used with the 
following protocol: Heated lid 110
 o
C; Hot start 95 min (for 1 cycle) and 15min 
(for 1 cycle); (95 
o
C for 45 s and 60
 o
C for 1min 30 s) repeated for a total of 45 
cycles; 72 
o
C for 7 min (for 1 cycle) followed by a holding temperature of 10 
o
C. The amplification protocol was repeated, with the same set of primers, as a 
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two step reaction to maximize DNA yield. Sixty two bp amplicons were 
visualized using gel electrophoresis (Figure 3.4 and Figure 3.5).  
2.2.7 Conventional nested PCR  
A nested PCR was run with two different sets of primers to amplify the 
SSU-rRNA 130 bp fragment of Giardia intestinalis. These primers have been 
investigated and found to offer the best combination for a conventional nested 
PCR (Nantavisai et al., 2007). The conventional nested PCR was also run to 
investigate further the apparent false positive results. The nested PCR used two 
different sets of primers to amplify the SSU-rRNA 130 bp fragment of Giardia 
intestinalis for visualization using gel electrophoresis (Nantavisai et al., 2007). 
The primers used were RH11/RH4 and GiarF/GiarR (Hopkins et al., 1997; 
Nantavisai et al., 2007) (Table 2. 9).  
In the nest 1 reactions, the RH11/RH4 amplified a 292-bp region of the 5' 
end of the (SSU) rRNA gene. The amplification was performed in 25 µl 
volumes with the final mix containing 5-50 ng DNA as per published method 
(Hopkins et al., 1997) using Biomix red (Bioline product), a complete ready-to-
use 2x reaction mix containing an ultra-stable Taq DNA polymerase. The 
amplification process consisted of 95 
o
C for 2 min (1 cycle); (94 
o
C 20 s, 59 
o
C 
20 s, and 72 
o
C 30 s) repeated for 40 cycles; 72 
o
C for 7 min (1 cycle) and the 
cocktail (reaction mix) was prepared as follows:  
 
Nest 1 cocktail     µl/test 
Biomix Red      10 
RNAse/DNAse free water      7 
Rh4 + Rh11 (10 µM)       1 
Final volume      18 
DNA         2 
Total reaction vol.     20 
 
65 
 
The nest 2 primers which identified 130bp fragments of Giardia 
intestinalis were GiarF and GiarR (Read et al., 2002) (see below). A Thermo 
electron Px2 thermal cycler was used with the following amplification protocol: 
95 
o
C for 2 min (1 cycle); (94 
o
C 20 s, 59 
o
C 20 s, and 72 
o
C 30 s) repeated for a 
total of 45 cycles; 72 
o
C for 7 min (1 cycle) as per published protocol using 
Biomix red (Hopkins et al., 1997; Read et al., 2002). The cocktail (reaction mix) 
was prepared as follows:  
 
Nest 2 cocktail     µl/test 
Biomix Red      10 
RNAse/DNAse free water       7 
GiarF + GiarR (10 µM)      1 
Final volume      18 
 DNA         2 
Total reaction vol     20 
 
2.3 Results 
The range of the serial dilutions of Giardia intestinalis cysts used did not 
allow the detection of a cut off point for the Verweij real-time PCR. The limit of 
detection (LOD) was therefore estimated to be ≤ 4.5 cysts/ml (< 5 cysts/ml). 
The LOD for the Primerdesign Ltd. PCR was ≤ 113.6 cysts/ml (≤ 114 cysts/ml) 
(Table 2.12). With the exception of an isolated positive result (Ct 38.9) in one 
of the triplicate run in tube 6, the Primerdesign Ltd. assay did not detect any 
positive in the rest of the tubes from 6 to 7 and therefore the LOD was estimated 
to be ≤ 114 cysts/ ml. The LOD for the CRS was assessed to be ≤ 2840 cysts/ml 
and analytical specificity was 100 % for each of the diagnostic test evaluated 
because no cross reaction was detected with any of the other microbial flora 
tested in the pooled Giardia-negative stool. 
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At an estimated figure of < 5 cysts/ml, the Verweij real-time PCR had the 
highest analytical sensitivity compared to the other tests. 
 
Test 
Tube nos. Pooled Giardia-
negative stool 1 2 3 4 5 6 7 
RMT + - - nt nt nt nt - 
OCP-M + + - - - - - - 
EIA + + + - - - - - 
Primerdesign + + + + + - - - 
Verweij + + + + + + + - 
Cysts/ml 71000 14200 2840 568 113.6 22.7 4.5  
nt = not tested; + = Positive; - = Negative. 
 
Detection limits for Giardia trophozoites were also assessed for all the 
diagnostics tests including the EIA and RMT which formed the CRS (Table 
2.13).  
Test 
Tube nos. Pooled Giardia-
negative stool 
1 2 3 4 5 6 7 
OCP-M + - - - - - - - 
Primerdesign + - - - - - - - 
Verweij + + - - - - - - 
RMT + + - nt nt nt nt - 
EIA + + + + - - - - 
Trophozoites/
ml 
92000 9200 920 92 9.2 0.92 0.092  
nt = not tested; + = Positive; - = Nagative. 
Antigen detection using EIA was the most analytically sensitive test for 
trophozoites with the estimated LOD of  ≤  92 trophozoites/ml. In practice, 
however, the PCR assays do not differentiate between DNA from trophozoites 
and DNA from cysts.  
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Using clinical samples, the Primerdesign Ltd. real-time PCR standard curve 
produced an efficiency of 203 % (the slope was -2.076) (Figure 2.7 B) whilst 
the Verweij real-time PCR standard curve gave an efficiency of 100 % (the 
slope is -3.326) (Figure 2.7 A).  
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Generally an efficiency between 90 % and 110 % is considered 
acceptable (Real-time PCR: Understanding Ct, 2011). The serially diluted 
positive control from the Primerdesign Ltd. kit (purified Giardia intestinalis 
DNA solution), however, produced an efficiency of 99 % and R
2
 value of 1.00 
using the same environmental mastermix as was used for the Verweij real-time 
PCR (Figure 2.8). Clinical samples (stools) are a more challenging material 
because of the host of microbial flora, faecal matter and PCR inhibitors that 
they contain. The Verweij real-time PCR with efficiency of 100 % on clinical 
sample, R
2 
= 0.99 and LOD of < 5 cysts/ml has shown robustness in 
performance compared with the Primerdesign Ltd. PCR.  
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The kit positive control appears to have been optimised by the 
manufacturer hence the better result compared with the 203.3 % obtained from 
clinical samples. This assumption was further investigated with a repeat run of 
the two real-time PCR assays.  
 
 
 
 
One in 10 serially diluted Giardia DNA solutions obtained from Table 
2.1, Tube no. 1 was employed. Figure 2.9 and Figure 2.10 show the 
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amplification graphs and the standard curves obtained for both PCR runs and 
the Table 2.14 and Table 2.15 provide a summary of the findings from the 
assays’ performances with the percentage variance (% var) between the given 
concentrations of cysts or copies/ ml. and the calculated equivalent also shown.  
 
Assay 
parameters 
Dec 2011: First testing of DNA extracted from   
1 in 5 dilutions of stool. Test performed in triplicate 
Purified Giardia DNA 
Verweij Primerdesign Ltd. Primerdesign Ltd. 
LOD  < 5 cysts/ ml ≤ 114 cysts/ ml ≤ 2 copies/µl 
Efficiency (%) 100 203 99 
 R
2
 0.99 0.93 1.00 
Slope -3.326 -2.076 -3.342 
Variance 
(% Var) 
Predominantly > 10 
%Var 
i.e.  
(66.7 %)14 samples > 10 
% Var 
(33.3 %) 7 samples < 10 
% Var 
All 21 samples detected 
(100 %) 
Predominantly > 10 
%Var 
 i.e.  
(57.1 %)12 samples > 10 
% Var 
(14.3 %) 3 samples < 10 
% Var 
6 out of 21 not detected 
(28.6 %) 
Predominantly < 10 
%Var 
i.e. 
(58.3 %)7 samples < 10 
% Var 
(41.7 %)5 samples > 10 
% Var 
All 12 samples detected 
(100 %) 
It is clear from the data in Table 2.14 and Table 2.15 that all of the 
Primerdesign Ltd. Ct values, for both the extracted stool and the diluted DNA 
from the stool showed a variance predominantly > 10 %. A variance ≤ 10 % is 
generally considered acceptable ((Dhanasekaran, Doherty, Kenneth, & Group, 
2010). Also R
2
 in both instances was < 0.99. The Verweij real-time PCR 
showed variance predominantly > 10 % with the extracted stool (Table 2.14). 
The figures improved in Table 2.15 when the 1 in 10 serially diluted DNA from 
the stool were tested producing a variance predominantly < 10 % in the 
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preferred range of values. R
2
 values were however consistently 0.99 in both 
cases of testing.  
Assay 
parameters 
July 2013: Second testing (20 months after the first) of  
1 in 10 dilutions of DNA solution. Tested in triplicate 
Verweij  Primerdesign Ltd. 
LOD (cyst/ml) < 3.55 ≤ 355 
Efficiency (%) 96 100 
 R
2
 0.99 0.95 
Slope -3.414 -3.342 
% Var Predominantly < 10 % Var 
i.e.   
(73.3 %) 11 samples < 10 %Var  
(26.7 %)4 samples > 10 % Var 
All 15 samples detected (100%) 
Predominantly > 10 % Var 
i.e.   
(13.3 %) 2 samples < 10 % Var 
(46.7 %) 7 samples > 10 % Var 
6 out of 15 not detected (40 %) 
 
The purified Giardia DNA in the Primerdesign Ltd. real-time PCR kit 
gave excellent results with the kit’s primers targeting the gdh gene of Giardia 
intestinalis. Efficiency was 99 %, R
2
 = 1.00, and LOD ≤ 2 copies/ml with a 
positive detection in all tubes of the dilution series in sharp constrast with the 
performance observed when a clinical (stool) sample was used (Table 2.14). 
Primerdesign 2x precision mastermix was also used with the Primerdesign Ltd. 
kit to retest 36 Giardia intestinalis positive samples previously tested positive 
with environmental mastermix. Out of the 36 samples, only one retested 
positive with a Ct of 22.85 (sample 71, Burkitts lymphoma case). Giardia 
intestinalis trophozoites only were seen on microscopy. The environmental 
mastermix performed better than the Primerdesign 2x precision mastermix and 
the latter was not used again anywhere else in this project. 
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2.4 Discussion 
The purpose for this chapter was to ascertain the analytical sensitivity (limit 
of detection) and specificity of the diagnostic tests deployed in this study in 
order to assess their suitability for diagnostic accuracy studies. The two main 
constituent tests of the CRS detected antigens of Giardia intestinalis, and the 
PCR assays detected 62 bp and 130 bp fragments of Giardia intestinalis DNA. 
It was only the OCP-M that detected whole parasites instead of components of 
the parasite. 
In general, analytical sensitivity was better for most of the diagnostic tests 
when cysts instead of trophozoites were used (Table 2.12 and Table 2.13). The 
OCP-M for example used about the equivalent 10 µl of liquid stool to prepare 
thin faecal smears which were stained for the visualization of Giardia 
intestinalis trophozoites and a drop of about 50 µl stool was used for wet 
preparation examination for the trophozoites. These volumes are relatively 
small and only stools with very high counts of Giardia trophozoites will 
produce positive results. The OCP-M does not concentrate trophozoites because 
the organic solvent (ethyl ether) used tends to destroy them and therefore only 
cysts were seen from the 1 ml of stool that was concentrated hence the better 
analytical sensitivity performance of cysts over trophozoites. The fatty plugs in 
the faecal concentration method are known to trap not only helminth ova but 
also parasite cysts to different degrees according to the organic solvent used 
(ethyl acetate or ethyl ether) and whether a preservative was added to the stool 
or not prior to performing the concentration technique. The addition of additives 
affect the specific gravity of fluid in the mixing chamber of the Parasep and 
subsequently the OCP-M sensitivity therefore centrifugal speed and timing need 
to be set accordingly (Saez, Manser, Andrews, & Chiodini, 2011; Zeeshan et al., 
2011). 
The RMT detected Giardia cyst membrane bound antigens and the test 
was not designed to be used on trophozoites. However, compared with the 
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OCP-M, there was only one dilution tube difference between both tests in 
respect of the detection of both cysts and trophozoites (Table 2.12 and Table 
2.13).  Their analytical sensitivity test performances were therefore similar 
howbeit low. The RMT had to be repeated on occasion because of poor 
diffusion of the fluid gradient on the membrane strip. If this was an inherent 
weakness in the design of the strip, that could explain its low analytical 
sensitivity. Availability of membrane bound antigens relies on the presence of 
cysts and in a situation where cyst numbers are low, detection of the parasite 
will be difficult because of the small sample volume tested (10 - 20 µl stool).  
Contrary to the RMT, the EIA detected Giardia soluble cyst wall antigens 
and performed better on trophozoites than cysts (Table 2.12 and Table 2.13). 
Encysting trophozoites secrete these antigens and it could be envisaged that in 
the diluents, antigens were secreted in an attempt to encyst hence their detection 
in the trophozoites dilution tube 4 (≤ 92 trophozoites/ml) at a higher titre 
compared with the ≤ 2840 cyst/ml in the cysts dilution tube 3. The EIA detected 
soluble antigens and performed better than the RMT. The test can therefore be 
performed even in the absence of cysts on microscopy because soluble antigens 
could still be floating around. Similarly, the EIA performed better on 
trophozoites than the two real-time PCRs suggesting that soluble antigen 
detection could be the better choice of test to use instead of DNA detection in 
situations where trophozoites are more likely to be encountered (e.g. as in 
duodenal aspirates). The assessed EIA detection limit for trophozoites (≤ 92/ml) 
suggested the possibility that any stool sample which had less than 92 Giardia 
parasites may not have been detected by the CRS because the EIA was 
relatively more sensitive than the RMT in the formation of the CRS. This meant 
that any index test more sensitive than the CRS will have more false positive 
results which would impact on its specificity.  
The Verweij real-time PCR was more analytically sensitive than the 
Primerdesign Ltd. real-time PCR with tests performed on both the cysts and 
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trophozoites of Giardia intestinalis. This is a reflection on the gene target used 
in both tests. The (SSU) rRNA targeted by the Verweij real-time PCR has been 
found to be more conserved with less variability and therefore it is used more 
for genotyping (Feng & Xiao, 2011). The gdh target for the Primerdesign real-
time PCR has been reported to be relatively less conserved and therefore used 
for both genotyping and sub-typing (Feng & Xiao, 2011).  
The DNA detection in cysts was not only superior to the detection of 
antigen in cysts; it was also superior to the detection of it in trophozoites as 
indicated by the LOD’s (Table 2.12 and Table 2.13). There appeared to be a lot 
more Giardia DNA present that would not be titred out using the Verweij real-
time PCR and in a way showed how sensitive the Verweij real-time PCR was. 
The reason for this could be the fact that Giardia intestinalis show genome 
polyploidy in their chromosome arrangement. Polyploid cells and organisms are 
those containing more than two paired (homologous) sets of chromosome 
(Bernander, Palm, & Svärd, 2001). Giardia trophozoites go through two 
successive rounds of chromosome replication without cell division event.  A 
fully differentiated cyst contains four nuclei, each with a ploidy of 4N, resulting 
in a cyst ploidy 16N (Bernander et al., 2001). The formation of multiple cells 
from a single cyst is likely to be one of the main reasons for the high titre in the 
serial dilutions of the DNA compared with the antigens because of the 
quadrupling of genome ploidy. Between the two real-time PCRs, the Verweij 
real-time PCR had a lower detection limit than the Primerdesign Ltd. PCR. In 
particular, there was no cut off limit for the detection of cysts using the dilutions 
employed in the LOD test for both real-time PCRs. The estimated Verweij  PCR 
LOD was < 5 cysts/ml of stool and that for the Primerdesign Ltd. was ≤ 114 
cysts/ml (Table 2.12). 
With almost every step the same for both assays from sample processing to 
the reading of the results, the differences in the analytical measures could only 
be attributed to the gene targets for the respective primers. The gene target for 
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the Primerdeisgn Ltd. PCR was the gdh gene and that for the Verweij real-time 
PCR was the (SSU) rRNA. It is known that the sensitivity of PCR amplification 
of the gdh gene is limited, in particular, when low numbers of cysts are present 
in faecal samples (Bertrand et al., 2005; Nantavisai et al., 2007). There was no 
positive Giardia intestinalis DNA detected when cysts count fell below the 
estimated 113.6 per ml (Table 2.12). This was in contrast with the real-time 
PCR SSU-rRNA primers Giardia-80F and Giardia-127R for there was no end 
point reached in the range of serial dilutions used in this study. The (SSU) 
rRNA gene is therefore a more reliable target to use as a first line test for the 
diagnosis of giardiasis. Asher et al. (2012), will however disagree with this 
conclusion because in a study to evaluate a PCR protocol for the detection of 
Giardia intestinalis, they reported a success rate of 90 % for (18S) rRNA and 
94 % for the gdh loci (Asher, Waldron, & Power, 2012). They amplified a 130 
bp product from the (18S) rRNA gene using the primers RH11 and RH4 as 
previously described (Hopkins et al., 1997) and the primers GiarF and GiarR for 
the secondary PCR as previously described (Read et al., 2002). They however 
reported extracting the DNA directly from only 50 mg of stool with no pre-
washing of the samples. This could account for the result that they got whereby 
gdh appeared to be the better loci to use for Giardia detection. In this study, 500 
mg of stool was pre-washed to remove soluble PCR inhibitors before DNA was 
extracted. The larger amount of stool used together with the pre-washing could 
account partly for the difference in performance. The LOD results therefore 
have shown an increased sensitivity level when the (SSU) rRNA is the target 
instead of the gdh and also underlines the importance of stool washing to reduce 
the effect of PCR inhibitors before extraction. 
In this study, the effect of PCR inhibitors was also seen in the improvement of 
efficiency for the Primerdesign Ltd. real-time PCR from E = 203 %, R
2
 = 0.93 
when DNA extracted directly from stool was tested to E = 100 %, R
2
 = 0.95  
when the extracted DNA was serially diluted 1 in 10 and retested 20 months 
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later (Table 2.14 and Table 2.15). The inhibitor concentrations/ effect were 
lowered by the serial dilutions and this reflected in the reduction of percentage 
variance (% var) figures. Test results with % variance > 10 % dropped from 12 
samples when first tested with DNA extracted directly from stool down to 7 
samples when tested with the 1 in 10 dilutions from the serially diluted DNA 
solution (Table 2.14 and Table 2.15). Overall degradation of DNA was not 
apparent from the set of results obtained after the 20 months storage at -20 
o
C 
(Table 2.14 and Table 2.15). The improvement in efficiency, notwithstanding, 
the Primerdesign Ltd. real-time PCR was not robust or sensitive enough to 
detect Giardia DNA in low concentrations even in the diluted DNA solution 
from the stool sample with reduced inhibitory substances. LOD ≤ 355cysts/ml 
was estimated (Table 2.15). For reasons already alluded to, the gdh gene 
targeted by the Primerdesign Ltd. real-time PCR is less sensitive and more 
discriminatory than the (SSU) rRNA and therefore it is capable of sub-typing of 
(Feng & Xiao, 2011). Genotyping at the (18S) rDNA locus is based on a 
relatively small amount of sequence data (e.g. 130 bp) compared to the 450 bp 
amplified at the gdh. The latter provides more data making it perhaps a more 
reliable assay on which to assign genotype/ sub-types (Read et al., 2004). 
Usually primers giving 60 bp to 150 bp amplicon sizes are considered ideal 
for a reliable PCR efficiency. Amplicons more than 150 bp may give < 100 % 
efficiency especially if they have not been designed to span exon-exon junctions 
giving rise to genomic DNA amplification and primer dimer formation 
(Dhanasekaran et al., 2010). With the exception of two out of the three 
Primerdesign Ltd PCR Tube 1 replicates showing % var < 10, increased 
variance, 13.7 to 138.8 %, were seen in all the standard solutions irrespective of 
whether the concentrations were low or high. The very low concentrations in 
tubes 4 and 5 (Table 2.1) were not detected at all. 
The Verweij real-time PCR efficiency dropped slightly from 100 % down 
to 96 % but stayed in the acceptable range of 90-100 %. The assay was robust 
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enough to detect Giardia DNA in all dilutions at both instances when the assay 
was performed. 
 R
2
 indicates how good one value is at predicting another. Usually 0.99 and 
above provides good confidence in correlating two values. The Verweij real-
time PCR gave R
2
 value 0.99 when it was first tested and again 0.99 when 
tested after 20 months. The figures for the Primerdesign Ltd. PCR (0.93 and 
0.95), however, never got up to 0.99 on both occasions of testing (Table 2.14 
and Table 2.15) indicating yet again the superiority of the Verweij real-time 
PCR over the Primerdesign Ltd. one. Copy number variations are known to 
occur as result of degradation of target sequences, which in turn can directly 
affect PCR efficiency but not the correlation coefficient R
2
 (Dhanasekaran et al., 
2010).  It has therefore been suggested that PCR efficiency, copy number 
variance and correlation coefficient R
2
 are equally important for quantification 
(Dhanasekaran et al., 2010). The two main reasons why these three parameters 
are equally important is 1) pipetting variations and 2) the large molecule of 
DNA. In this study, 20 months of DNA storage did not appear to have adversely 
affected PCR efficiency. DNA degradation, if any, was minimal judging from 
the efficiency figures (Table 2.14 and Table 2.15). Pipetting variations could 
also be the reason behind the > 10 % variations and not just PCR inhibitors 
alone. DNA molecules are large and they are likely to make interactions with 
other molecules as well as intramolecular (electrostatic) interactions. The 
molecules do not behave like smaller molecules in solution and the interactions 
are hard to predict (Mygind et al., 2002). It has been suggested that for gene 
expression studies, primers targeting 60 bp to 150 bp amplicon sizes are 
considered ideal because > 150 bp amplicon sizes may give < 100 %  PCR 
efficiency(Dhanasekaran et al., 2010). This could explain why the variances in 
the Verweij real-time PCR and the Primerdesign Ltd. real-time PCR showed a 
Predominantly > 10 % but the Verweij real-time PCR alone showed a variance 
predominantly < 10 % after the DNA was serially diluted but Primerdesign Ltd. 
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real-time PCR remained predominantly > 10 % when the same set of dilutions 
were tested. The 62 bp amplicon sizes targeted by the SSU-rRNA primers of the 
Verweij real-time PCR appeared smaller than the gdh target (Read et al., 2004) 
The latter DNA sequence has not been disclosed by Primerdesign Ltd. and all 
attempts to amplify the DNA by using it as one of the positive controls for the 
Verweij real-time PCR failed. Even though the performance figures for the 
Primerdesign Ltd. PCR using the provided Giardia positive control is excellent 
(E = 99 %, R
2
 = 1.00, LOD ≤ 2 copies/ µl, and % var = Predominantly 10 %), it 
has been optimised for the kit and does not represent the harsh environment of 
clinical faecal samples. The information derived from the test run has been used 
only in a comparative sense to highlight the effect of PCR inhibitors and 
accuracy in pipetting. 
 It is also known that the detection very low copy numbers do not follow 
normal distribution of template but rather a Poisson type which stipulates that in 
a large number of replicates with an average of one copy of starting template, 
approximately 37 % will have no copies, 37 % will have one copy, and  18 % 
will have two copies (Real-time PCR: Understanding Ct, 2011). Thus in this 
study the 1 in 10 dilutions for standard curves were tested in triplicate to 
overcome the Poisson distribution limitation (Figure 2.9 and Figure 2.10).  
The OC&P method is not designed for trophozoites because the organic 
solvents used in the procedure tends to destroy them. However, direct smears 
from the unconcentrated stool can be prepared and stained with rapid Field’s 
stain for Giardia trophozoites and also wet preparations can be prepared to look 
for live Giardia trophozoites. Even with the improved OCP-M, the analytical 
sensitivities for both trophozoites and cysts obtained in this study were 
relatively very low with detection limits of ≤ 92,000 trophozoites/ml of stool 
and ≤ 14,200 cysts/ml stool respectively (Table 2.12 and Table 2.13). The OCP-
M method uses ethyl ether as an extractor of fat and debris from stools. The 
advantage of this method is that it will recover most ova, cysts and larvae and 
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retain their morphology thus facilitating their identification; it is not for Giardia 
species only. This method can be used on fresh as well as preserved samples, 
e.g. samples which have been preserved in formalin, sodium acetic acid 
formalin (SAF), and polyvinyl alcohol (PVA). It however has the disadvantage 
of destroying trophozoite stages and distorting cellular exudates. Also, mucoid 
stools do not concentrate well and therefore it will be necessary in these cases to 
examine the stool by direct microscopy instead of the concentration method. 
Cysts of Giardia intestinalis can be trapped in the ethyl-fatty plug and be lost. It 
is not surprising therefore that the assessed LOD for the OCP-M was very high, 
≤ 14,200 cysts/ml. The RMT test was not performed on samples containing 
trophozoites from tube 4 to tube 7 and cysts from tube 4 to 7 because the test 
result had already gone negative by tube 3 in both cases. About three of the 
RMT strips were repeated because of unsatisfactory diffusion of fluid on the 
strips. This was caused by the mucoid consistency of the stool impeding the 
lateral flow of the stool and buffer suspension. Vortexing the faecal suspension 
for longer resolved the situation. 
So far, of the five tests investigated, the EIA gave the best detection level 
of ≤ 92 cysts/ml. The EIA detects soluble antigens released into the stool 
environment by Giardia intestinalis particularly when encystation is taking 
place. These results are exploratory as they were meant to find a baseline for 
comparing the tests for when the diagnostic sensitivities and specificities are 
tested. The detection limits with cysts showed the superiority of PCR over the 
antigen detection tests of the RMT and EIA, and also over the OCP-M.  
Analytical specificity for these tests were also investigated and no cross 
reactivity was detected in any of the tests when used on a pooled Giardia 
negative stool sample containing a host of faecal microbial flora. If a test has a 
high Analytical sensitivity it does not automatically mean that it will have a 
high diagnostic sensitivity and/or specificity(Saah & Hoover, 1997). The next 
section will show how the analytical sensitivities of the Index tests translated 
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into diagnostic sensitivities and specificities. The CRS LOD for trophozoites 
was good but with an estimated LOD of ≤ 2840 cysts/ml, it will be difficult to 
detect low numbers of Giardia cysts and considering that cysts forms of 
Giardia are found in stools more often than trophozoites, false positive results 
will have to be investigated further in the verification exercise in the next 
chapter.  
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Chapter 3: Verification of 
diagnostic sensitivities and 
specificities of tests for Giardia 
intestinalis 
3.1 Introduction 
The choice of the gold standard in any diagnostic test verification is crucial 
for the determination of true positive and true negative cases. Microscopy is 
considered to be the gold standard for the diagnosis of giardiasis but it is an 
imperfect gold standard and the sensitivity of parasite detection rarely gets to 90 
% due to the intermittent pattern of excretion of the parasite which can lead to 
their sub-optimal levels that cannot be detected using the direct smear or 
concentration method (Duque-Beltrán et al., 2002). Even when multiple 
samples taken on different days have been examined, a much improved 
sensitivity of parasite identification has been reported to be only 85 % (Duque-
Beltrán et al., 2002; Gaafar, 2011). To avoid the risk of bias and to ensure the 
quality of this diagnostic research, the current version of the quality assessment 
of studies (QUADAS) tool, i.e. QUADAS 2, was consulted in the design of this 
diagnostic accuracy study. The tool is recommended in systematic reviews for 
the assessment of the risk of bias and sources of variation in  studies (Whiting et 
al., 2011). From the tool the following information were used to design this 
diagnostic accuracy study: 
 1. A composite reference standard was used in the absence of a gold 
standard avoiding incorporation bias with the index tests by selecting different 
targets for the tests. 
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2. Bias in the selection of samples was avoided by using a consecutive non-
probability sampling technique.  
3. Second qualified (biomedical scientists) readers who had no knowledge 
of the results were used to avoid workup bias, and 
4. All the study samples were individually tested with each of the index tests 
thereby avoiding verification bias 
A composite reference standard (CRS) of RMT and EIA was used in the 
comparative study of the three index tests, viz. OCP-M, Primerdesign Ltd. real-
time  and Verweij real-time PCR assays. The procedure has been recommended 
by the Health Technology Assessment (HTA) for  studies when there is no gold 
standard (Rutjes, Reitsma, Coomarasamy, Khan, & Bossuyt, 2007). These 
reference tests detect Giardia antigens and avoid any incorporation bias with 
the index tests. The index tests have the intact parasite (detected by the OCP-M) 
and genomic DNA (detected by the real-time PCR assays) as their targets for 
the identification of the parasite. Some researchers have used other 
experimental designs that involved combinations of the index test as extended 
reference test in the absence of a gold standard(Elsafi et al., 2013; Schuurman et 
al., 2007).  
Whilst QUADAS 2 deals with quality issues in methodology, STARD, which 
stands for the Standard of Reporting of Studies, similarly deals with quality in 
the reporting of studies by emphasizing on its accuracy and completeness at the 
end of the study. To ensure accurate and full reporting of this study, a flow chart 
has been provided to show the outline of the investigatory path beginning with 
sample selection through to the results of the index tests (Figure 3.1) with 
explanations provided in the text. STARD format of introduction, method, 
result, and discussion has been adopted as the style for the reporting of this 
study. The STARD statement has recommended this approach to introduce 
clarity, accuracy and completeness of the information given in the reporting of 
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studies (Bossuyt et al., 2003; Standards for the Reporting of Diagnostic 
accuracy studies (STARD) Statement, 2008).  
 
 
Whereas STARD checks the information that ideally should be reported, 
QUADAS evaluates the quality of the reported information (Oliveira, Gomes, & 
Toscano, 2011).  
  
Samples archived from previouly 
diagnosed cases of giardiasis, clinical 
suspicion based on  classical symptoms 
of  giardiasis, and microscopy positive 
samples for Giardia. March 2010 to 
July 2011, n = 213 
Giardiasis, study group, n = 170 
Composite reference 
standard true positive 
n =  91 
Index test (OCP-M), in 
house real-time PCR, or 
Primerdesign Ltd. real-
time PCR 
Giardia 
positive 
fraction 
Giardia 
negative 
fraction 
Composite reference 
standard true negative 
n =  79 
Index test (OCP-M), in 
house real-time PCR, or 
Primerdesign Ltd. real-
time PCR 
Giardia 
positive 
fraction 
Giardia 
negative 
fraction 
Not included, 
n = 43 
Dried up in 
storage  
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3.2 Methods 
The (SSU) rRNA and the gdh genes of Giardia intestinalis have been used 
in the molecular characterization of Giardia intestinalis (Gómez-Couso et al., 
2012). Using a composite reference standard of EIA and RMT, the sensitivity 
and specificity of OCP-M, Primerdesign Ltd. real-time PCR and Verweij real-
time PCR were compared (see Section 2.2 for how the individual tests were 
performed). A conventional PCR simulation of the Verweij real-time PCRand a 
nested PCR protocol amplifying fragments of 62 bp and 130 bp respectively of 
the (SSU) rRNA gene of Giardia intestinalis, were also performed as backup 
tests for the CRS to resolve any discrepant results.  
3.2.1 Sample selection 
All samples received for standard diagnosis by stool OCP-M in the 
Department of Clinical Parasitology at HTD, London were considered for 
inclusion in this study. A non-probability sampling technique with consecutive 
samples was adopted for this study. Over a 15-month period, from 30th March 
2010 to 22nd July 2011, biomedical scientists processing stools for OCP-M 
investigations were asked to archive all samples which were positive for 
Giardia intestinalis by microscopy. In addition they were also asked to archive 
samples which were negative for Giardia intestinalis but fulfilled any of the 
criteria given in Table 3.1.  
 
 
Sample Groups Total 
Clinical suspicion (specific request to 
test for Giardia ) 
213 Previously diagnosed Giardia 
Other GI disturbances where giardiasis 
was not singled out for investigation.  
Total 
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In all, 213 samples were archived, comprising 98 Giardia microscopy 
positive samples and 115 microscopy negative samples. Each sample was split 
and stored at 4-6°C and at -20°C.The actual testing of these samples took about 
8 months from July, 2011 to February, 2012.  
Forty three samples were excluded for the following reasons: Samples with 
small volumes < 2 g or < 5 ml and samples dried up in storage. Also excluded 
were the oldest of multiple samples from the same patient. All identification 
labels on the 170 samples were masked and the samples were relabelled 
randomly from 1-170 by a biomedical scientist who had no prior information 
about the OCP-M results for these samples. Following the re-labelling, all the 
170 samples were tested with EIA and then with RMT (composite reference 
standard) (Table 3.2). 
 
 
Sample
Group 
Reference Tests 
Composite
Ref. Test 
result 
No. of 
samples 
Total Enzyme 
immunoassay (EIA) 
Rapid Membrane 
Test (RMT) 
1 P  or WP N TP 10  
 
91 2 N 
P or WP TP 2 
3 P or WP P or WP TP 79  
4 N N TN 79 79 
 Total 170 
P = Positive, WP = Weak positive, N = Negative, TP = True positive, TN = True negative 
 
Seventy nine true negative samples were designated using the criteria 
given in sample group 4 in (Table 3.2) and 91 true positive Giardia intestinalis 
stools were also designated using sample groups 1 to 3 in Table 3.2 as a guide. 
The 170 stool samples were all individually tested with both constituent 
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reference tests of the CRS, and the three index tests (Tables 3.6 displays the 
results table).  
3.2.2 Verification of power and sample size estimations 
Power and sample size estimations are measures of the number of subjects 
enrolled in a study.  They provide the number of participants required to avoid 
type I (false positive) and type II (false negative) errors. In a comparative study, 
“power” refers essentially to the number of subjects required to avoid type II 
error. Sample size is more encompassing and is applicable to all types of studies 
(Jones, Carley, & Harrison, 2003).  
This research project being a comparative study and because the sample 
size of 170 (91 positive and 79 negative stool samples) was the available sample 
size fixed by the study design (see sub-section 3.2.1), it was put through sample 
size investigations to determine whether at 91 samples for sensitivity and 79 
samples for specificity, it could support 95 % confidence limit and 0.95 power 
(probability) calculations. The power of the study is the probability that, given 
the sample sizes specified, and the expected confidence level, the study will be 
able to detect a predetermined difference in performance between two 
diagnostic tests if a difference truly exists. 
 The sample size interrogation was based the work of Flahault, Caldihac 
and Thomas (2004). They described the determination of sample size for binary 
diagnostic test assessment studies, and provided exact tables based on the 
binomial distribution and 0.95 power (see Figures 3.2 and 3.3) (Flahault, 
Cadilhac, & Thomas, 2005).  
Before using the tables, the works of three groups of researchers were 
consulted (Table 3.3) for the accuracy measures that they obtained using the 
same SSU-rRNA primers used in this study. 
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As a guide to the sample size verification, the accuracy figures from the study 
by Haque et al. (2007) (Table 3.3) was used because, for a gold standard, they 
used a composite reference standard (ELISA and PCR) in the design of the 
study as has been used in part in this study. So using Haque et al. (2007) 
measures as a reference guide, and assuming the expected sensitivity for this 
study to be ≥ 0.90 with the lower 95 % confidence limit not falling below 0.75, 
with 0.95 probability (power), the exact number of cases required for sensitivity 
estimation was 70 (Figure 3.3).  
 
Sample size & confidence intervals (CI) 
      No. Sensitivity (%)  95 % CI     Specificity (%)    95 % CI       Total            Reference                                                                                  
1.     90.7             78.9 - 96.5        98.7            91.8 - 99.9     129  (Haque et al., 2007) 
2.     100              95.4 - 100         91.9            84.2 - 96.2     20    (Schuurman et al., 2007) 
3.     98.1             92.5 - 99.7        70.6            52.3 - 84.3     138  (Verweij et al., 2003) 
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Similarly, with specificity of 98.7 % (95 % CI: 91.8 to 99.9 %) from the 
same study (Haque et al. (2007)), assuming the expected specificity for this 
research study to be  ≥ 0.98 with the lower 95 % confidence limit not falling  
below 0.89, with 0.95 probability (power), the exact number of cases required 
for specificity estimation was 69. The 170 samples (91 for sensitivity and 79 for 
specificity) used in this study therefore satisfied the sample size minimum 
requirement of 139 samples (70 for sensitivity and 69 for specificity) (Flahault 
et al., 2005) for the estimation of sensitivity ≥ 90 % and specificity ≥ 98 %. 
 
With these verifications established, the set of results obtained from the 
testing of the 170 samples would therefore be adequate for the examination for 
statistical significance.  
Statistical tests: 
Before diagnostic sensitivities and specificities were calculated, McNemar 
statistics were performed to compare the index test with the CRS to establish 
90 
 
the extent of any differences in performance that there might be among the 
diagnostic tests. McNemar’s test was used to analyse paired data obtained from 
the three index tests (OCP-M, Primerdesign Ltd. real-time PCR and Verweij 
real-time PCR) when used to test all the 170 samples in this study. This was 
done to find out any significant differences in performance among the three 
tests. The test data was analysed using a 2x2 table (Table 3.4): 
 
Test Negative Positive Total 
Negative A B (A+B) 
Positive C D (C+D) 
Total (A+C) (B+D) (A+B+C+D) 
 
In McNemar’s test, the null hypothesis assumes that the total rows are 
equal to the sum of columns, i.e. (A+B) = (A+C), and (C+D) = (B+D) (Table 
3.4) and therefore there will be no significant difference in performance 
between the paired tests. This situation will occur in this study if the real-time 
PCR and the OCP-M performed at the same level testing the 170 stool samples. 
The alternative hypothesis assumes that the total number of rows is not equal to 
the total number of columns and therefore significant difference in performance 
exists between the paired tests. McNemar’s test’s calculated value is compared 
with the Chi-square table value. If the calculated value for McNemar’s test 
value is greater than the table value, the null hypothesis is rejected. If, however, 
the calculated value is less than the table value, the null hypothesis is accepted. 
Statistical Product and Service Solutions (SPSS software) was used for the 
calculations. Cross tabulation statistics were also used to analyse the results data 
(Table 3.5). The sensitivity, specificity, and likelihood ratios were calculated 
using the following formula: 
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Test 
Composite reference standard 
Total 
Positive Negative 
Positive a (TP) b (FP) (a+b) 
Negative c (FN) d (TN) (c+d) 
Total (a+c) (b+d) (a+b+c+d) 
Key: TP= True Positive, TN= True Negative, FP= False Positive, FN= False Negative 
 
Sensitivity = a/(a+c); Specificity = d/(b+d), positive likelihood ratio (LR+) = 
Sensitivity/ 1 – specificity, and negative likelihood ratio (LR-) = 1 – sensitivity/ 
specificity. Medcalc diagnostic test calculator was used to calculate the values 
with the accompanying confidence intervals. 
3.2.3 Sequencing 
MO BIO Laboratories UltraClean 15 DNA purification kit was used in an 
attempt to recover 62 bp Giardia DNA from TAE agarose gels. The kit can 
purify DNA size range 60 bp - 50 kb. The desired DNA band was cut from the 
agarose gel after electrophoresis and melted irreversibly in a chaotropic salt 
solution. The kit uses ULTRA BIND silica particles to bind DNA. The 
DNA/silica complex was pelleted by centrifugation and the pellet washed once 
before the concentrated DNA was collected in Tris buffer. The manufacturer’s 
guidelines as provided in Appendix VI were followed in an attempt to obtain 
purified Giardia DNA for sequencing from the twenty samples with discrepant 
results from the Verweij real-time PCR (Table 3.8). 
3.3 Results  
Cross tabulation results: 
The results of the 2x2 analysis for diagnostic sensitivities and specificities as 
well as positive and negative likelihood ratios are shown in Table 3.6 and 3.7. 
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Test No. of samples 
Total 
CRS True positive True negative 
EIA & RMT 91 79 170 
Index 
True 
positive 
fraction 
False 
positive 
fraction 
True negative 
fraction 
False negative 
fraction 
Total 
OCP-M 76 3 76 15 170 
Primerdesign 56 1 78 35 170 
Verweij 85 20 59 6 170 
OCP-M & 
Verweij 
85 21 58 6 170 
 
The Verweij real-time PCR, with detection limit < 5 cysts/ml, gave a sensitivity 
of 93.4 % (95 % CI: 86.2 to 97.5 %), which was the best among the three index 
tests (Table 3.7). The LOD of the Primerdesign Ltd. real-time PCR of ≤ 114 
cysts/ml of stool produced a diagnostic sensitivity of 61.5 % (95 % CI: 50.8 to 
71.6 %), whilst the LOD of the OCP-M of ≤ 14200 cysts/ml of stool gave a 
diagnostic sensitivity of 83.5 % (95 % CI: 74.3 to 90.5 %). 
Index tests 
Sensitivity Specificity Likelihood ratios 
% 95 % CI % 95 % CI LR+ 95 % CI LR- 95 % CI 
OCP-M 83.5 
74.3 to 
90.5 % 
96.2 
89.3 to 
99.2 % 
22.0 7.2 to 67.0 0.17 
0.11 to 
0.27 
Primerdesign 61.5 
50.8 to 
71.6 % 
98.7 
93.1 to 
99.8 % 
47.3 
6.9 to 
343.2 
0.39 
0.30 to 
0.51 
Verweij 93.4 
86.2 to 
97.5 % 
74.7 
63.6 to 
83.8 % 
3.7 2.5 to 5.4 0.09 
0.04 to 
0.19 
OCP-M plus 
Verweij 
93.4 
86.2 to 
97.5 % 
73.4 
62.3 to 
82.7 % 
3.51 2.4 to 5.1 0.09 
0.04 to 
0.20 
LR+ = Positive likelihood ratio; LR- = Negative likelihood ratio; 95 % CI = 95% confidence 
interval.  
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The Verweij real-time PCR had the highest analytical as well as diagnostic 
sensitivity of < 5 cysts/ml and 93.4 % (95 % CI: 86.2 to 97.5 %) respectively 
compared with the ≤ 114 cysts/ml analytical sensitivity and 61.5 % (95 % CI: 
50.8 to 71.6 %) diagnostic sensitivity of the Primerdesign Ltd. PCR. The gdh 
gene has been investigated for Giardia sp identification and has been found to 
be less efficient than that of the (SSU) rRNA gene (Boontanom, 
Siripattanapipong, Mungthin, Tan-ariya, & Leelayoova, 2010) and this study 
confirms that.  
 
No. 
Study case 
no. 
CRS 
CPCR  Verweij real-time PCR 
Nested Simulation of the Verweij PCR Result Ct 
1 20 NEG POS POS POS 18.66 
2 80 NEG NEG POS POS 33.41 
3 26 NEG NEG POS POS 33.99 
4 89 NEG NEG POS POS 34.31 
5 74 NEG NEG POS POS 34.82 
6 73 NEG NEG POS POS 35.04 
7 21 NEG NEG POS POS 35.66 
8 34 NEG NEG POS POS 36.80 
9 51 NEG NEG POS POS 37.13 
10 103 NEG NEG POS POS 38.77 
11 12 NEG NEG POS POS 39.08 
12 104 NEG NEG POS POS 39.99 
13 11 NEG NEG POS POS 37.14 
14 101 NEG NEG POS POS 38.50 
15 44 NEG NEG NEG POS 39.81 
16 42 NEG NEG NEG POS 36.42 
17 57 NEG NEG NEG POS 37.80 
18 37 NEG NEG NEG POS 38.13 
19 67 NEG NEG NEG POS 38.64 
20 96 NEG NEG NEG POS 38.78 
CRS= Composite reference standard; CPCR = Conventional PCR; Ct = Cycle threshold; NEG = 
Negative; POS = Positive. 
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The OCP-M had a very low analytical sensitivity which is reflected in the 
naturally low diagnostic sensitivity of 83.5 % (95% CI: 74.3 to 90.5 %). This 
notwithstanding, microscopy is a very useful test in the sense that the presence 
of other parasites apart from Giardia can be detected. 
 The Verweij real-time PCR had about 20 apparent false positive test 
results because the positive results could not be confirmed by the CRS (Table 
3.8) and these were recorded as false positives in the statistical calculations.  
 
DNA extraction from gel for sequencing 
 
 
 
 
DNA sequencing, the process of determining the precise order of nucleotides 
within a DNA molecule, was planned for use to further investigate 20 false 
   1        2          3           4          5          6           7         8           9          10        11        12         13       14 
50 bp 
 
75 bp 
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positive samples. The sequencing was to be done at the London School of 
Hygiene and Tropical Medicine (LSHTM) where the facilities are based. 
However, all attempts to purify 62 bp Giardia intestinalis DNA, from the 
samples with discrepant results, for use in sequencing were unsuccessful from 
both the real-time PCR amplicons and from the conventional nested PCR assay 
(Figures 3.4, 3.5, 3.6). The 5 products that failed to move out from the origin 
were selected initially to begin the DNA extraction from gel because of their 
relatively low Ct. Even though all the twenty discrepant results showed high 
Cts, these five samples stood a better chance of showing bands on agarose gel. 
The DNA that failed to move from the starting point on the gel (Figure 3.4) 
were cut out and extracted using MO BIO Laboratories UltraClean 15 DNA 
purification kit. 
  
 
 
 
The electrophoresis was repeated on these extracted DNA samples and no 
Giardia intestinalis DNA was detected in any of the samples including the 
75 bp 
50 bp 
Artifact on perspex plate 
                 1         2           3            4             5          6          7            8           9          10    
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positive control (Figure 3.5) when 2 µl of each extract was run on 3% agarose 
gel as a test run to show the presence of the required DNA bands which would 
have indicated a successful extraction and would have meant that 62 bp Giardia 
intestinalis DNA amplicons could be isolated and sequenced. 
The pre-extraction procedures were not performed on the remaining 15 
samples because of their relatively high Cts. They had even less chance of 
producing bands when samples with even less Cts values had failed to be 
extracted from the agarose gel. Figure 3.6 shows an example of the many 
fruitless attempts to get Giardia intestinalis 62 bp DNA for sequencing.  
 
 
 
A considerable amount of time was spent trying to resolve issues by varying the 
amounts of reagents and agarose gel concentrations used as well as the length of 
time gels were run (1.5 - 3 h). The exercise became too costly and in the end no 
62 bp Giardia intestinalis DNA was isolated. 
Alternative strategies that could have been explored, if time and resources had 
allowed obtaining a good yield of DNA for sequencing would be cloning of the 
   1          2           3            4            5              6           7            8           9           10            11          12         13            14 
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Giardia parasite. This procedure has been used in a multi-locus analysis of 
Giardia intestinalis (Wielinga, Ryan, Thompson, & Monis, 2011). It has also 
been explored in a novel method using cultures and faecal samples and no 
genetic difference was found between any of the clones and the parent isolates 
(Binz, Thompson, Meloni, & Lymbery, 1991). Also DNA could be pelleted and 
reconstituted with a small volume of buffer to increase it concentration 
(Personal communication, R. Chalmers 14/07/2013). Polyacrylamide gel 
electrophoresis was also suggested as it is capable of providing very high 
resolution of DNA molecules in the 10 - 3 kb size range.  
  Some researchers have used larger volumes of DNA solution (500 µl) with a 
measure of success (Calderaro et al., 2010) but the resources and time available 
for this study did not allow further experimentation in this area. 
As a direct alternative to sequencing, restriction fragment length polymorphism 
(RFLP) together with PCR could also be used to further characterize Giardia 
intestinalis. RFLPs are detected and identified with the aid of DNA molecular 
markers when restriction digest are separated on agarose gel by electrophoresis. 
This procedure has been used to identify genotypes of Giardia intestinalis by 
targeting the gdh locus (Read et al., 2004). This is an area that could be 
explored in the future in situations where direct sequencing becomes a problem. 
  For this study, in the absence of direct sequencing, the presence of 62 bp 
fragments of Giardia intestinalis was investigated using conventional nested 
PCR. Sixty two bp fragments were the amplicon sizes produced by the SSU-
rRNA primers of the Verweij real-time PCR. The decision was therefore taken 
to remove the probe from the Verweij real-time PCR and run the product, after 
amplification, on agarose gel to visualize 62 bp diagnostic bands that the 
Verweij real-time PCR primers were meant to amplify. This has been called 
CPCR simulation of the Verweij real-time PCR (section 2.2.6). Fourteen of the 
20 samples appeared confirmed by the CPCR simulation of the real-time PCR 
to contain the target gene (62 bp Giardia DNA fragments) (Figures 3.4 and 3.5) 
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and the six samples in which the CPCR simulation failed to confirm the 
presence of 62 bp fragments were deemed more likely to be due to non specific 
amplification and less likely to be due to environmental contamination. The six 
samples had weak Ct reactions with values in the range of 37.8-39.8 (38-40) 
(Table 3.8) which suggested a minimal amount of target DNA (Real Time PCR 
Ct Values, n.d.). In this study a Ct of 35.7 was equivalent to 1.98 (~ 2) Giardia 
cysts and 36.8 was equivalent to 0.89 of a Giardia cyst (~ 1). Two of the 14 
samples were positive by microscopy with Cts of 18.7 and 34.0 (Table 3.8). All 
14 samples were retested with the nested CPCR and only the sample with Ct of 
18.7 (no. 20) gave a positive result which indicated the identification of a 130 
bp fragment of Giardia intestinalis (Figure 3.9).  
 
 
Therefore, at least one result was independently verified. The Ct for the 
microscopy positive sample that failed to produce a positive result with the 
composite reference standard and the nested CPCR (study case no. 26) was 34 
(33.99) (Table 3.8). The Verweij real-time PCR cut-off for a positive result was 
1      2       3       4      5       6       7        8      9        10     11     12      13     14     15     16    17    18  
100 bp 
62 bp 
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40 and Cts of 30-37 are positive reactions indicative of moderate amount of 
target nucleic acid (Real Time PCR Ct Values, n.d.). The issue is that of 
sensitivity for the amount of starting DNA was below the detection level of both 
the CRS and nested CPCR. 
 
 
 
Adjusted 
Diagnostic 
accuracy 
Diagnostic test 
OCP-M Verweij real-time PCR 
% 95 % CI % 95 % CI 
Sensitivity 75 65.55 to 82.97 94.3 87.97 to 97.86 
Specificity 98.5 91.81 to 99.75 90.8 80.97 to 96.51 
LR+ 49.5 7.05 to 347.31 10.2 4.76 to 21.92 
LR- 0.25 0.18 to 0.35 0.06 0.03 to 0.14 
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When the 14 samples that showed the 62 bp fragments were considered as true  
positive cases for the restricted comparison between the OCP-M and the 
Verweij real-time (Incorporation bias was avoided), the adjusted accuracy 
figures that ensued showed a much improved performance for the Verweij real-
time PCR (Table 3.9). Specificity, for example rose up to 90.8 % (80.97 to 
96.51 %) from 74.7 % (63.6 to 83.8 %). 
A combination of tests was also investigated by combining OCP-M and 
the Verweij real-time PCR to form an index test to see whether the combined 
effect will maximize the sensitivity of the Giardia assay. The result showed no 
improvement in sensitivity which remained at the same level of 93.4 % (Table 
3.7). The specificity however was reduced as a result of the combination and 
fell from 74.7 % (95 % CI: 63.6 to 83.8 %) down to 73.4 % (95 % CI: 62.3 to 
82.7 %). 
 
 
 
 
McNemar’s test results: 
 
For all three of the paired tests (i.e. Verweij real-time PCR vs. OCP-M, 
Verweij real-time PCR vs. Primerdesign Ltd. PCR, and OCP-M vs. 
1     2       3       4      5    6      7       8      9    10 
130 bp 
Study case no. 20 
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Primerdesign Ltd. PCR), p-values were < 0.05, which was statistically 
significant (Tables 3.9-3.11). Therefore the null hypothesis that said there was 
no difference in the performance of the three tests was rejected. The index tests 
produced different sets of results on the same 170 samples and the p-values (< 
0.05 in each case) (Table 3.10, Table 3.11, Table 3.12) indicated that there were 
significant differences in performance among the tests and this warranted 
further investigations. 
 
Test 
OCP-M 
Total 
p-value 
- + 
< 0.05 
Verweij real-time 
PCR 
- 64 1 65 
+ 27 78 105 
Total 91 79 170 
 
 
Test 
OCP-M Total p-value 
- +  
< 0.05 Primerdesign Ltd. real-
time PCR 
- 87 26 113 
+ 4 53 57 
Total 91 79 170 
 
 
Test 
Primerdesign Ltd. real-time PCR 
Total 
p-value 
- +  
< 0.05 Verweij real-time 
PCR 
- 65 0 65 
+ 48 57 105 
Total 113 57 170 
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3.4  Discussion 
The aim of this study was to determine the diagnostic accuracy of real-time 
PCR methodology as a frontline test for the laboratory diagnosis of giardiasis. 
In any diagnostic accuracy study, the performance of the gold standard is 
crucial and because there is no established gold standard for the investigation of 
Giardia intestinalis (Vesy & Peterson, 1999), a composite reference standard 
(CRS) of EIA and RMT was adopted together with two conventional PCR 
(CPCR) assays to act as confirmatory tests for discrepant results (Table 3.8). 
The CRS in this study had an estimated detection limit of ≤ 2840 cysts/ml 
compared with the ≤ 114 cysts/ml detection limit of the Primerdesign Ltd. real-
time PCR and < 5 cysts/ml of the Verweij real-time PCR. Using both manual 
and automated DNA extraction methods and different reaction volumes but the 
same Verweij real-time PCR primers and probes, Calderaro et al. (2010) 
reported detection limit of 2000 cysts/g of stool for the Verweij real-time PCR. 
This corresponded to a theoretical value of 2 cysts/ reaction and again 
emphasised the analytical superiority of the Verweij real-time PCR over the 
CRS. 
The CRS detection limit showed that Giardia parasites would be detected 
by the two index real-time PCR assays that the CRS failed to detect. This 
situation partly accounted for the highest number of false positive test results 
(about 20 of them) that the Verweij real-time PCR produced and had to be 
investigated further first with CPCR simulation of the Verweij real-time PCR 
and then with a nested CPCR (Table 3.8). This composite reference standard 
approach differed from previous investigators (Elsafi et al., 2013; Schuurman et 
al., 2007) who used experimental designs that utilized combinations of index 
tests as extended reference test in the absence of a gold standard. The approach 
in this study was however similar to that used by Calderaro et al. (2010) to get 
around the problem of non-availability of a gold standard for Giardia 
investigations. They used a composite reference standard of microscopy (OCP-
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M and direct immuno-fluorescence) and ImmunoCard STAT! enzyme 
immunoassay assay. They reported a total of 26 false positive results out of a 
total number of 602 true negative samples tested resulting in a percentage false 
positive rate of 4.3 % [(26/602) x 100]. Using the same set of primers and probe 
that Calderaro et al. (2010) used, the percentage false positive rate in this study 
was 25.3 % [(20/79) x 100]. The difference could be due to the fact that the 
researchers used microscopy for their gold standard and with a sensitivity of 
86.7%, selected samples with reasonable amount of Giardia parasites that could 
not be easily missed by the Verweij real-time PCR.  In other words fewer false 
positives (4.3 %) and no false negative (0 %) were reported which produced a 
calculated specificity of 95.7 % and a sensivity of 100 %. They however 
reported a sensitivity of 100 % as well when the 26 false positives were shown 
to have the 62 bp fragments. It also showed that the non-microscope based CRS 
in this study performed less than the ideal gold standard and therefore 
incorporated more positive cases with lesser amount of Giardia parasite as true 
negatives that were detected by the Verweij real-time PCR hence the higher 
percentage rate of 25.3 % for false positives and 6.6 % for false negatives 
resulting in sensitivity of 93.4 % and specificity of 74.7 %. 
The strength of the CRS in this study was in the EIA component which 
was analytically more sensitive than the two real-time PCRs in detecting 
Giardia trophozoites. This suggests that in situations where Giardia 
trophozoites are encountered more than cysts (e.g. as in duodenal aspirates), the 
EIA will be a more useful test to use. Giardia cysts are however found in stools 
more than trophozoites and the use of the CRS was still limited in spite of the 
high analytical sensitivity it showed. The CRS however avoided incorporation 
bias with the index tests which otherwise could have inflated accuracy measures 
like sensitivity and specificity. This was certainly the case when Calderaro et al. 
(2010) included their 26 false positive samples with the true positives after 
showing that they were true Giardia intestinalis DNA using conventional PCR 
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followed by sequencing and obtained a sensitivity of 100% and specificity of 
100% (Calderaro et al., 2010). Without the inclusion of the 26 cases as true 
positives, the specificity would have been 95.7%. 
This appears to be the first time an independent and a comprehensive 
evaluation of Giardia intestinalis diagnostic tests has been performed in a 
hospital laboratory setting in the UK. The gene target for the Primerdesign Ltd. 
PCR was the gdh gene and that for the Verweij real-time PCR was the (SSU)   
rRNA gene (Verweij et al., 2004; Verweij et al., 2003). The SSU-rRNA 
sequence has been found to be more conserved and could be the explanation for 
why primers amplifying the (SSU) rRNA gene worked better (Nantavisai et al., 
2007).  
The nested conventional PCR used as one of two confirmatory tests in this 
study confirmed one out of 14 samples tested for 130 bp amplicons of Giardia 
intestinalis. The nested PCR did not detect Giardia DNA in 13 of these 14 
samples even though the first confirmatory test (i.e. CPCR non-probe based 
simulation of the Verweij real-time PCR) gave positive results (Table 3.8) and 
diagnostic bands of 62 bp fragments were seen on electrophoresis gels (Figure 
3.7 and Figure 3.8). It is apparent that the nested CPCR detection limit was 
higher than that of the Verweij real time PCR and so the samples with Cts in the 
range of 33.4-40, indicating moderate to minimal copies of DNA target in the 
amount of specimen extracted, were not detected (Real Time PCR Ct Values, 
n.d.) (Table 3.8).  
No bands were observed when the real-time PCR amplification products 
for the discrepant cases were run on agarose gel (Figure 3.5). Calderaro et al. 
(2011) reported a similar problem in their study with the explanation that the 
problem could be related to the poor amount of DNA amplicon in the real-time 
PCR product. There is the possibility of DNA quality issues as well for in this 
study the real-time PCR products did not migrate from the gel wells under 
electrical charge (electrophoresis) (Figure 3.4) and when the DNA were excised 
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from the gel and extracted, no bands were detected after repeating the 
electrophoresis. The DNA amplicons may have been denatured by the real-time 
PCR procedure. Further investigation into this was however not undertaken 
because of time and money constraints. Calderaro et al. (2011) managed to 
sequence three out of six samples only after using a larger amount of DNA (500 
µl) for their conventional PCR which yielded enough DNA amplicons for 
sequencing. In this study the total amount of the original DNA extract was only 
100 µl and this hampered the amount of further or repeated testing that could be 
done.   
There was only one apparent PCR amplification failure where cysts were 
seen on microscopy but the Verweij real-time PCR failed to give a positive 
result even though the GFP extraction control was positive. The problem was a 
sampling issue for the portion of the stool used did not have Giardia intestinalis 
cysts due to the unequal distribution of cysts in the sample. The problem was 
resolved when the sample (study case no. 142) was re-extracted and the PCR 
repeated.  
The Primerdesign Ltd. real-time PCR sensitivity was 61.5 % (95 % CI: 
50.8 to 71.6 %) with an efficiency of 100 % (the slope = -3.342) using the same 
environmental mastermix as the Verweij real-time PCR. Generally an efficiency 
between 90-110 % is what is considered acceptable (Real-time PCR: 
Understanding Ct, 2011). The low diagnostic sensitivity for the Primerdesign 
Ltd. assay was due to the relatively high number of false negatives (FN) 
recorded, 35 in total. Because sensitivity relates inversely to the number of FNs 
i.e. Sensitivity = true positive/(true positive + false negative), any increase in 
the false negative samples will adversely affect sensitivity.  The diagnostic 
specificity for the Primerdesign Ltd. real-time PCR was 98.7 % (95 % CI: 93.1 
to 99.8 %). This means that a test result that is positive rules in giardiasis 
(SpPIN: a highly Specific test if Positive, rules IN disease). The Primerdesign 
Ltd. real-time PCR was not robust enough because Giardia DNA at lower 
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concentrations was not detected (Table 2.12, Tubes 6 and 7). The real-time PCR 
will therefore need optimization to overcome PCR inhibitors in faecal samples 
in order to perform efficiently on clinical samples. Until then its usage will be in 
the research laboratory delineating Giardia intestinalis complex into 
Assemblages A and B.  
The Verweij real time PCR appears to be the most useful test for 
consideration as a frontline test for the laboratory diagnosis of giardiasis with a 
sensitivity of 93.4 % (95 % CI: 86.2 to 97.5 %), reaction efficiency of 96 % (the 
slope = -3.414) and R
2
 = 99. The relatively reduced diagnostic specificity for 
the Verweij real-time PCR, 74.7 % (95 % CI: 63.6 to 83.8 %), was due to the 20 
samples classified as false positive (FP) by the composite reference standard 
(Table 3.8). Because Specificity = true negative/(true negative + false positive), 
any increase in the number of false positive samples will lower the specificity 
figure. Upon further investigation, only 6 out of the 20 samples appeared to be 
genuinely false positive due perhaps to non-specific amplification rather than 
contamination. The clinical relevance of this assay is seen in the fact that, in this 
project, had it not been for the use of the Verweij real-time PCR assay, 10 % of 
giardiasis positive cases would have been diagnosed as not having Giardia 
intestinalis by using the OCP-M. OCP-M, on the otherhand, with a sensitivity 
of 83.5 %, failed to detect 16.5 % of true giardiasis cases in this study. 
Similarly, with a sensitivity of 93.4 %, the Verweij real-time PCR failed to 
detect 6.6 % Giardia positive cases. The Verweij real-time PCR therefore 
diagnosed approximately 10 % more giardiasis cases than the OCP-M. Also, the 
Verweij real-time PCR’s robustness and excellent performance meant that 70 % 
(14/20) of the discrepant cases were correctly identified as cases of giardiasis. 
The OCP-M correctly identified only 10 % (2/20) (Table 3.8) and when these 
14 samples are accounted for as true positive samples, the specificity and the 
likelihood ratios showed a remarkable improvement in performance of the 
Verweij real-time PCR over the OCP-M (Figure 3.9).  The real-time PCR has 
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become an appealing alternative to conventional methods for diagnosing 
infectious diseases (Espy et al., 2006) and has also made the requirement to 
submit three stools for Giardia clearance non critical. A single stool sample, 
suitably timed post treatment, may be all that is required for the test of cure in 
the absence of other pathogenic intestinal parasites. With an enclosed system to 
minimise contamination risk coupled with the ease of performance, the real-
time PCR technology has become an appealing alternative to conventional 
methods for diagnosing infectious diseases (Espy et al., 2006). 
The specificity of the Verweij real-time PCR in this study will rise with the 
reduction in the number of false positive samples but in order to avoid the risk 
of verification bias, the specificity was not recalculated for this diagnostic 
accuracy study and was left at 74.7 % (95 % CI: 63.6 to 83.8 %) which was 
even better than what the original researchers, Verweij et al. (2003), had (i.e. a 
specificity of 70.6 % (95 % CI: 52.5 to 84.9 %)). However, as a potential 
diagnostic assay to replace the OCP-M, the Verweij Real-time PCR showed a 
relatively better improvement over the OCP-M when both were compared in an 
isolated case using the adjusted accuracy figures when the 14 confirmed true 
positives were noted in the CRS as true positive cases (Table 3.9). The 
specificity for the Verweij real-time PCR went up to 90.8 % (80.97 to 96.51 %) 
and the OCP-M sensitivity fell to 75 % (65.55 to 82.97).   
Another issue that affect diagnostic specificity of PCR is “viability”. The 
PCR assay may detect Giardia DNA fragments from dead parasites incapable 
of reproducing or causing disease. The test has not lost diagnostic specificity 
but gives results that will need clinical information about the patient for 
treatment purposes (Saah & Hoover, 1998). 
A highly sensitive test like the Verweij real-time PCR with very low LOD 
is vulnerable to contamination and in the light of this, the cut-off Ct value for a 
positive test result has been set at 40 and any Ct value above this is reported as 
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negative provided the GFP internal control Ct is within the acceptable range as 
previously mentioned.  
Positive predictive values (PPV) and negative predictive values (NPV) 
depend on disease prevalence and in diagnostic accuracy studies do not offer 
information that can be generalized. The disease prevalence in this study is 
about 53.5 % and this figure can easily change with a change in the positive 
samples to negative samples ratio in the sample size. Because the prevalence in 
the clinical population being examined has to be identical to the prevalence in 
the study population from which the predictive values are derived, the 
usefulness of predictive values in diagnostic accuracy studies for making 
clinical decisions is always going to be limited (Cook, Cleland, & Huijbregts, 
2007).  
Likelihood ratios are clinically more useful for they provide information 
on how many times more (or less) likely patients with, e.g. giardiasis, are to 
have a particular result than patients without giardiasis. A positive likelihood 
ratio greater than one means that a positive test result is more likely to occur in 
people with giardiasis than in people without giardiasis (It increases certainty 
about a positive result).  A positive likelihood ratio less than one means that a 
positive test result is less likely to occur in people with giardiasis compared to 
people without. A negative likelihood ratio, when greater than one, means that a 
negative test for giardiasis is more likely to occur in people with the disease 
than in people without it. When negative likelihood ratio is less than one, a 
negative test is less likely to occur in people with giardiasis compared with 
people without giardiasis (Akobeng, 2007). The greater than one the likelihood 
ratio is, the stronger the evidence of disease association. Conversely, the less 
than one the likelihood ratio is, the stronger the association with the absence of 
disease (Deeks & Altman, 2004). Likelihood ratios above 10 and below 0.1 are 
considered to provide strong evidence to rule in or rule out diagnoses 
respectively in most circumstances (Jaeschke, Guyatt, & Lijmer, 2002). The 
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OCP-M and Primerdesign Ltd. PCR had positive likelihood ratios (PLR) above 
10 indicating a strong likelihood of disease if test results are positive, however, 
the large width of the confidence intervals i.e. 95 % CI: 22.0 (7.2 to 67) for 
OCP-M and 95 % CI: 47.3 (6.9 to 343.2) for the Primerdesign Ltd. real-time 
PCR make these likelihood ratios less precise. Three things affect the width of 
confidence intervals. They are sample size, level of confidence, and variability 
(standard deviation)(Jones et al., 2003). Given that the sample size (170) and 
the confidence interval level (95 % CI) were fixed in this study, the increased 
width of the confidence intervals for the OCP-M and the Primerdesign Ltd. real-
time PCR could be attributed to the increased variability in the spread of the 
data generated by these two assays. The data differed significantly and to a 
greater degree more than the Verweij real-time PCR results, when all were 
compared with the CRS. The OCP-M and the Primerdesign Ltd. real-time PCR 
negative likelihood ratios (NLR) were 0.17 and 0.39 respectively but when 
compared with that of the Verweij real-time PCR of 0.09, are not small enough 
to rule out giardiasis with confidence. They indicate low likelihood of disease 
according to Cook et al. (2007) diagnostic value guidelines. In this study, the 
Verweij real-time PCR gave a PLR of less than 10 (i.e. 3.7) and showed a small 
increase in the likelihood of disease. The assay with its high sensitivity of 93.4 
% gave 0.09 NLR which provided a strong evidence to rule out giardiasis with 
confidence (NLR = ((1-sensitivity)/Specificity). The PLR value of the Verweij 
assay was affected by its modest specificity of 74.7 % that produced a PLR 
value which was less than 10 (PLR = Sensitivity/(1-specificity)). The PLR value 
however rose up to 10.2 % (4.76 to 21.92) when the 14 confirmed true positive 
samples were included in the CRS as true positives. The NLR also improved 
with a value of 0.06 (0.03 to 0.14) (Table 3.9). These adjusted figures are 
mentioned here only in the context of an isolated comparison of the Verweij 
real-time PCR with the OCP-M and not in relation with the other diagnostic 
tests.  
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Sensitivities and specificities describe how a condition is associated with a 
particular set of results. They do not predict the risk of having the condition or 
abnormality which is of particular interest in clinical practice. Because of the 
reliance of predictive values on the prevalence of an abnormality, likelihood 
ratios are more acceptable in diagnostic accuracy studies and are used to 
calculate the likelihood of the abnormality.  
Of the three index tests evaluated, the OCP-M method with a sensitivity of 
83.5 % (95% CI: 74.3 to 90.5 %), failed to detect 16.5 % of Giardia parasites. 
The Primerdesign Ltd. PCR is not as sensitive as the Verweij real-time PCR and 
requires optimisation. The Verweij real-time PCR was compared with a 
combination of it and OCP-M and there was no improvement in diagnostic 
sensitivity which remained at 93.4 %. The OCP-M, however, detects other 
parasites that singleplex real-time PCR will not find.  
The storage of stool samples was investigated and the results indicate that for a 
period of three months, storing stools at 4 
o
C with IMS was to be preferred 
above all the conditions tested. Storage at RT with IMS was also satisfactory 
but not as good as 4 
o
C with IMS. At -20 
o
C freezer condition, there was no 
significant benefit whether IMS was added or not. Either way, the result was not 
as good as storing at fridge temperature (4-6 
o
C) with IMS. IMS as a common 
replacement for absolute ethanol is readily available and the finding that IMS 
preserved stool samples stored at 4-6 
o
C gave the best storage condition prior to 
the extraction of DNA is useful to discover. Some laboratories usually avoid 
room temperature storage by keeping untreated stools at 4-6 
o
C and sometimes 
at -20 
o
C. The problem with -20 
o
C is that as the samples get taken out from the 
freezer and put in the post, they thaw out and as a result cysts rupture and 
release their DNA contents which then become subjected to degradation as has 
been discussed previously. IMS can be added to stool and stored in the fridge to 
slow down any deterioration of DNA during transportation.  
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Chapter 4: The influence of 
different storage conditions on 
Giardia intestinalis DNA 
detection 
4.1 Introduction 
Hospital for Tropical Diseases (HTD) receives stool samples from general 
practitioners and district general hospitals mainly in England but on occasion 
from any part of the UK. How the stool samples are stored is important for the 
success of subsequent molecular analyses. In a study conducted by Palayo et al. 
(2008) when they studied Giardia genotypes among Cuban children, they 
reported as unfortunate their inability to obtain genotyping data on 75 out of 95 
Giardia-positive samples as only 20 (21 %) were successfully genotyped. They 
hypothesised that the low success rate was due to the storage conditions, -20 
o
C 
in 70 % ethanol. The degraded DNA was thought to have led to the false 
negative findings. They were, however, not able to explore the effect of storage 
on samples meant for molecular amplification studies. 
Many factors can affect the integrity of DNA in a specimen, e.g. preservative 
treatment, age of specimen, and environmental factors like storage temperature 
(Lindahl, 1993). The degradation of the DNA could be hydrolytic or oxidative 
and the sites of the DNA molecule particularly vulnerable to these attacks are 
depicted in Figure 4.1. The consequence of these attacks is that the DNA 
molecule loses its integrity and therefore becomes undetectable. Denaturants 
like excessive heat and hydrolytic agents can open up or disrupt the duplex 
nature of DNA and cause accelerated damage. Also, chemical modification of 
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the nucleotide sequence can occur, resulting in alteration of how the DNA 
reacts chemically. Biological specimens can undergo autolysis and preservative 
treatment of these samples is aimed at halting that (Brown, 1999). 
 
 
 
Use of primary alcohol, ethanol, as a preservative causes precipitation of 
proteins and also replaces water molecules in a specimen (Pearse, 1980; 
Stoddart, 1989). Industrial methylated spirit (IMS) should have a similar effect 
on specimen preservation as ethanol for it is made up of approximately 95 % 
ethanol and 4 % methanol. The addition of the methanol makes IMS exempt 
from the customs duty that ethanol attracts, hence reducing its cost. IMS is 
therefore much more affordable than ethanol resulting in its wide scale use as a 
biological preservative (Carter, 2003). This chapter presents the investigation of 
the effect of IMS at room temperature, ordinary fridge temperature (4-6 
o
C), and 
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freezer temperature (-20 
o
C) on the extraction of Giardia DNA from stool 
samples. The facilities for these storage conditions are available in the 
Department of Clinical Parasitology HTD and they are also expected to be 
available in any standard district hospital laboratory. Stool specimens can be 
preserved in potassium dichromate 2.5 % (1:1 dilution) or in absolute ethanol 
(1:1 dilution) for molecular analysis to be performed (Wilke & Robertson, 
2009). However, IMS was selected for investigation because it is a stock 
consumable in most laboratories and would be cost effective. The Verweij real-
time PCR assay having proved to be the most sensitive of the tests compared 
was used to test samples stored under different conditions in order to provide 
answers for the following three questions:  
1. Has IMS any effect on storage? i.e. is there any difference in the paired 
ΔCts of  samples stored in IMS vs. no-IMS? 
2. Has temperature any effect on storage? i.e. is there any difference in the 
ΔCts when the different temperatures are compared? 
3. Which conditions emerge as the best for sample storage pending DNA 
extraction?  
4.2 Methods 
The Verweij real-time PCR was used for this part of the research project. The 
methodology has been previously described. 
Samples and storage conditions 
An OCP-M Giardia positive stool was used in this study. IMS was added 
to a portion of the stool sample (1:1) and was vortexed to mix.  The stool was 
divided into 12 replicate pea-size samples (0.2-0.3 g) and kept in 1.5 ml Sarstedt 
tubes. The other portion of the stool was used untreated (i.e. no IMS or any 
other additive was added) and was also divided into12 replicate pea-size (0.2-
0.3 g) samples and kept in 1.5 ml Sarstedt tubes. A total of 24 samples were 
prepared for use in this study and these were made up as IMS and no-IMS to 
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provide 12 paired stool samples. The stool was tested to provide baseline 
estimation for the Ct value of Giardia DNA. This step is equivalent to what 
Wilke and Robinson (2009) did when they studied the preservation of Giardia 
cysts in stool samples for subsequent PCR analysis. They assayed seven 
replicate aliquots per sample at each sampling point and then found the average 
of each seven (Wilke & Robertson, 2009). In this study, each storage 
temperature was assayed four times within a period of three months (Table 4.1). 
Pairs of samples were taken out on four occasions at approximately 0.7-0.8 
month intervals and assayed using the Verweij real-time PCR previously 
described.  
 
Storage condition 
for 3 months 
 
Sample replicates 
No-IMS  1 2 3 4 
Room temperature √ √ √ √ 
Fridge (4–6 oC) √ √ √ √ 
Freezer (-20
 o
C) √ √ √ √ 
IMS     
Room temperature √ √ √ √ 
Fridge (4–6 oC) √ √ √ √ 
Freezer (-20
 o
C) √ √ √ √ 
 
4.2.1 Statistical analysis  
The Friedman test was used to calculate the effect of temperature on the amount 
of DNA yield expressed as delta Cts (ΔCts) from Giardia intestinalis positive 
stool samples following three months in storage. It tests for differences in 
related data and gives the overall difference and does not pinpoint which groups 
in particular differ from each other (Laerd Statistics: SPSS Tutorials, 2012). To 
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pinpoint which groups in particular differ, a post-hoc test was performed using 
Wilcoxon matched-pairs signed-rank test with the pairs matched for a particular 
sample at a particular sampling point (Laerd Statistics: SPSS Tutorials, 2012). 
To test for the effect of IMS on the amount of DNA yield from Giardia positive 
stool samples, the Wilcoxon rank-sum test instead was used. It is based on 
repeated-measures designs and it is used to determine whether participants 
changed significantly across occasions (or conditions) with two independent 
groups involved. This test is similar to the Mann-Whitney test and is limited to 
nominal variables with only two values. The Wilcoxon matched-pairs signed-
rank test, the Wilcoxon rank-sum test, and the Friedman test rearranged the 
original dataset into ascending or descending order by a system of numbering 
called ranking. The mean of the ranks was used to show differences across 
groups. 
4.3 Results 
 
 
Storage for 3 
months 
Cycle threshold values (Ct) of samples tested on 4 
different days in 3 months 
 
Total 
ΔCt 
(ΣΔCt) 
 
Mean  
Δ Ct 
1 2 3 4 
No IMS, Cto = 23.2 Ctn ΔCt Ctn ΔCt Ctn ΔCt Ctn ΔCt 
Room temperature 32.7 9.5 32.3 9.1 32.7 9.5 33.1 9.9 38 9.5 
Fridge (4–6 oC) 26.7 3.5 27.7 4.5 26.8 3.6 31.4 8.2 19.8 5.0 
Freezer(-20 
o
C)  26.3 3.1 26.1 2.9 23.6 0.4 27.3 4.1 10.5 2.6 
IMS,  Cto = 21.5 1 2 3 4 ΣΔCt 
Mean  
Δ Ct 
Room temperature 23.6 2.1 24.7 3.2 25.2 3.7 24.8 3.3 12.3 3.1 
Fridge (4–6 oC) 23.3 1.8 23.0 1.5 22.2 0.7 23.7 2.2 6.2 1.6 
Freezer (-20 
o
C) 27.0 5.5 22.9 1.4 22.6 1.1 24.3 2.8 10.8 2.7 
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The analysis has been presented under the two sub-headings of: Effect of 
temperature and Effect of IMS. There was an increase in Cts for all the samples 
over the 3-month period under all the different conditions. This is represented 
by positive delta Cts (ΔCts) in Table 4.2. This showed DNA degradation in 
storage and the most affected condition was storage at room temperature 
without the addition of IMS. It had the highest mean delta Ct (ΔCt) of 9.5. 
Analysis of how temperature and IMS affected the detection of Giardia cysts 
DNA now follows. 
4.3.1 Effect of temperature 
The calculated Friedman’s test p-values for both the IMS treated and 
untreated samples shown in Table 4.2 were χ2 (2, N = 4) = 4.500, p = 0.105 and 
χ2 (2, N = 4) = 8.000, p = 0.018 respectively. In each case, the dependent 
variable was “delta Cts” and the independent variable was “temperature” which 
consisted of three categories: room temperature, fridge (4-6 
o
C), and freezer (-
20 
o
C). With the IMS treated samples, there was no statistically significant 
difference in the DNA yield and therefore pairwise comparisons were not 
performed. Stool samples for molecular studies can therefore be treated with 
IMS and kept or transported at any of the three temperatures within 3 months. 
There was, however, a significant difference in the medians of the Cts for the 
untreated stool samples, χ2. Because the overall test was significant, pairwise 
comparisons among the three groups was completed by analyzing the data with  
Wilcoxon signed-rank tests in a post-hoc analysis. Type I error (i.e. calling a 
result significant when it is not) across tests was controlled by using the 
Bonferroni approach. The results of these tests indicated no significant 
difference among the three pairs of room temperature vs. fridge (z = - 1.826, p = 
0. 0.125), room temperature vs. freezer (z = - 1.826, p = 0.125), and fridge vs. 
freezer (- 1.826, p = 0. 0.125) conditions. The a priori alpha level (0.05) divided 
by the number of tests (i.e. 3) gave p = 0.017 (Bonferroni adjustment).  The p-
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value of 0.017 was therefore used to judge the level of significance in the post-
hoc analysis. After the adjustment, it turned out that none of the results were 
significant (Table 4.3). Thus, the spuriously significant difference detected by 
the Friedman’s test among the no-IMS samples (χ2 (2, N = 4) = 8.000, p = 
0.018) have been removed with the result that no significant differences have 
been detected for the effect of temperature on Giardia DNA extraction from 
untreated stool samples stored for 3 months under the three temperatures of 
room, fridge, and freezer (Table 4.3). All three temperature conditions led to a 
loss of Giardia DNA within the three months (+ΔCt, Table 4.2). 
α
 
 
Temperature 
Samples (with no IMS) tested on 4 different 
days in 3 months at 0.7-0.8 month intrevals 
(ΔCt) 
Wilcoxon signed-rank 
tests (p) (2-tailed) with 
Bonferroni correction 
1 2 3 4  
0.068 (room/fridge) 
0.068 (room/freezer) 
0.068 (fridge/freezer) 
Room Temp 9.5 9.1 9.5 9.9 
Fridge 3.5 4.5 3.6 8.2 
Freezer 3.1 2.9 0.4 4.1 
 
4.3.2  Effect of IMS 
 Figure 4.2 shows the effects of IMS and the three temperatures on 
Giardia intestinalis DNA extracted from stored stool samples. IMS preserved 
samples had more DNA extracted from them than the untreated samples as 
indicated by the lower ΔCt values. Also colder temperatures slow down 
considerably the deterioration of Giardia intestinalis DNA indicated by the 
lower ΔCt values. 
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The Wilcoxon rank sum test (similar to the Mann-Whitney test) which 
was used to evaluate the difference between medians for IMS-treated and 
untreated stool samples showed significant difference with z = -2.656, and p = 
0.008. The mean of the ranks in favour of alcohol-treated stools was 8.67, while 
the mean of the ranks in favour of untreated stools samples was 16.33. The 
untreated stool therefore had comparatively less amount of DNA left at the end 
of the three months (the higher the Ct the less DNA there is to start with).  
Therefore at the level α = 0.05 of significance, there was enough evidence to 
conclude that IMS reduced DNA losses or deterioration in treated stool samples.  
4.4 Discussion 
Stool samples contain many compounds that can degrade Giardia DNA 
and inhibit downstream enzymatic reactions. Also inappropriate storage 
conditions for these samples can adversely affect subsequent quality DNA yield 
for clinical laboratory diagnosis. Such a failure in methodology is likely to 
result in mis-diagnosed cases. I studied the effect of storage conditions for the 
preservation of stool samples and the extraction of Giardia intestinalis DNA. 
119 
 
As Giardia cysts are encountered more commonly in stools that are formed than 
in unformed stool and Giardia trophozoites encountered more in watery stool 
than in formed stool (Figure 4.3), a formed stool already seeded with Giardia 
cysts was used as the optimum sample for exploring storage conditions whilst 
minimising cost at the same time.  
 
 
The influence of storage conditions on Giardia DNA detection from stool 
samples is discussed under the following headings: 
1. The effect of time 
2. The effect of temperature 
3. The effect of IMS 
In the analysis of these results, I attempted to find justification for either of the 
following two hypotheses: 1. The null hypothesis (H0) which states that there is 
no significant difference in the DNA amounts expressed as delta Cts (ΔCts) 
being compared (p > 0.05), and 2, the alternate hypothesis (H1), which rejects 
H0 and states that there is a significant difference between matched pairs of 
results (p ≤ 0.05). 
1. The effect of time 
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There is a degree of degradation of DNA in stool samples during storage 
and as shown in Table 4.2, the ΔCts over the three month period showed 
unpreserved stool samples at room temperature to be the worst affected among 
three temperatures with a ΔCt of 9.5 for the untreated stool sample (i.e. no IMS 
added) and ΔCt of 3.1 for the treated sample (with IMS added). Storage 
conditions, including time, cause cysts to rupture with the release of their DNA 
content into the faecal environment. The DNA is then subjected to hydrolytic or 
oxidative degradation which can be accelerated by the presence of nucleases 
produced by the bacterial flora in the stool sample as nucleases break down 
DNA. These results confirm the breakdown of Giardia cysts and the 
degradation of DNA that was released during storage and before the extraction 
procedures were performed on the stool samples. As stool samples contain a 
large number of bacteria, they are able to degrade DNA rapidly. This is 
particularly marked in dead parasites when normal cellular repair processes 
have ceased, endogenous endonuclease activity and spontaneous depurination 
can result in relatively rapid breakage of DNA strands. Studies on stool storage 
conditions used for Giardia molecular epidemiological studies conducted in 
different countries and by different research groups and which produced a 
relative success of the molecular analyses in the range of 10-80 % reported time 
in storage ranging from 2 months to 15 years (Wilke & Robertson, 2009).  
As the deterioration and degradation of Giardia parasites and their DNA 
in storage is established, it is important also to determine the point in time in 
storage at which DNA breakdown significantly. Knowing the storage 
temperature, the type of preservative, and the point in time in storage will help 
establish better conditions for sample transportation for molecular analyses. 
2. The effect of temperature 
It is clear that samples kept at room temperature without IMS preservative had 
higher ΔCts, meaning lesser amount of DNA than those kept at fridge 
temperature and freezer temperature without IMS Table 4.2. This and the 
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findings of  Cnops & Esbroeck (2010) suggest that long term storage of stool 
samples for Giardia DNA extraction may require fridge or freezing 
temperatures. They used real-time PCR to evaluate the influence of storage time 
and temperature on the detection of Entamoeba dispar and Entamoeba 
histolytica and demonstrated an improved DNA detection in frozen stool 
samples compared to freshly stored samples. Comparing fridge conditions with 
freezer conditions, there was a lot more DNA available (ΔCt 2.6) in samples 
frozen at -20
0
C without IMS than there were in those stored at fridge 
temperature of 4-6 
oC without IMS (ΔCt 5.0) Table 4.2. DNA is less susceptible 
to degradation under freezing conditions when cysts have not released their 
DNA content, which they are more likely to do under fridge conditions than 
freezer conditions in the absence of IMS.  
So far, in the absence of IMS, degradation of DNA during storage 
increases from lowest to highest: from freezer (ΔCt 2.6) to fridge (ΔCt 5.0) to 
room temperature (ΔCt 9.5). However, the best conditions as indicated in (Table 
4.2) was IMS preserved stool at ordinary fridge temperatures (4-6 
oC) with ΔCt 
1.6. Refrigerating IMS preserved stool samples at 4-6 
o
C was better than storing 
them with IMS at -20 
oC (ΔCt 2.7). It is also better than room temperature with 
IMS added (ΔCt 3.1).  This result agrees with the findings of Wilke and 
Robertson (2009) who reported the superiority of storing ethanol preserved 
stool samples at 4-6
 o
C after using microscopy and real-time PCR to investigate 
storage conditions for seven different samples over a period of three months 
(Wilke & Robertson, 2009). 
In summary, over a period of three months, freezer conditions for storage 
of stool samples without IMS appeared to be better than fridge and RT 
conditions for the extraction of Giardia DNA. But with IMS added, fridge 
conditions appeared to be the best of the three with the lowest ΔCt value of 1.6 
indicating the best DNA detection. But how significant are these observed 
differences? For the IMS treated samples there were no statistical difference in 
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the distribution of ΔCt values, meaning DNA detection was comparable in 
samples stored at  all three temperatures, upholding the null hypothesis (χ2 (2, N 
= 4) = 4.500, p = 0.105). This is quite different from the result of the untreated 
samples. The Friedman results of the analysis of the untreated samples indicated 
that there was a significant difference in the medians of the Cts (χ2 (2, N = 4) = 
8.000, p = 0.018). But when this data was further analysed using the Wilcoxon 
matched-pairs signed-rank test  and controlling for Type I error (false positive) 
across tests using the Bonferroni correction, the results indicated no significant 
difference in ΔCts between the three pairs of room temperature/fridge (p = 
0.068), room temperature/freezer, (p = 0.068) and fridge/freeze (p = 0.068) 
conditions (Table 4.3). The implication here is that the Friedman test result of 
(χ2 (2, N = 4) = 8.000, p = 0.018) was perhaps a Type 1 error which was 
corrected by the Bonferroni adjustment using a stringent p-value of 0.017 
instead of 0.05 to determine significance levels. The 0.017 value was obtained 
by dividing 0.05 by the number of comparisons (3 in this study). Therefore in 
the no-IMS samples, the differences expressed as ΔCts among the three 
temperatures for the three-month period were not statistically significant.  
In practice, stool samples stored at these temperatures for three months 
would still be satisfactory for Giardia DNA extraction for use in molecular 
amplification studies. Colder conditions are better for storing samples for 
molecular amplification studies. Freezing and thawing, however, tends to 
rupture cysts with the release of their DNA content. This increases the 
vulnerability of the DNA to attack by nucleases or other agents. Freezing 
samples may limit bacterial growth and enzymatic activity, but it can also break 
a sizable proportion of Giardia cysts exposing their DNA content to degradative 
processes when the sample is brought to room temperature (Wilke & Robertson, 
2009).  
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3. The effect of IMS 
When IMS preservation was considered together with the storage 
temperatures, there was a statistically significant higher amount of DNA 
detected. As shown in Figure 4.2, ΔCts for the IMS treated samples at room 
temperature and in the fridge were below that of the untreated samples 
indicating much improved Giardia intestinalis DNA detection in samples stored 
in IMS. The Wilcoxon rank sum test, which was used to evaluate the difference 
between medians of ΔCt for IMS-treated and untreated stool samples, was 
significant, z = -2.656, p = 0.008. Therefore, at the level α = 0.05 of 
significance, there was enough evidence to conclude that storage in IMS 
improved DNA detection. IMS therefore has a preservative effect on the cysts 
in storage. It is also to be noted that IMS appeared to have no effect on Giardia 
DNA yield at -20 
oC (ΔCt 2.7) compared with the no-IMS samples (ΔCt 2.6) 
(Figure 4.2). What this means in practice is, it may not be necessary to add IMS 
to stool samples when storing at -20 
o
C but will be beneficial to add IMS when 
storing in the fridge (4-6 
o
C) or at room temperature. Despite the improvement 
in DNA detection when IMS is used, IMS can also have adverse affect on DNA 
integrity as shown in Figure 4.4. The DNA turns from a solid band on the gel to 
a smear when it is denatured by IMS Figure 4.4 (a) and (b). 
(a)       (b) 
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Methanol is closely related in structure to water and therefore can 
compete with water for hydrogen bonds. Consequently as a component in IMS, 
methanol can cause localized points of weakness in the dsDNA as a result of 
hydrogen bonding (Pearse, 1980). This effect notwithstanding, IMS does a lot 
more good than harm in the harsh environment of stool samples where DNA 
released from Giardia is subjected to hydrolysis, chemical, and enzymatic 
degradation. Extracted DNA from IMS preserved samples have been found to 
give positive results with both prokaryotic 16s and eukaryotic 18s PCR 
amplifications, and was digested by the RE enzyme Hinf1(Carter, 2003). This 
shows that even though the DNA was affected by the IMS, it was still good 
enough to be used to perform molecular analysis. 
As a result, it appears evident that the most suitable storage condition, for 
stool samples to permit the isolation of Giardia intestinalis DNA among those 
investigated, was storage in IMS at 4-6 
o
C or frozen at -20 
o
C without IMS even 
though in the latter, there was very little difference in ΔCts between the IMS 
treated and untreated samples Figure 4.2. Under these conditions, stool samples 
may be stored for three months. Factors other than storage conditions can affect 
the successful amplification of DNA from stool samples. Cyst quantity, 
extraction technique, inhibitors, gene targeted, and choice of primers and 
cycling conditions can all impact on the success of molecular analyses. 
However, the use of optimum storage conditions is of paramount importance. 
The Biospecimen Reporting for Improved Study Quality (BRISQ) guidelines is  
a set of reporting recommendations for authors of biospecimen-related research 
(Moore et al., 2011). They provide consistent and standardized information to 
better evaluate, interpret, compare, and reproduce experimental results (Moore, 
Kelly, McShane, & Vaught, 2012). The recommendations in the guidelines that 
this project addressed were on stabilization, preservation, storage temperature 
and duration of storage. The findings of this study support the case for BRISQ 
in the standardization of biospecimen-related research.  
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Chapter 5: Implementation of 
Giardia intestinalis real-time PCR 
5.1 Implication for practice 
After the demonstration of Kary Mullis’ invention of the PCR technique 
on December 16, 1983, the technique has revolutionized the way clinical 
microbiology laboratories diagnose human pathogens. In clinical parasitology 
the OC&P method for a long time has remained the de facto gold standard for 
examining stools for parasites. Even though the method is time consuming and 
relatively less sensitive, it has remained popular and widely used because of its 
high specificity and the simultaneous detection of multiple parasites. There is, 
however, a good reason to look at alternate ways of examining stools for 
Giardia intestinalis as this research project has shown. Treating patients on 
clinical suspicion alone has had a measure of success in patients who diagnosed 
as microscopically negative for Giardia. If the parasites were present, but could 
not be seen using the microscope, then perhaps they were there in very low 
concentration or in a disrupted state and therefore a very sensitive test was what 
was required to confirm their presence in the sample examined. 
In 1995 Low and McGeer published an article in New Horizon on the use 
of molecular biology techniques for diagnostic microbiology and hospital 
epidemiology. They predicted, in this paper, the development of molecular 
techniques for routine laboratory use in the “next decade” (Low & McGeer, 
1995). The prediction has become a reality for the Department of Clinical 
Parasitology inasmuch as molecular techniques for the diagnosis of 
microsporidia (Polley et al., 2011) has replaced microscopy and the case for a 
real-time PCR to replace OCP-M for Giardia infections has been explored in 
this project (see a summary of the achieved objectives in Table 5.1). 
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 Objectives Description 
01 
To carry out an exploratory investigation using spiked stool samples to 
determine any differences in performance between the index tests: Ova, cyst 
and parasite-microscopy (OCP-M) and real-time PCR. 
01 
Achieved 
The Verweij real-time PCR had a p-value of < 0.05 for performance and a 
limit of detection that was even lower than the assay parameters for this 
study (< 5 cysts/ml of stool) 
02 
To carry out an exploratory investigation using spiked stool samples to 
ascertain the analytical sensitivity and specificity of the reference tests: EIA 
(Enzyme immunoassay) and rapid membrane test (RMT). 
02  
Achieved 
The limit of detection of ≤ 2840 cysts/ml and ≤ 92 trophozoites/ml 
determined the strength of detection of the composite reference standard. 
 
03 
To evaluate and compare the accuracy measures for OCP-M and real-time 
PCR using a non-probability sampling technique with consecutive samples. 
03  
Achieved 
See Table 3.7 for tabulation of all the results. The Verweij real-time 
PCRhad the highest sensitivity of 93.4 %. 
 
04 
To compare the accuracy measures for real-time PCR to that of a 
combination of OCP-M and real-time PCR. 
04  
Achieved 
The sensitivity remained unchanged at 93.4 % following the amalgamation 
of the two tests. 
 
05 
To investigate the effect of different storage conditions on the detection of 
Giardia intestinalis DNA in human stool samples. 
05 
Achieved 
IMS preserved stool at 4-6 
o
C for three months appeared to be the best 
condition for keeping stools before DNA extraction. 
 
06 
To develop an algorithm and a business plan for use in the Department of 
Clinical Parasitology for the laboratory investigation of giardiasis 
incorporating real-time PCR. 
06 
Achieved 
See Figure 5.1 for the algorithm and Appendix V for the business plan. 
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The information provided in the section that follows form part of a 
business plan (see Appendix V) I have written up to introduce the Verweij real-
time PCR into the Department of Clinical Parasitology at the HTD in London. 
In this section 5.1, the algorithm to be followed and the pricing of the test 
consequent on the adoption of the real-time PCR into routine practice are 
presented. For a wider discussion of the business plan which includes service 
delivery, research and development, see Appendix V. This Section 5.1 and the 
business plan dossier in Appendix V address objective 06 of this study. 
5.1.1 Algorithm 
The following algorithm is recommended for the laboratory diagnosis of 
giardiasis (Figure 5.1). 
 
         Gastro-intestinal symptoms 
? Giardia intestinalis   ? Giardia intestinalis  
? Other 
OCP-M                           IMS treated faecal samples batched and stored at 4 
o
C for 1 week 
  -ve 
 
                                            Verweij real-time PCR assay for Giardia intestinalis  
 
+ve       +ve   -ve  
 
Treatment     Treatment Consider other diagnosis  
                                                                                        (e.g. Cryptosporidiosis or Amoebiasis) 
+ve = Positive for Giardia intestinalis; -ve = Negative for Giardia intestinalis. 
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Microscopy will still be useful as part of differential diagnosis but should 
not be relied upon in all post treatment follow up investigations. This algorithm 
has an important step that was discovered in this research project and it is the 
addition of IMS to stool samples before DNA extraction. The IMS treated 
samples are to be stored at 4-6 
o
C and used for Giardia DNA extraction.  
5.1.2 Pricing 
The running cost per test for the Verweij real-time PCRwas worked out 
according to Table 5.2 consumables (£6/test) and Table 5.3 labour costs 
(£331/test).  
    Item                             Price per pack (£)      No. of tests performed per pack  Cost per test (£) 
                                                                                                                                                         
Direct costs 
Primers & Probes (Working           209.40                             300                                   0.70 
solution) (a) 
Environmental mastermix (b)        565.00                              400                                  1.40 
 
QIAamp DNA mini QIAcube 
Kit (c)                                            1576.80                             480                                  3.30 
 
Pastettes (d)                                    10.00                               500                                   0.02 
 
Extended Fine tip pastettes (e)       17.20                               250                                    0.07 
 
1.5 ml Eppendorf tube (f)                 26.31                            1000                                   0.03 
 
Sarstedt  tubes (g)                             15.50                             500                                     0.03 
 
Sarstedt  tube caps (g)                      24.90                             500                                     0.05 
 
                                                                                                             Total:      5.60 (~6.00) 
Keys (manufacturers): 
(a)  Eurofins (b)  Applied Biosystems (c)   Qiagen ltd., (d)  Elkay Precision Laboratory     
 (e)  Alpha Laboratories (f) Eppendorf, (g) Apex. 
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Sample processing  (£)                 Time taken (min)     BMS Band 7 salary per minute (£)         Cost  
 
Washing                                       240                                    0.30                                                   72 
 
Lyses                                            384                                    0.30                                                 115.2 
 
Extraction                                     240                                   0.30                                                   72 
 
Real-time PCR                              240                                   0.30                                                   72 
 
                                                                                                                           Total:                   331.2 
 
This provided the running cost per test as £337. This approach was taken 
since there is no competition currently. The amount is heavily subsidized due to 
the fact that additional equipment and materials required to run this test are 
available and already catered for under the departments purchases for PCR 
work. The running cost per test (£337) for Giardia investigations is equivalent 
to that for Cryptosporidia and Entamoeba histolytica in a multiplex reaction and 
so requesting Giardia PCR has the other two PCRs added on as well. The 
current listed price (2013) for requesting a protozoal PCR for any of the three 
parasites is £53 for National Health Service patients and £68 for private 
patients. 
5.2 Further research 
1. One of the strongest reasons to continue to use OCP-M is that other 
parasites apart from Giardia intestinalis are detected. Multiplexing the Verweij 
real-time PCR to include other diarrhoea causing parasites like Cryptosporidium 
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and Entamoeba histolytica has been done and it will be good to widen its scope 
to include other parasites producing similar clinical symptoms (e.g. Cyclospora) 
and possibly also parasites across the genus divide of bacteria and viruses. PCR 
based diagnostic tests have arrived and the modernisation and formation of joint 
ventures between pathology services will be the driver for the increased use of it 
in diagnostic laboratories because of the multiplexed tests for panels of 
gastrointestinal pathogens (R.M. Chalmers, 2009). 
2. Further research will be needed to improve upon the analytical sensitivity 
of the Verweij real-time PCR using Giardia intestinalis trophozoites and to 
optimise the assay for non-faecal samples like duodenal aspirates and biopsies 
where trophozoites of Giardia intestinalis are likely to be encountered, and also 
for pus or liver aspirates in amoebic abscess cases where Entamoeba histolytica  
are likely to be encountered in multiplex reactions.  
3. Further research is required to optimise the Primerdesign Ltd. real-time 
PCR kit for use in longitudinal surveillance and genotyping of positive cases of 
giardiasis. The use of this kit will provide more information on the potential 
public health risk from domestic dogs and cats and the frequency of zoonotic 
Giardia transmission. 
4. There is the need for large-scale molecular epidemiological surveys of 
Giardia infections in humans to determine the geographical distribution and 
prevalence of human-infective genotypes. This type of information can also 
shed light on asymptomatic giardiasis as to whether it is “assemblage”-related 
or not. 
5.3 Conclusion  
1.  OCP-M, with a sensitivity of 83.5 %, failed to detect 16.5 % of true 
giardiasis cases in this study. Similarly, with a sensitivity of 93.4 %, the 
Verweij real-time PCR failed to detect 6.6 %. The Verweij real-time PCR 
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therefore diagnosed approximately 10 % more giardiasis cases than the OCP-M 
and 19.3 % (94.3 - 75 = 19.3) more positive cases with adjusted sensitivities.  
2. The Verweij real-time PCR has been shown to be a more efficient and 
robust diagnostic test for use as a first line test for giardiasis. Compared with the 
OCP-M, the Verweij real-time PCR correctly diagnosed 70 % (14/20) of the 
discrepant cases as giardiasis and the OCP-M correctly identified only 10 % 
(2/20).  
3. The Verweij real-time PCR can be used as a standalone test (if it needs 
be) for the diagnosis of giardiasis. In combination with the OCP-M, there was 
no improvement in sensitivity over the Verweij real-time PCR when compared 
with the latter alone. The sensitivity remained at 93.4 %. OCP-M, however, has 
the advantage of identifying the presence of other parasites.  
5. With LOD < 5 cysts/ml, the requirement for the submission of three 
stools for the diagnoses of giardiasis or for post treatment follow up 
investigation is now non-critical as a result of the robustness of the Verweij 
real-time PCR. 
6. Storage of stool samples in IMS at 4-6 
o
C prior to DNA extraction for 
Giardia intestinalis was the best storage condition among those investigated. 
 
The aim of this thesis has been to investigate the possibility of deploying a non-
microscopy based test (i.e. Real-time PCR) as a frontline test for the diagnoses 
of giardiasis. The Verweij et al. (2003, 2004) real-time PCR provided a 
worthwhile  platform for this study and has shown a lot of potential over the 
OCP-M that is currently in use. In patients with suspected giardiasis, the use of 
the Verweij real-time PCR will lead to improved detection of Giardia 
intestinalis in their stool samples. 
 Even though the Verweij real-time PCR has proved to be a very sensitive 
diagnostic tool for testing faecal samples for Giardia intestinalis, it has some 
132 
 
limitations and the recommendations given below, when followed, will improve 
upon the performance and turnaround times of the assay. 
Recommendations: 
1.  IMS should be added to stool samples meant for Giardia intestinalis 
DNA extraction.  
2. It takes a long time to wash the stool samples, 3–4 h or even more 
depending on the number in order to get them ready for the lyses stage which 
then requires overnight incubation. Automated washing and extraction devices 
will speed up these essential first steps in the real-time PCR protocol. Extra 
investment in equipment to automate the process will however be required. 
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Chapter 6: Reflection 
6.1 Introduction  
The final chapter of this thesis heralds the end of the study of a well-put 
together study programme that, for me, has been fantastic and very rewarding in 
every way.  I will be reflecting on this experience shortly, after this brief 
account of an episode of giardiasis I had over three decades ago which gave me 
the passion for this project and the reason to be curiously interested in it.    
A personal experience I had with giardiasis took place towards the latter 
part of the 1970s when I was training to be a multi-disciplinary medical 
laboratory technician in Accra, Ghana. For a period of time, I experienced 
irregular bowel movement which later gave me a skin rash with mild itching 
sensations. Normal bacterial cultures at the time yielded nothing and I was 
asked to submit a stool sample for ova, cysts and parasite examination. It was 
then that I was diagnosed with giardiasis. I had the opportunity to look down the 
microscope myself and saw the intestinal flagellates that Antony Van 
Leeuwenhoek saw in his stool 332 years ago in 1681. The intestinal flagellates 
were Giardia intestinalis. I was treated with Metronidazole and got better. 
Despite the fact that my experience with Giardia was not the most pleasant 
moments in my life, it gave me the impetus to undertake this project with 
greater interest. 
6.2 Critical reflection of the learning 
During the first year of this doctorial study in 2008/9, I justified the use of 
Gibbs’ reflective cycle when I reflected on my previous learning before 
enrolling on this course. Reflective practice was then a new area of study for me 
and Gibbs’ model was less complicated to follow at the time. I have decided to 
use a different model now to critically reflect on my learning as this study 
program draws to the end. Reid (1993) has been quoted as saying that reflection 
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is “a process of reviewing an experience of practice in order to describe, 
analyse, evaluate and so inform learning about practice”(Bulman & Shutz, 
2004). With that  in mind, the model I have, therefore, chosen is the Atkins and 
Murphy’s model of reflection (Atkins & Murphy, 1994). This model (Figure 
6.1) provides a useful questioning framework for reflection based on the 
definition given above. 
 
 
An example of how the cycle works is given briefly below using the audit 
for service improvement study I did years ago before enrolling on this course. I 
am using it to illustrate how the process of reflection works with this cycle. The 
example relates to a very specific incident and truly forms part of my overall 
experience on this course. The fact that I have extracted this experience from 
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the big picture to illustrate how the reflective cycle works, does not mean that 
this incident was not directly related or relevant to my overall experiences on 
this course. 
Awareness of uncomfortable feelings and thoughts 
Due to staff shortages, I spent an unusually long time on the enteric bench 
in the microbiology department. The rota for moving from bench to bench was 
not working properly and as a result, I became tied and fed up for been in one 
section for so long.  
Describe the situation, including thoughts and feelings 
One particular aspect of the work in this section was tedious and that 
made me unhappy. It was concerned with a particular screen profile (acid and 
gas only producers in triple sugar iron agar) that suggested a pathogen 
(Salmonella or Shigella species) but most of the time produced negative results 
upon further lengthy investigations. I thought to myself to find a way of looking 
into this testing procedure in order to introduce a test that will be less laborious 
to perform in the least amount of time. When I shared this with my section 
head/ laboratory manager, I was given the permission to proceed with the work. 
I collected about seventy one of the isolates that fitted this profile (see above) 
and searching through the literature found a test for β-galactosidase activity and 
used it over a series of timed periods to classify these isolates on the bases of 
the production of the β-galactosidase enzyme. The latter determines the ability 
to ferment lactose and Salmonella and Shigella with very little exception are 
known as non-lactose fermenters. 67 % of the isolates which produced Beta-
galactosidase also broke down the substrate within 30 min and therefore they 
were classified as non-pathogens. This test is now used routinely as a result of 
my work. 
Analyse feelings and knowledge relevant to the situation 
I felt a sense of accomplishment that I have made the identification 
procedure more efficient by challenging the status quo and successfully 
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exploring alternatives. What I did not have then was the no-how of publication 
and dissemination of research information to enable me publish a paper on this 
work. 
Evaluate the relevance of knowledge 
Even though I had the technical expertise to investigate and solve this 
problem, my knowledge was not complete, in that publication and 
dissemination were lacking in my experience.  
Identify any learning which has occurred 
I acquired a deeper understanding of the diagnostic procedure to a level 
that only comes by experience (Kolb, 1984) and which is higher than Bloom’s 
taxonomy level two (Anderson, Krathwohl, & Bloom, 2001). I needed to 
publish as expected of research scientists. 
Action / New experience 
I enrolled on this Professional Doctorate’s course and as a result had the 
experience of preparing a paper on this piece of work for publication. The paper 
was accepted and has since been published in the Journal of Clinical Pathology 
under the title: Selective testing of β-galactosidase activity in the laboratory 
identification of Salmonella and Shigella species (Boadi, Wren, & Morris-
Jones, 2010). The process of reflection has gone full cycle and it begins again 
with the new experiences that come with studying at doctoral level.  
This is the format that I will now use to analyse my learning over the past 
4-5 years since October, 2008 when I enrolled on this course. 
I will also be relying on the “Cake mix” method of keeping portfolios to reflect 
on my learning experiences. The “Cake mix” model provides an overarching 
narrative of one’s learning journey with the main features of this model being 
reflectivity, practice and professional development (Endacott et al., 2004).  
The timeline of my experiences showing the relative level of satisfaction 
in percentage (%) at any stated point in time is shown in Figure 6.2. This 
timeline illustrates what is being discussed. 
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(OCT.’08–
JAN.’09 (PDd01)    
(FEB.’09–JUL.’09 
(PDd02)    
(NOV.’09–
APR.’10 (PDd03)    
(APR.’10–OCT’12) 
(PDd04)                                                                                                                                                                            
 
 
Awareness of uncomfortable feelings and thought: 
Less than a month into this professional doctorate course, I wrote in my 
online journal on the 8th of November, 2008 the following excerpt after I have 
had my first ever lecture on reflective thinking and writing about ten to twelve 
hours earlier. Unaware that it had already gone midnight, I wrote: 
“Date: 08 November 2008 00:03  
Today's lecture on the subject above has revealed how very little reflective 
writing & thinking I have been doing in my professional life so far.... I am 
engaged in a lot of CPD activities but have not been doing any reflective 
writing or thinking about them. 
I need to think critically and do reflective writing from now onwards if I am 
going to be an expert in my area of practice. This area of learning is new to me. 
It was not part of the curriculum for my previous studies and it is a challenge 
that I have to take on now”. 
  a 
  c 
  d 
   b   
50% 
100% 
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This experience captures the “awareness of uncomfortable feelings and 
thoughts” that Atkins and Murphy (1994) put as the first step in their model of 
reflection.  
Describe the situation, including thoughts and feelings: 
OCT.’08 – JAN.’09 (PDd01)      
The awareness of uncomfortable feelings and thoughts triggered by the 
reflective writing/critical thinking lecture, made me question myself whether I 
can succeed in the studies at doctoral level. It was just a feeling at that early 
stage but an uncomfortable one at that. This was a low moment for me (Figure 
6.2 arrow [a]) about three weeks into the study of this unit haven started this 
course with high hopes of succeeding. I later on read a review of the NHS 
Knowledge and Skills Framework (NHS KSF) (Standards of proficiency - 
Biomedical scientists, 2012). It discussed the relevance of the Government’s 
aim to achieve strong and educated workforce in the NHS and this also 
generated further impetus for my personal development. It helped me to set and 
work on one of the principal objectives of the unit, PDd01, which was to 
identify, manage, and demonstrate a reflective and self critical approach to the 
application of learning to one’s professional practice. The PDd01 unit was 
completed on 23rd January, 2009 and by that time my satisfaction level was 
rising again from the decline it suffered earlier on when the unit started (Figure 
6.2).  
FEB.’09 – JUL.’09 (PDd02)  
The Advanced Research Technique (ART) unit, PDd02, began with an 
assessment of research skills. The areas of low confidence levels for me were 
e.g. the search for research papers online. This was resolved with formal 
lectures and the online studies. I also undertook an Epigeum course on project 
management and I completed it successfully. These courses together with the 
appraisal of quantitative and qualitative research exercises and the statistics 
course helped me a great deal to put my research guide exercise for this unit 
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together successfully. I was one of the only two people who passed the first 
time without re-submitting it. My satisfaction level was on the ascendency 
during the course of this unit. This satisfaction was also bolstered by the 
identification of a service improvement audit at my work place. With the help of 
other staff members, I successfully carried out this audit to justify the need to 
bring in a new diagnostic test for the diagnosis of microsporidial parasites. 
NOV.’09 – APR.’10 (PDd03) 
I have enjoyed the course so far and the graph was on the ascendency 
throughout the ART/PDd02 unit (Figure 6.2 arrow [b]) to the middle of the 
Publication and Dissemination (PDd03) unit when my level of satisfaction 
dipped again (Figure 6.2 arrow [c]) because an article I wrote as a class exercise 
was improperly handled by a colleague who peer reviewed it. I am happy to 
report that the article was subsequently reviewed by two experienced work 
colleagues and has since been accepted and published by the Journal of Clinical 
Pathology. This was the article (selective testing of β-galactosidase activity) that 
was mentioned above when Atkins and Murphy’s 1994 model of reflection was 
illustrated. My level of satisfaction rose again when the article was accepted for 
publication (Figure 6.2 arrow[d]).  
APR.’10 – JUL.’11 (PDd04) 
My satisfaction level has continued to rise. The latest addition to that was 
the passing of my project proposal (PDd04) at the first attempt without re-
submission. The above are the salient events/key features as I have been on the 
course so far. I will now proceed to analyze these events. 
Analyse feelings and knowledge relevant to the situation: 
The Part One studies has been a thorough and worthwhile experience for 
me. I have acquired thinking, writing, and presentation skills that are 
fundamentally important for this level of academia/professional life. What is 
even more exciting for me is that these skills have all been used in the studying 
and application of the advanced research techniques unit (PDd02).  Ultimate 
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learning was acquired through exposure and by actually practicing the use of 
these skills in real life scenarios. This brings into focus Kolb’s experiential 
learning theory. Kolb defines learning as  “The process whereby knowledge is 
created through the transformation of experience”(Kolb, 1984). Kolb’s 
experiential learning theory is a holistic perspective that combines experience, 
perception, cognition, and behaviour. The theory presents a cyclical model of 
learning, consisting of four stages: Concrete experience (DO), reflective 
observation (OBSERVE), abstract conceptualization (THINK) and active 
experimentation (PLAN). Any of the stages can be a potential starting point for 
the cycle (Figure 6.3).  
.  
Looking at the big picture, my concrete experience began when I did 
enrol on this course and through the reflective writing/critical thinking lectures I 
observed the importance of this area of study and used it to think back in my 
professional life and also think ahead into the future. Specifically in the area of 
publication and dissemination I became acutely aware of the need to publish. I 
put a plan together and wrote an article for publication. The learning experience 
has been holistic and exciting and in every sense beneficial to my professional 
life. Kolb also identified four learning styles which correspond to these stages. 
The styles highlight conditions under which learners learn better. These styles 
are: assimilators, who learn better when presented with sound logical theories to 
consider; convergers, who learn better when provided with practical 
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applications of concepts and theories; accommodators, who learn better when 
provided with “hands-on” experiences; and divergers, who learn better when 
observing and collecting a wide range of information. As much as I agree with 
the sentiments of Kolb’s experiential learning cycle, I find it difficult to 
comprehend how these four learning styles could be compartmentalised in one’s 
experiences. For me, I can identify with all four styles at one time or another in 
life/professional experiences.  
Evaluate the relevance of knowledge: 
Learning is a major process of human adaptation to new situations and 
throughout this course, it has entailed a great deal of sacrifice and self discipline 
in the midst of life’s challenges. The endurance of any building enterprise, 
including that of life, relies very much on the strength of its foundation and life 
experiences. These experiences could arise from a personal study project or a 
totally unplanned occurrence in daily life (Boud, Keogh, & Walker, 1985). It 
could be initiated by an external or personal interest and will have smaller 
experiences involved, a kind of a wheel in a wheel effect. 
Identify any learning which has occurred: 
The learning which has occurred now is the acquisition of reflective 
writing and critical thinking skills, presentation skills, oral as well as written, 
publication and dissemination skills, and advanced research techniques for 
searching for and using information. 
Action/New experience: 
As a consequence of the learning which has occurred, the new experience 
of a leadership role is beckoning and I think will be demanded on successful 
completion of this course. This will be the potential new experience that re-
starts the model of reflection. 
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6.3 What has the Professional Doctorate done for me? 
As I reflect on my experiences, I am profoundly amazed at the depth of 
understanding that I have acquired in my professional life as a result of 
embarking on this programme of studies. I am confident that I have displayed 
originality in using my knowledge base and methods of inquiry in practice and 
hence have addressed the specific learning outcome which requires students to 
instigate theory of quantitative research methodologies with professional 
expertise to propose strategies to solve problems relevant to health. 
In the process, I have developed some contacts at the LSHTM and through 
networking have progressed in my professional and academic development.  
One significant improvement since I have been on this course is in the 
area of publishing. I had no experience at all in publishing when I enrolled on 
this course and since the publication and dissemination unit, I have authored 
and published a paper and have also been co-author of two other articles also 
published. I have also reviewed two articles submitted for publication in the 
Journal of Clinical Pathology. All these publication activities (listed below) 
together with reflective practice have enabled me to be a confident practitioner, 
able to help trainee biomedical scientists to develop these skills as well. 
Publications activities 
1. First author: 
Published  
Boadi, S., Wren, M. W., & Morris-Jones, S. (2010). Selective testing of ß- 
galactosidase activity in the laboratory identification of Salmonella and Shigella  
species. J Clin Pathol, 63(12), 1101-1104. 
2.  Second author: 
Published  
Polley, S. D., Boadi, S., Watson, J., Curry, A., & Chiodini, P. L. (2011).  
Detection and species identification of microsporidial infections using SYBR  
Green real-time PCR. J Med Microbiol, 60(Pt 4), 459-466. 
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3.  Co-author: 
Published Open Access Research 
Roberts, C. H., Armstrong, M., Zatyka, E., Boadi, S., Warren, S., Chiodini, P.  
L., et al. (2013). Gametocyte carriage in Plasmodium falciparum-infected  
travellers. Malar J, 12(1), 31. 
 
4. Reviewer: 
a. Reviewer of manuscript # jclinpath-2011-200127 entitled "When  
histopathology is not needed:  Macroscopic identification of botfly  
Dermatobium hominis) infection." for Journal of Clinical Pathology. 
 
b. Reviewer of manuscript # jclinpath-2011-200403 entitled "Forgotten 
opportunistic parasitoses emerging in patients receiving alemtuzumab" 
for Journal of Clinical Pathology. Published on 3/11/2011 as: “Two cases 
of opportunistic parasite infections in patients receiving alemtuzumab” 
 
Not only in the area of diagnostics did I experience advancement but also 
I gained a modicum of business acumen during my project work. I 
communicated with customer services of the manufacturer’s of the items I used 
in my project and by that have gained more experience in my communication 
skills. Putting together the business plan was a new experience and I had to 
learn new terminologies used in the business world (e.g. direct cost and labour 
cost). 
6.4 What has learning been for me? 
Learning for me has been experiential, the equipping and the application 
of knowledge refined through dialogue and networking with other professionals. 
The Advanced Research Technique unit enabled me to put together a research 
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guide and my project proposal. The Publication and Dissemination unit enabled 
me to publish work done. Reflective practicing and critical thinking enabled me 
to review my work and make the necessary changes that ushered in progress. 
All together, the professional doctorate course has given me the tools I need for 
advancement in my career and life in general. Albert Einstein has been credited 
with the saying: "Insanity is doing the same thing, over and over again, but 
expecting different results". As I draw to a close, five years of new experiences 
in my life, I can say that the truth of Albert’s statement resonates with my life. I 
am not where I hope to be yet, but I can truly say that I am not where I used to 
be.  
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